<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="EN" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Appl Bio Mater</journal-id><journal-id journal-id-type="iso-abbrev">ACS Appl Bio Mater</journal-id><journal-id journal-id-type="pmc-domain-id">822</journal-id><journal-id journal-id-type="pmc-domain">acssd</journal-id><journal-id journal-id-type="publisher-id">mt</journal-id><journal-title-group><journal-title>ACS Applied Bio Materials</journal-title></journal-title-group><issn pub-type="epub">2576-6422</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>ACS AuthorChoice</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10354806</article-id><article-id pub-id-type="pmcid-ver">PMC10354806.1</article-id><article-id pub-id-type="pmcaid">10354806</article-id><article-id pub-id-type="pmcaiid">10354806</article-id><article-id pub-id-type="pmid">37310896</article-id><article-id pub-id-type="doi">10.1021/acsabm.3c00108</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group><subject>Review</subject></subj-group></article-categories><title-group><article-title>The Diamond Concept
Enigma: Recent Trends of Its Implementation
in Cross-linked Chitosan-Based Scaffolds for Bone Tissue Engineering</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2689-0991</contrib-id><name name-style="western"><surname>Agnes</surname><given-names initials="CJ">Celine
J.</given-names></name><xref rid="aff1" ref-type="aff">&#8224;</xref><xref rid="aff2" ref-type="aff">&#8225;</xref></contrib><contrib contrib-type="author" id="ath2"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0657-7746</contrib-id><name name-style="western"><surname>Karoichan</surname><given-names initials="A">Antoine</given-names></name><xref rid="aff2" ref-type="aff">&#8225;</xref><xref rid="aff3" ref-type="aff">&#167;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath3"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5050-4480</contrib-id><name name-style="western"><surname>Tabrizian</surname><given-names initials="M">Maryam</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#8224;</xref><xref rid="aff3" ref-type="aff">&#167;</xref></contrib><aff id="aff1"><label>&#8224;</label>Department
of Biomedical Engineering, <institution>McGill University</institution>, Montreal, Quebec H3A 2B4, <country>Canada</country></aff><aff id="aff2"><label>&#8225;</label><institution>Shriner&#8217;s
Hospital for Children</institution>, Montreal, Quebec H4A 0A9 <country>Canada</country></aff><aff id="aff3"><label>&#167;</label>Faculty
of Dental Medicine and Oral Health Sciences, <institution>McGill University</institution>, Montreal, Quebec H3A 1G1 <country>Canada</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>maryam.tabrizian@mcgill.ca</email>. Phone: <phone>514-398-8129</phone>. Fax: <fax>514-398-7461</fax>.</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>06</month><year>2023</year></pub-date><pub-date pub-type="collection"><day>17</day><month>07</month><year>2023</year></pub-date><volume>6</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">440986</issue-id><fpage>2515</fpage><lpage>2545</lpage><history><date date-type="received"><day>08</day><month>02</month><year>2023</year></date><date date-type="accepted"><day>30</day><month>04</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>20</day><month>07</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-07-20 10:25:09.490"><day>20</day><month>07</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="mt3c00108.pdf"/><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="ab-d33e161" position="float" orientation="portrait" xlink:href="mt3c00108_0016.jpg"/></p><p>An increasing number of publications over the past ten
years have
focused on the development of chitosan-based cross-linked scaffolds
to regenerate bone tissue. The design of biomaterials for bone tissue
engineering applications relies heavily on the ideals set forth by
a polytherapy approach called the &#8220;Diamond Concept&#8221;.
This methodology takes into consideration the mechanical environment,
scaffold properties, osteogenic and angiogenic potential of cells,
and benefits of osteoinductive mediator encapsulation. The following
review presents a comprehensive summarization of recent trends in
chitosan-based cross-linked scaffold development within the scope
of the Diamond Concept, particularly for nonload-bearing bone repair.
A standardized methodology for material characterization, along with
assessment of <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> potential for bone regeneration, is presented based on approaches
in the literature, and future directions of the field are discussed.</p></abstract><kwd-group><kwd>Chitosan-Based Scaffolds</kwd><kwd>Bone Tissue Engineering</kwd><kwd>Diamond Concept</kwd><kwd>Cross-linking</kwd><kwd>Osteogenic
Cells</kwd><kwd>Growth Factors</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>Canadian Institutes of Health Research</institution><institution-id institution-id-type="doi">10.13039/501100000024</institution-id></institution-wrap></funding-source><award-id>CIHR PJT-162413</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Canada Research Chairs</institution><institution-id institution-id-type="doi">10.13039/501100001804</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Fonds de Recherche du Qu&#195;&#169;bec - Sant&#195;&#169;</institution><institution-id institution-id-type="doi">10.13039/501100000156</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Natural Sciences and Engineering Research Council of Canada</institution><institution-id institution-id-type="doi">10.13039/501100000038</institution-id></institution-wrap></funding-source><award-id>NSERC CHRPJ 538864-19</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC-ND</meta-value></custom-meta><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>mt3c00108</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>mt3c00108</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Advancement of the bone
tissue engineering field in recent years
has opened new potentials for the design of alternative treatments
of various orthopedic conditions. Naturally, bone tissue relies on
its self-healing capabilities through direct or indirect healing,
but this can be hindered following severe traumas or other underlying
conditions.<sup><xref ref-type="bibr" rid="ref1">1</xref>&#8722;<xref ref-type="bibr" rid="ref3">3</xref></sup> Current conventional bone graft treatments, while
advantageous in some respects, present many limitations including
invasiveness, donor site morbidity, limited graft volume, and long
hospitalization times.<sup><xref ref-type="bibr" rid="ref4">4</xref>&#8722;<xref ref-type="bibr" rid="ref10">10</xref></sup></p><p>Interest has since shifted to the design and implementation
of
tissue engineered substitutes. These designs focus on targeting the
regeneration of native tissue both at the structural and functional
level using a complex polytherapy approach called the &#8220;Diamond
Concept&#8221;.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref11">11</xref>&#8722;<xref ref-type="bibr" rid="ref13">13</xref></sup> This design
framework established by Giannoudis <italic toggle="yes">et al.</italic> provides
a guideline for the minimal requirements needed for efficient bone
healing: osteoconductive scaffolds, osteogenic and angiogenic cells,
osteoinductive mediators, and a suitable mechanical environment<sup><xref ref-type="bibr" rid="ref9">9</xref>&#8722;<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref14">14</xref>&#8722;<xref ref-type="bibr" rid="ref16">16</xref></sup> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A).</p><fig id="fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Comprehensive overview
of the literature review presented in this
manuscript. (A) &#8220;Diamond Concept&#8221; for Bone Regeneration,
which encompasses an osteoconductive scaffold, osteogenic cells, osteoinductive
mediators, and vascularization in a suitable mechanical environment.
This builds the foundation for the organization of the review. (B)
Increasing number of publications within the chitosan-based cross-linked
scaffold/hydrogel domain for bone tissue engineering applications
in the last 20 years. (C) The review&#8217;s novelty within the combined
domain of chitosan based cross-linked hydrogel/scaffolds for bone
tissue engineering applications implementing the Diamond Concept.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr2" position="float" orientation="portrait" xlink:href="mt3c00108_0001.jpg"/></fig><p>Each component within this approach plays a critical
role in the
overall ability of the biological substitute for bone healing and
regeneration.<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref17">17</xref>&#8722;<xref ref-type="bibr" rid="ref21">21</xref></sup> The biomaterial scaffold acts as a 3D microenvironment for cells
by providing structural support thereby necessitating similarities
in mechanical properties between a chosen biomaterial and native tissue
environment. In terms of bone regeneration, the scaffold needs to
have a sufficiently high mechanical strength,<sup><xref ref-type="bibr" rid="ref22">22</xref>&#8722;<xref ref-type="bibr" rid="ref24">24</xref></sup> in addition
to a biodegradation rate similar to that of new bone tissue formation.<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref25">25</xref>&#8722;<xref ref-type="bibr" rid="ref30">30</xref></sup> The architecture of the scaffold should be porous to allow for cellular
migration and vascular network infiltration.<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup></p><p>Incorporation of cells is also necessary since cells are responsible
for the secretion of the extracellular matrix along with different
growth factors and cytokines involved in tissue healing.<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> For bone applications, this aspect often encompasses osteoblast
lineage cells such as preosteoblasts since they are already lineage
committed and require less effort in differentiation processes.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup> More recent work has also focused on the usage of mesenchymal stem
cells with subsequent differentiation once encapsulated in the scaffold.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup> Finally, osteoinductive mediators such as bone morphogenetic proteins
2, 4, and 7 (BMP2, 4, 7) are a crucial consideration as their incorporation
aids in developing the scaffold into an optimal environment for cell
growth, differentiation, and new tissue formation.<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref36">36</xref>&#8722;<xref ref-type="bibr" rid="ref42">42</xref></sup> While the three previously discussed components make up the tissue
engineering triad for the regeneration of many tissues, vascularization
and mechanical environment are specific considerations for bone applications.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> These are added due to the complex nature of
bone tissue thereby necessitating a more complex design approach.</p><p>Polymers represent the largest class of biomaterials investigated
for various biomedical and tissue engineering purposes. These chains
of repeating monomers can be sourced naturally such as chitosan, alginate,
and collagen or fabricated synthetically like poly(glycolic acid)
(PGA), poly(lactic-<italic toggle="yes">co</italic>-glycolic acid) (PLGA), and
poly(methyl methacrylate) (PMMA), among many others.<sup><xref ref-type="bibr" rid="ref44">44</xref>&#8722;<xref ref-type="bibr" rid="ref47">47</xref></sup> As evidenced throughout the literature, chitosan is among the most
widely investigated polymers for the design of ideal scaffolds for
bone tissue engineering.<sup><xref ref-type="bibr" rid="ref44">44</xref>&#8722;<xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref48">48</xref></sup> Its usage is often compounded with a physical or chemical cross-linker,
which serves to improve material properties such as compressive strength,
elastic modulus, degradation rate, structural stability, and architecture.<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref48">48</xref>&#8722;<xref ref-type="bibr" rid="ref51">51</xref></sup> The implementation of cross-linking for chitosan-based scaffolds
in bone applications has continued to become more popular in literature
studies, thus requiring a more thorough investigation of its demonstrated
benefits (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B).</p><p>In the scope of this review, we aim to provide in-depth comparisons
of material and osteogenic properties for chitosan-based cross-linked
scaffolds within the ideals of the Diamond Concept for bone tissue
engineering of nonload bearing tissues. Each subcategory of the Diamond
Concept will be discussed according to the most recent advances in
that component. This literature review is to our knowledge the first
of its kind to review the design of chitosan based cross-linked scaffolds
for bone in this manner (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C). To accomplish this, a literature search was conducted
using the SCOPUS database with keywords: chitosan, cross-linked, and
bone, and resulting articles were further screened for availability
and intended application (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>).</p><fig id="fig2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Results of literature search conducted for this manuscript.
The
search was performed using the keywords: Chitosan, Crosslinked (or
Cross-linked), Bone, and Scaffold or Hydrogels. These results were
also limited to publications from the last ten years and written in
the English language. From this search, 188 articles were found to
be suitable and screened further to examine the specific target of
the study.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr3" position="float" orientation="portrait" xlink:href="mt3c00108_0002.jpg"/></fig><p>Although the need for assessment of scaffold material
properties
and bone regenerative capabilities is evident in many studies found
in the literature, no clear set standardized methodology has been
presented in the literature for bone applications. Thus, our additional
goal of this review is to highlight the most popular methods of experimental
testing to drive the construction of a more standardized methodology
in the development of biomaterial substitutes for bone.</p></sec><sec id="sec2"><label>2</label><title>Chitosan as a Biomaterial</title><p>Among the
various polymers available for scaffold fabrication,
chitosan remains one of the most attractive biomaterials in the field
due to various desirable inherent properties such as excellent biocompatibility
and biodegradability, antibacterial properties, as well as its mucoadhesive
nature and versatility for further chemical and physical modification.<sup><xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref53">53</xref></sup> Chitosan is derived from chitin
through the deacetylation of N-acetylglucosamine residues into N-glucosamines
following treatment with an alkaline compound. Similarities in structure
between the attained chitosan and glycosaminoglycans found in the
extracellular matrix provide chitosan biomaterials with the ability
to interact well with cells.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> Numerous
studies have demonstrated the material&#8217;s potential for bone
applications since it can support the proliferation and adhesion of
osteoblastic lineage cells as well as mesenchymal stem cells.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> Further to this benefit, the wide abundance of chitin in nature
designates chitosan as an accessible and cost-effective biomaterial
for use in many different applications including both tissue engineering
and pharmaceuticals.<sup><xref ref-type="bibr" rid="ref53">53</xref></sup></p><p>The physicochemical
and biological properties of chitosan are largely
influenced by its degree of deacetylation, which is defined by the
percentage of N-glucosamine residues formed.<sup><xref ref-type="bibr" rid="ref55">55</xref>,<xref ref-type="bibr" rid="ref56">56</xref></sup> Degree of deacetylation (DD) of commercially available chitosan
can vary from low (&lt;50%) to full deacetylation (100%), but many
studies have shown that a higher DD is favorable in bone tissue regeneration.<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> These newly formed amine groups allow for chitosan
to become soluble under dilute acidic conditions, which yields the
advantage of fabricating minimally invasive, injectable chitosan-based
scaffolds. Use of chitosan with a higher DD often correlates with
higher solubility and offers more protonated sites that can be exploited
to modify the chitosan chains or complex them with other biomaterials,
lipids, proteins, and genetic material for a wide range of therapeutic
applications.<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> These chemical modifications
of chitosan solutions such as quaternized, carboxyalkyl, and thiolated
chitosan have more recently emerged as additional options for base
materials in designed bone regenerative scaffolds since they aid in
attaining more optimal material properties.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup></p></sec><sec id="sec3"><label>3</label><title>Cross-linking for Chitosan Scaffolds</title><p>Although chitosan possesses many beneficial properties for consideration
as a biomaterial substitute, previous literature has shown insufficiencies
in certain parameters of the material needed to achieve optimal bone
healing.<sup><xref ref-type="bibr" rid="ref58">58</xref>&#8722;<xref ref-type="bibr" rid="ref60">60</xref></sup> For instance, chitosan lacks the necessary mechanical
strength for bone related applications and exhibits issues with stability
and control of biodegradation rates.<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref48">48</xref>&#8722;<xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref61">61</xref>,<xref ref-type="bibr" rid="ref62">62</xref></sup> To overcome these limitations, the addition of small molecule cross-linkers
is explored to improve chitosan&#8217;s capability for healing.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> Particularly, in recent years, cross-linking
of chitosan has become a popular trend allowing for not only the development
of chitosan scaffolds with optimal properties but also the development
of composite scaffolds through cross-linking with other materials
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p><table-wrap id="tbl1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Common Cross-linkers for Chitosan-Based
Scaffolds in the Literature</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">Scaffolds</th><th style="border:none;" align="center" colspan="1" rowspan="1">Method of
Cross-linking</th><th style="border:none;" align="center" colspan="1" rowspan="1">Cross-linkers
Used</th><th style="border:none;" align="center" colspan="1" rowspan="1">Influence
of Cross-linking on Mechanical/Rheological Properties</th></tr></thead><tbody><tr><td rowspan="13" style="border:none;" align="left" valign="middle" colspan="1">Chitosan</td><td rowspan="7" style="border:none;" align="left" valign="middle" colspan="1">Chemical cross-link &#8211; Covalent
bonding</td><td style="border:none;" align="left" colspan="1" rowspan="1">EDC/NHS<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref></sup></td><td rowspan="7" style="border:none;" align="left" colspan="1">Increased Young&#8217;s
modulus for chitosan scaffolds with <bold>vanillin</bold> (and bioglass)
compared to chitosan scaffold.<sup><xref ref-type="bibr" rid="ref79">79</xref></sup> Increased
resistance to compression for <bold>glutaraldehyde</bold> cross-linked
scaffolds compared to uncross-linked scaffolds, concentration dependent
increase in strength for the cross-linker.<sup><xref ref-type="bibr" rid="ref81">81</xref></sup> No significant difference in Young&#8217;s modulus with different <bold>genipin</bold> concentrations (0.25 and 0.5 M final concentration)
under compression.<sup><xref ref-type="bibr" rid="ref500">500</xref></sup> Increased stiffness
for cross-linked scaffold with <bold>genipin</bold> compared to chitosan
scaffold<sup><xref ref-type="bibr" rid="ref73">73</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Genipin<sup><xref ref-type="bibr" rid="ref66">66</xref>&#8722;<xref ref-type="bibr" rid="ref78">78</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Vanillin<sup><xref ref-type="bibr" rid="ref500">500</xref>,<xref ref-type="bibr" rid="ref79">79</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Glutaraldehyde<sup><xref ref-type="bibr" rid="ref80">80</xref>&#8722;<xref ref-type="bibr" rid="ref83">83</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Schiff&#160;base&#160;reaction<sup><xref ref-type="bibr" rid="ref84">84</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Hexamethylene-1,6-diaminocarboxysulfonate&#160;(HDACS)<sup><xref ref-type="bibr" rid="ref74">74</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Citric&#160;acid<sup><xref ref-type="bibr" rid="ref85">85</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td rowspan="5" style="border:none;" align="left" valign="middle" colspan="1">Physical cross-link &#8211; Other bonding</td><td style="border:none;" align="left" colspan="1" rowspan="1">Purines&#160;&#8211;&#160;Guanosine&#160;Diphosphate<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref86">86</xref>&#8722;<xref ref-type="bibr" rid="ref89">89</xref></sup></td><td rowspan="5" style="border:none;" align="left" colspan="1">Increased compressive
modulus with increasing concentrations of <bold>TPP</bold> in scaffolds.<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> Increased compressive strength with <bold>TPP</bold> cross-linking compared to uncross-linked scaffolds.<sup><xref ref-type="bibr" rid="ref94">94</xref></sup> Increased stiffness for cross-linked scaffold with <bold>pectin</bold> compared to chitosan scaffold<sup><xref ref-type="bibr" rid="ref73">73</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#946;-Glycerophosphate<sup><xref ref-type="bibr" rid="ref84">84</xref>,<xref ref-type="bibr" rid="ref90">90</xref>&#8722;<xref ref-type="bibr" rid="ref92">92</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Tripoly&#160;phosphate&#160;(TPP)<sup><xref ref-type="bibr" rid="ref93">93</xref>&#8722;<xref ref-type="bibr" rid="ref98">98</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Copper<sup><xref ref-type="bibr" rid="ref99">99</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Pectin<sup><xref ref-type="bibr" rid="ref73">73</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td rowspan="17" style="border:none;" align="left" valign="middle" colspan="1">Chitosan-composite</td><td rowspan="9" style="border:none;" align="left" valign="middle" colspan="1">Chemical cross-link &#8211; Covalent bonding</td><td style="border:none;" align="left" colspan="1" rowspan="1">EDC/NHS<sup><xref ref-type="bibr" rid="ref100">100</xref>&#8722;<xref ref-type="bibr" rid="ref102">102</xref></sup></td><td rowspan="9" style="border:none;" align="left" colspan="1">Increased elastic
and loss Modulus with increasing DF-P1000 cross-linker concentration
(<bold>Schiff Base</bold> and <bold>EDC</bold> dual cross-linking).<sup><xref ref-type="bibr" rid="ref100">100</xref></sup> Increased modulus and compressive strength
with cross-linking using <bold>glutaraldehyde</bold> (increasing concentrations
and soaking time).<sup><xref ref-type="bibr" rid="ref108">108</xref></sup> Increase in compressive
strength for cross-linked scaffolds with <bold>glutaraldehyde</bold> alone or in combination with <bold>calcium cations</bold>. (<xref ref-type="bibr" rid="ref110">110</xref>) Increased compression modulus with <bold>genipin</bold> cross-linking (also with graphene oxide addition).<sup><xref ref-type="bibr" rid="ref120">120</xref></sup> Increase in compressive strength with <bold>glyoxal</bold> cross-linking compared to uncross-linked scaffolds.<sup><xref ref-type="bibr" rid="ref106">106</xref></sup> Increased compressive strength with increasing
concentration of inorganic phase (<bold>GPTMS</bold>)<sup><xref ref-type="bibr" rid="ref131">131</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Schiff&#160;base&#160;reaction<sup><xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref103">103</xref>&#8722;<xref ref-type="bibr" rid="ref105">105</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Glyoxal<sup><xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref107">107</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Glutaraldehyde<sup><xref ref-type="bibr" rid="ref108">108</xref>&#8722;<xref ref-type="bibr" rid="ref116">116</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Genipin<sup><xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref117">117</xref>&#8722;<xref ref-type="bibr" rid="ref129">129</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">N&#8242;-Methylene&#160;bis(acrylamide)<sup><xref ref-type="bibr" rid="ref130">130</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">3-Glycidoxypropyl&#160;trimethoxysilane&#160;(GPTMS)<sup><xref ref-type="bibr" rid="ref131">131</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">2-Hydroxyethyl&#160;methacrylate&#160;(HEMA)<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Hexamethylene&#160;diisocyanate&#160;(HDI)<sup><xref ref-type="bibr" rid="ref132">132</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td rowspan="7" style="border:none;" align="left" valign="middle" colspan="1">Physical cross-link
&#8211; Other bonding</td><td style="border:none;" align="left" colspan="1" rowspan="1">Tripoly&#160;phosphate&#160;(TPP)<sup><xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref133">133</xref>&#8722;<xref ref-type="bibr" rid="ref135">135</xref></sup></td><td rowspan="7" style="border:none;" align="left" colspan="1">Decreasing
compressive strength with lemon grass oil addition due to decreased H-bonding potential of <bold>HPMC</bold>.<sup><xref ref-type="bibr" rid="ref136">136</xref></sup> Increase in compressive strength with addition
of <bold>calcium cations</bold> as cross-linker compared to uncross-linked
scaffolds.<sup><xref ref-type="bibr" rid="ref110">110</xref></sup> Increased elastic modulus
(<italic toggle="yes">G</italic>&#8242;) in scaffold with <bold>Mg</bold><sup><bold>2+</bold></sup><bold>ions</bold> and BMP due to increased
cross-linking density.<sup><xref ref-type="bibr" rid="ref130">130</xref></sup> Increased compressive
strength for <bold>DHT treated</bold> scaffolds compared to <bold>IR treated</bold>, <bold>glutaraldehyde</bold>, and <bold>HEMA</bold> cross-linked<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Hydroxypropyl&#160;methyl&#160;cellulose&#160;(HPMC)<sup><xref ref-type="bibr" rid="ref136">136</xref>,<xref ref-type="bibr" rid="ref137">137</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Calcium&#160;cations<sup><xref ref-type="bibr" rid="ref110">110</xref>,<xref ref-type="bibr" rid="ref113">113</xref>,<xref ref-type="bibr" rid="ref138">138</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Mg<sup>2+</sup>&#160;ions<sup><xref ref-type="bibr" rid="ref130">130</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Dehydrothermal&#160;(DHT)&#160;Treatment<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Irradiation&#160;treatment<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Cu<sup>2+</sup>&#160;ions<sup><xref ref-type="bibr" rid="ref139">139</xref></sup></td></tr></tbody></table></table-wrap><p>Various studies in the literature have examined the
use of cross-linkers
including genipin, glutaraldehyde, and sodium tripolyphosphate as
means to ensure stability within the polymer network.<sup><xref ref-type="bibr" rid="ref48">48</xref>&#8722;<xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref63">63</xref></sup> The incorporation of these cross-linkers
relies on physical or chemical means through bonding to the polymer&#8217;s
functional groups either by covalent bonding or supramolecular interactions.<sup><xref ref-type="bibr" rid="ref58">58</xref>,<xref ref-type="bibr" rid="ref60">60</xref></sup> With respect to chitosan, this bonding often implements its amine
groups, which can form a bond to hydroxyl groups.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup></p><p>As discussed previously, this cross-linking can be
further improved
in chitosan through modifications of the polymer backbone by methacrylate
or substitution of carboxymethyl derivatives.<sup><xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref141">141</xref></sup> While physical methods of cross-linking
including UV or gamma irradiation treatments tend to allow for a reversible
process in certain pH and temperature environments, the use of chemical
treatments for cross-linking is more commonly found in regenerative
medicine applications.<sup><xref ref-type="bibr" rid="ref59">59</xref>,<xref ref-type="bibr" rid="ref62">62</xref>,<xref ref-type="bibr" rid="ref63">63</xref>,<xref ref-type="bibr" rid="ref142">142</xref></sup> Treatment with chemical reagents has been
shown to result in a higher degree of cross-linking and formation
of a permanent network rather than a reversible one.<sup><xref ref-type="bibr" rid="ref60">60</xref>,<xref ref-type="bibr" rid="ref62">62</xref></sup></p><p>In the selection of a cross-linker for chitosan, many factors
need
to be considered including the intended use of the scaffold and the
properties of the cross-linking agent itself. For tissue engineering
applications, the cross-linking agent must not induce an immunogenic
effect and should not affect cell and material interactions.<sup><xref ref-type="bibr" rid="ref58">58</xref>&#8722;<xref ref-type="bibr" rid="ref60">60</xref></sup> Within the chemical domain, glutaraldehyde and genipin are the most
used cross-linkers for chitosan-based scaffold applications since
their beneficial abilities have been well-documented in the literature.<sup><xref ref-type="bibr" rid="ref63">63</xref></sup> However, the toxicity of the functional aldehyde
group of glutaraldehyde has resulted in its limited usage in commercial
products.<sup><xref ref-type="bibr" rid="ref58">58</xref>,<xref ref-type="bibr" rid="ref60">60</xref></sup> Conversely, genipin has been shown to be
less cytotoxic, as it stems from natural roots.<sup><xref ref-type="bibr" rid="ref58">58</xref>,<xref ref-type="bibr" rid="ref60">60</xref>,<xref ref-type="bibr" rid="ref63">63</xref></sup></p><sec id="sec3.1"><label>3.1</label><title>Methodology for Material Property Studies
of Chitosan-Based Scaffolds</title><p>Addition of a cross-linking agent
to scaffolds is expected to have significant effects with regards
to material properties including degradation rate, structural architecture,
and mechanical properties. This notion thus requires further testing
of non-cross-linked and cross-linked materials for comparison to attain
a more thorough understanding of its effects (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>, <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). Within recent literature, 91% of material property
studies are shown to include some form of evaluation of structural
architecture, 71% show an examination of mechanical properties, and
54% look at biodegradation mechanisms.</p><fig id="fig3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Material properties to
consider following cross-linking of chitosan
scaffolds. Each property is presented with common methodology for
testing found in the literature.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr4" position="float" orientation="portrait" xlink:href="mt3c00108_0003.jpg"/></fig><table-wrap id="tbl2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Common Methodologies for Material
Property Testing in Chitosan Cross-linked Scaffolds for Bone (<italic toggle="yes">N</italic> = 100)</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">Material
Properties</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Incorporation
in Property Studies (%)</th><th style="border:none;" align="center" colspan="1" rowspan="1">Methodology</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Method Usage
in Specific Property (%)</th><th style="border:none;" align="center" colspan="1" rowspan="1">Information
Obtained</th></tr></thead><tbody><tr><td rowspan="7" style="border:none;" align="left" colspan="1">Mechanical
properties</td><td rowspan="7" style="border:none;" align="char" char="." colspan="1">71%</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Compression
testing</bold>(<xref ref-type="bibr" rid="ref64">64</xref>&#8722;<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref72">72</xref>,<xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref76">76</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref91">91</xref>,<xref ref-type="bibr" rid="ref93">93</xref>&#8722;<xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref97">97</xref>,<xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref101">101</xref>&#8722;<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref105">105</xref>&#8722;<xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref114">114</xref>&#8722;<xref ref-type="bibr" rid="ref117">117</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref131">131</xref>&#8722;<xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref141">141</xref>,<xref ref-type="bibr" rid="ref143">143</xref>&#8722;<xref ref-type="bibr" rid="ref160">160</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>87.3%</bold></td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Compressive
strength,
Young&#8217;s modulus</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Dynamic mechanical analyzer<sup><xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref138">138</xref>,<xref ref-type="bibr" rid="ref161">161</xref>&#8722;<xref ref-type="bibr" rid="ref163">163</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">8.4%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Creep and recovery properties</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Tensile testing<sup><xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref164">164</xref>&#8722;<xref ref-type="bibr" rid="ref166">166</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">5.6%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Tensile strength, Tensile
strain</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Nanoindentation testing<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref119">119</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">4.2%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Nanomechanical properties</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Atomic force
microscopy<sup><xref ref-type="bibr" rid="ref79">79</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.4%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Young&#8217;s modulus of
hydrated samples</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Hardness testing<sup><xref ref-type="bibr" rid="ref97">97</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.4%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Hardness of material</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Flexural strength testing<sup><xref ref-type="bibr" rid="ref83">83</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.4%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Flexural strength</td></tr><tr><td rowspan="3" style="border:none;" align="left" colspan="1">Rheological
properties</td><td rowspan="3" style="border:none;" align="char" char="." colspan="1">28%</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Frequency
sweep</bold>(<xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref89">89</xref>,<xref ref-type="bibr" rid="ref92">92</xref>,<xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref104">104</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref134">134</xref>,<xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref147">147</xref>,<xref ref-type="bibr" rid="ref149">149</xref>,<xref ref-type="bibr" rid="ref158">158</xref>,<xref ref-type="bibr" rid="ref167">167</xref>,<xref ref-type="bibr" rid="ref168">168</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>64.3%</bold></td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Storage modulus
(<italic toggle="yes">G</italic>&#8242;) and Loss modulus (<italic toggle="yes">G</italic>&#8242;&#8242;)
with angular frequency</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Strain sweep<sup><xref ref-type="bibr" rid="ref92">92</xref>,<xref ref-type="bibr" rid="ref104">104</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref118">118</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref125">125</xref>,<xref ref-type="bibr" rid="ref126">126</xref>,<xref ref-type="bibr" rid="ref128">128</xref>,<xref ref-type="bibr" rid="ref168">168</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">35.7%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Storage modulus (<italic toggle="yes">G</italic>&#8242;) and loss modulus (<italic toggle="yes">G</italic>&#8242;&#8242;)
with respect to strain</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Time sweep<sup><xref ref-type="bibr" rid="ref92">92</xref>,<xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref158">158</xref>,<xref ref-type="bibr" rid="ref162">162</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">21.4%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Determination of gelation</td></tr><tr><td rowspan="8" style="border:none;" align="left" colspan="1">Structural
architecture properties</td><td rowspan="8" style="border:none;" align="char" char="." colspan="1">91%</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Scanning electron
microscopy</bold>(<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref64">64</xref>&#8722;<xref ref-type="bibr" rid="ref68">68</xref>,<xref ref-type="bibr" rid="ref70">70</xref>&#8722;<xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref79">79</xref>&#8722;<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref89">89</xref>&#8722;<xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref99">99</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref102">102</xref>,<xref ref-type="bibr" rid="ref104">104</xref>&#8722;<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref114">114</xref>&#8722;<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref124">124</xref>,<xref ref-type="bibr" rid="ref126">126</xref>,<xref ref-type="bibr" rid="ref128">128</xref>&#8722;<xref ref-type="bibr" rid="ref141">141</xref>,<xref ref-type="bibr" rid="ref145">145</xref>&#8722;<xref ref-type="bibr" rid="ref171">171</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>96.7%</bold></td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Morphology
and architecture
of the scaffold, Pore size measurements with ImageJ</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Liquid Displacement<sup><xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref97">97</xref>,<xref ref-type="bibr" rid="ref102">102</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref107">107</xref>,<xref ref-type="bibr" rid="ref109">109</xref>&#8722;<xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref114">114</xref>&#8722;<xref ref-type="bibr" rid="ref116">116</xref>,<xref ref-type="bibr" rid="ref132">132</xref>,<xref ref-type="bibr" rid="ref133">133</xref>,<xref ref-type="bibr" rid="ref136">136</xref>,<xref ref-type="bibr" rid="ref138">138</xref>,<xref ref-type="bibr" rid="ref141">141</xref>,<xref ref-type="bibr" rid="ref148">148</xref>&#8722;<xref ref-type="bibr" rid="ref150">150</xref>,<xref ref-type="bibr" rid="ref152">152</xref>&#8722;<xref ref-type="bibr" rid="ref154">154</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">28.6%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Porosity and density measurement</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">MicroCT imaging<sup><xref ref-type="bibr" rid="ref68">68</xref>,<xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref89">89</xref>,<xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref124">124</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">7.7%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Porosity and interconnectivity</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Mercury porosimeter<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref126">126</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref158">158</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">6.6%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Porosity measurement</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Physisorption analyzer<sup><xref ref-type="bibr" rid="ref117">117</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.1%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Measurement
of specific
surface area and pore structure</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Atomic force microscopy<sup><xref ref-type="bibr" rid="ref65">65</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.1%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Surface structure</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Stereomicroscope<sup><xref ref-type="bibr" rid="ref154">154</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.1%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Surface structure</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Pycnometer<sup><xref ref-type="bibr" rid="ref93">93</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.1%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Bulk volume
of scaffold
to find porosity</td></tr><tr><td rowspan="5" style="border:none;" align="left" colspan="1">Biodegradation
properties</td><td rowspan="5" style="border:none;" align="char" char="." colspan="1">54%</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>In solution
(PBS,
SBF, or water) with additives (lysozymes, muramidase, collagenase
I, etc.)</bold>(<xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref72">72</xref>,<xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref89">89</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref124">124</xref>&#8722;<xref ref-type="bibr" rid="ref126">126</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref136">136</xref>,<xref ref-type="bibr" rid="ref138">138</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref141">141</xref>,<xref ref-type="bibr" rid="ref149">149</xref>,<xref ref-type="bibr" rid="ref155">155</xref>,<xref ref-type="bibr" rid="ref158">158</xref>,<xref ref-type="bibr" rid="ref159">159</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>46.3%</bold></td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Percentage
of degradation,
Weight loss over time</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>In PBS</bold>(<xref ref-type="bibr" rid="ref72">72</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref104">104</xref>,<xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref108">108</xref>&#8722;<xref ref-type="bibr" rid="ref110">110</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref114">114</xref>,<xref ref-type="bibr" rid="ref115">115</xref>,<xref ref-type="bibr" rid="ref125">125</xref>,<xref ref-type="bibr" rid="ref130">130</xref>&#8722;<xref ref-type="bibr" rid="ref132">132</xref>,<xref ref-type="bibr" rid="ref134">134</xref>,<xref ref-type="bibr" rid="ref135">135</xref>,<xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref152">152</xref>,<xref ref-type="bibr" rid="ref155">155</xref>,<xref ref-type="bibr" rid="ref164">164</xref>,<xref ref-type="bibr" rid="ref169">169</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>46.3%</bold></td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Weight remaining
ratio,
Weight loss percentage</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">In simulated body fluid<sup><xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref116">116</xref>,<xref ref-type="bibr" rid="ref133">133</xref>,<xref ref-type="bibr" rid="ref145">145</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">7.4%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Degradation weight</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">In culture media<sup><xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref150">150</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.7%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Degradation rate</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">In water<sup><xref ref-type="bibr" rid="ref157">157</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.8%</td><td style="border:none;" align="left" colspan="1" rowspan="1">Degradation percentage</td></tr></tbody></table></table-wrap><p>With respect to mechanical assessment, the most reported
technique
(87.3%) in the literature is found to be compression testing due to
its ability to closely mimic the experience of bone <italic toggle="yes">in vivo</italic>. This is expected since it is thought to more accurately represent
the material&#8217;s mechanical behavior when placed in the body.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> However, in addition to compressive modulus
and strength, other parameters such as Young&#8217;s modulus, toughness,
fatigue strength, and shear modulus of materials have also been reported
in the literature but to a lesser extent.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref172">172</xref></sup> For derivation
of these parameters, other methodologies are utilized including a
mechanical tester for tensile properties, atomic force microscopy
or nanoindentation for nanoindentation and stiffness, and a dynamic
mechanical analyzer to measure the response of force versus displacement.</p><p>Further mechanical scaffold characterization has focused on examining
the material&#8217;s viscoelastic properties under deformation using
rheology. For chitosan-based scaffolds, literature studies often include
either one or a combination of frequency,<sup><xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref134">134</xref>,<xref ref-type="bibr" rid="ref147">147</xref>,<xref ref-type="bibr" rid="ref149">149</xref>,<xref ref-type="bibr" rid="ref167">167</xref></sup> strain,<sup><xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup> or time sweep<sup><xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref104">104</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref126">126</xref>,<xref ref-type="bibr" rid="ref128">128</xref>,<xref ref-type="bibr" rid="ref168">168</xref></sup> tests, which all provide complementary
information about the material&#8217;s mechanical properties. However,
recent literature has shown a popularity in using frequency sweeps
especially since they can provide information such as the elastic
and loss modulus with respect to angular frequency. These particular
sweeps are performed 64.3% of the time in recent studies, whereas
strain sweeps and time sweeps are performed 35.7% and 21.4% of the
time, respectively.</p><p>With respect to assessment of scaffold morphology
and architecture
changes, scanning electron microscopy (SEM) is considered as the most
popular method with a percentage of usage around 96.4% in recent publications
of the field. This technique is so popular as it allows researchers
to determine the pore size, interconnectivity, and distribution as
well as the distribution of any other added materials within the scaffold.
Furthermore, researchers can also use this technique to observe and
image the surface morphology of the designed material. Other techniques
including liquid displacement (28.6%), Micro CT (7.7%), or porosimeter
usage (6.6%) have also been explored in the literature to a lesser
extent, either alone or in conjunction with SEM, to determine the
percentage of porosity and density. Assessment of biodegradation rate
in the literature generally encompasses weight measurements at multiple
time points after incubation of scaffolds in either PBS alone, with
enzyme solutions, or in media. In the scope of chitosan-based scaffolds,
the effect of cross-linker incorporation is beneficial to optimize
and increase native material properties for bone related application.</p></sec><sec id="sec3.2"><label>3.2</label><title>Influence of Chitosan Cross-linking on Mechanical
Properties</title><p>The protectoral function of bones in the body
necessitates the consideration of mechanical properties of the material
in the design of biological substitutes, that will provide sufficient
mechanical support and integrity throughout the entire repair process.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> This explains why the mechanical environment is considered as one
of the essential branches of the diamond concept on its own. Insufficiencies
in mechanical strength have been demonstrated to be detrimental to
the functionality of encapsulated cells rendering healing unsuccessful.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref173">173</xref></sup> For instance, variations in stiffness result in the differentiation
of cells into other lineages, since cells can sense mechanical changes
to their microenvironment through mechanosensation and respond accordingly.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref173">173</xref></sup> Increased mechanical properties and stiffness of chitosan-based
materials with cross-linking can favor the differentiation of mesenchymal
stem cells into the osteogenic lineage compared to others since osteogenic
cells favor stiffer substrates.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup></p><p>Design criteria often suggest that a material&#8217;s mechanical
properties should be similar to those of the native bone tissue, which
tend to vary based on the type of bone.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref23">23</xref></sup> The compressive
strength and Young&#8217;s modulus of healthy human cortical bone
has been illustrated in the literature to be between 130 to 200 MPa
and 7 to 30 GPa, respectively, whereas trabecular bone values are
reported to be between 0.1 to 16 MPa and 0.05 to 0.5 GPa.<sup><xref ref-type="bibr" rid="ref174">174</xref></sup> Mechanical properties of a material tend to
vary in response to a variety of factors. Changes in structural items
such as the incorporation of other polymeric components,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref117">117</xref>,<xref ref-type="bibr" rid="ref154">154</xref>,<xref ref-type="bibr" rid="ref155">155</xref></sup> cross-linkers,<sup><xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref97">97</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref110">110</xref>,<xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref117">117</xref>,<xref ref-type="bibr" rid="ref131">131</xref>,<xref ref-type="bibr" rid="ref135">135</xref>,<xref ref-type="bibr" rid="ref152">152</xref></sup> and additives<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref115">115</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref131">131</xref>&#8722;<xref ref-type="bibr" rid="ref133">133</xref>,<xref ref-type="bibr" rid="ref136">136</xref>,<xref ref-type="bibr" rid="ref138">138</xref>,<xref ref-type="bibr" rid="ref143">143</xref>,<xref ref-type="bibr" rid="ref148">148</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup> can have dramatic effects on
the mechanical properties of the chitosan-based biomaterial substitute.<sup><xref ref-type="bibr" rid="ref175">175</xref></sup> However, comparison between studies is often
difficult since chitosan can be used with different modifications,
molecular weights, and degree of deacetylations.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></p><p>The incorporation of a cross-linker as previously
mentioned is
used with the intention of improving the mechanical properties of
chitosan scaffolds. Improved compressive strengths and young&#8217;s
modulus values compared to uncross linked scaffolds have regularly
been demonstrated in the literature.<sup><xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref97">97</xref></sup> A study by
Pinto <italic toggle="yes">et al.</italic> showed that the addition of glutaraldehyde
in increasing concentrations to a chitosan scaffold, produced increasing
Young&#8217;s modulus values from 0.27 MPa with 0% to 1.7 MPa in
10% resulting in a more rigid and stable structure.<sup><xref ref-type="bibr" rid="ref81">81</xref></sup> Since many different cross-linking methods exist, some
authors have chosen to compare the effects of multiple cross-linkers
on the mechanical properties to determine which methodology is most
efficient. Karakecili <italic toggle="yes">et al.</italic> evaluated different
cross-linkers including EDAC/NHS, tripolyphosphate, and glyoxal
in chitosan and collagen type I composite scaffolds, with results
indicating a significant effect of cross-linking method on mechanical
strength.<sup><xref ref-type="bibr" rid="ref101">101</xref></sup> The glyoxal cross-linking
showed the highest percentage of increase for the compression modulus,
whereas EDAC/NHS was found to have the lowest values of the three
cross-linkers. Interestingly, significant differences between cross-linkers
are not always observed within the literature. A study comparing tripolyphosphate
and genipin cross-linkers in a chitosan and nano beta-tricalcium phosphate
scaffold suggested a bimodal trend in concentrations with no significant
differences between the cross-linkers.<sup><xref ref-type="bibr" rid="ref75">75</xref></sup> Demonstration of both these cross-linker modality effects indicates
the necessity of significant testing for optimal composition when
designing scaffolds prior to exploration of <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> osteogenic potential of materials.</p><p>In addition to the influence of cross-linking, some studies of
composite chitosan cross-linked scaffolds have also examined the effect
of different polymeric ratios within the scaffold. Nair <italic toggle="yes">et
al.</italic> tested for compressive strength differences between chitosan
and collagen scaffolds at varying ratios (75/25, 50/50, and 25/75)
before and after cross-linking with glyoxal (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A,B). Results demonstrated that as the concentration
of chitosan decreased, the compressive strength of the material also
decreased (with cross-linking: CH&#8211;CO 75/25:19.3 kPa to CH&#8211;CO
25/75:9.3 kPa).<sup><xref ref-type="bibr" rid="ref106">106</xref></sup> This is promising as
it suggests the possible benefit of chitosan for mechanical properties
compared to collagen. Another study was also able to support this
possible benefit, but this time examining changes in concentration
of N,O-carboxymethyl chitosan with aldehyde containing hyaluronate
acid in a scaffold cross-linked through Schiff base reactions.<sup><xref ref-type="bibr" rid="ref105">105</xref></sup> Increasing the concentration of N,O-carboxymethyl
chitosan in the scaffold resulted in a significant increase in compressive
modulus from 4.35 kPa with 4% to 20.99 kPa in 8%.</p><fig id="fig4" position="float" orientation="portrait"><label>Figure 4</label><caption><p>Influence of scaffold
design changes on the mechanical properties.
(A) Compressive strength measurements of chitosan and collagen composite
scaffolds at different ratios (75:25, 50:50, 25:75) prior to cross-linking.
(B) Measurements of the same composite scaffolds after cross-linking
with glyoxal. Both A and B were reproduced with permission from ref (<xref ref-type="bibr" rid="ref106">106</xref>). Copyright 2021 Royal
Society of Chemistry and the Centre National de la Recherche Scientifique.
(C) Elastic modulus and compressive strength of gelatin chitosan composite
scaffolds with increasing concentrations of bioglass (0 to 30%). C
was reproduced and adapted under open access conditions (Creative
Commons Attribution License) from ref (<xref ref-type="bibr" rid="ref115">115</xref>). Copyright 2016 Kanchan Maji et al. and Hindawi.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr5" position="float" orientation="portrait" xlink:href="mt3c00108_0004.jpg"/></fig><p>As the addition of compounds and mediators have
been widely studied
to improve the material and osteogenic properties of scaffolds, the
influence of these additions on mechanical properties must also be
considered. Some additives are included for the purpose of improving
mechanical properties while others are not expected to have a significant
effect. One of the main methods for improving the mechanical strength
is the incorporation of hydroxyapatite or the induction of scaffold
mineralization . A study by Lu <italic toggle="yes">et al.</italic> examined compressive
stress values of mineralized and nonmineralized N,O-carboxymethyl
chitosan scaffolds with cross-linking through amidation reactions
using EDC/NHS.<sup><xref ref-type="bibr" rid="ref141">141</xref></sup> The mineralization of
the scaffold presented a marked increase in ultimate compressive stress
from 19.5 to 91.6 kPa. This effect was expected, as n-HA is known
for its reinforcing ability. Fucoidan was also examined in this study
as a potential drug delivery vehicle, but authors suggest that its
addition could improve the ability of the scaffold to mineralize as
well. Fucoidan incorporated scaffolds showed increased nonmineralized
and mineralized values of compressive stress compared to pure N,O-carboxymethyl
chitosan scaffolds alone. Another study demonstrated that through
the addition of increasing concentrations of bioactive glass (0, 10,
20, 30 wt %) in chitosan and gelatin scaffolds, the compressive strength
and elastic modulus were able to increase (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C).<sup><xref ref-type="bibr" rid="ref115">115</xref></sup> However,
not all additives have been shown to have a beneficial effect. An
example of this is the addition of lemongrass oil, which was found
to produce a decrease in compressive strength with increasing concentrations.<sup><xref ref-type="bibr" rid="ref136">136</xref></sup> This undesirable effect was explained to be
due to a disruption in cross-linking of hydroxypropyl methyl cellulose
and chitosan with this addition.</p><p>These results therefore suggest
extensive testing for additive
effects in scaffold design studies. It is important to note that an
intimate relationship exists between mechanical properties and multiple
other material parameters, including the structural architecture.
Incorporation of higher porosity and larger pores, which are often
necessary for cellular functionality and vascular network infiltration,
often are a result of decreased cross-linking and thus the materials
present decreased mechanical strength.<sup><xref ref-type="bibr" rid="ref173">173</xref></sup> Therefore, a balance must be struck between the architectural design
and the corresponding scaffold mechanical properties.</p></sec><sec id="sec3.3"><label>3.3</label><title>Influence of Chitosan Cross-linking on Rheological
Properties</title><p>Strain sweep tests are often conducted as a preliminary
step to frequency sweeps to determine in what amplitude range the
material exhibits viscoelastic properties by applying a strain signal
with increasing amplitudes. The frequency sweep test is often performed
over a range of frequencies (0.01 to 100 Hz) with a constant strain
to attain important parameter values including the shear elastic modulus
(<italic toggle="yes">G</italic>&#8242;), loss/viscous modulus (<italic toggle="yes">G</italic>&#8242;&#8242;) and loss tangent (tan(&#948;)) values. Together,
these values give further insight to the stability of cross-linked
scaffolds. A study by Dessi et al. used frequency sweep testing to
demonstrate the deformation behavior of Beta tricalcium phosphate
(1 and 1.5%) and chitosan cross-linked composite scaffolds.<sup><xref ref-type="bibr" rid="ref98">98</xref></sup> Since the <italic toggle="yes">G</italic>&#8242; elastic
modulus was higher than the loss modulus <italic toggle="yes">G</italic>&#8242;&#8242;
throughout the frequency range, authors were able to conclude that
the behavior was primarily elastic indicating a stable structure.
Interestingly, no significant difference was observed due to concentration
changes, but this conclusion should be further examined through comparison
to a scaffold without beta tricalcium phosphate (&#946;-TCP). While
the loss tangent values were below one for this study, confirming
the materials viscoelasticity, the elastic modulus values (at 1 Hz: <italic toggle="yes">G</italic>&#8242; of 55 Pa for &#946;-TCP 1% and 75 Pa for &#946;-TCP
1.5%) seem relatively low compared to the use of other cross-linkers
and additives reported in the literature. Another study examining
scaffolds of chitosan-cysteine conjugates with difunctionalized PEG
cross-linkers demonstrated a range of elastic modulus values between
962.5 to 1561.8 Pa with increasing weight to volume percentages of
chitosan-cysteine solutions from 1.5 to 2.5% (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A).<sup><xref ref-type="bibr" rid="ref100">100</xref></sup> Results
presented in this study suggest a beneficial effect of increasing
concentrations of chitosan-cysteine solutions as well as an increased
concentration of difunctionalized PEG cross-linkers (0.3 to 0.6 w/v
%). The large difference (one to 2 orders of magnitude) between <italic toggle="yes">G</italic>&#8242; and <italic toggle="yes">G</italic>&#8242;&#8242; was observed
as well, indicating again the stability of the scaffold. The null
effect of pyrophosphatase addition to a chitosan-based guanosine diphosphate
cross-linked scaffold on its rheological properties has recently been
demonstrated using this methodology.<sup><xref ref-type="bibr" rid="ref86">86</xref></sup></p><fig id="fig5" position="float" orientation="portrait"><label>Figure 5</label><caption><p>Rheological
property evaluation. (A) Effect of increasing chitosan-cysteine
(CH&#8211;CY) solutions (1.5 to 2.5%) and difunctionalized PEG cross-linkers
(0.3 to 0.6 w/v %) on <italic toggle="yes">G</italic>&#8242; and <italic toggle="yes">G</italic>&#8242;&#8242; values. Reproduced and adapted under open access
conditions (Creative Commons Attribution License) from ref (<xref ref-type="bibr" rid="ref100">100</xref>). Copyright 2022 Qing
Min et al. and MDPI. (B) Percentages of published articles for inclusion
of mechanical properties, rheological properties, both, and none.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr6" position="float" orientation="portrait" xlink:href="mt3c00108_0005.jpg"/></fig><p>Time sweeps can also be beneficial in providing
knowledge about
the elastic modulus as a function of time. This particular technique
has been well implemented in the literature as means to determine
gelation time measurements. For example, An <italic toggle="yes">et al.</italic> were able to tune the gelation time of a methyl acrylate chitosan
and aldehyde containing oxidized hyaluronate acid using this technique.<sup><xref ref-type="bibr" rid="ref104">104</xref></sup> The gelation time was determined as the time
point where <italic toggle="yes">G</italic>&#8242; and <italic toggle="yes">G</italic>&#8242;&#8242;
crossed over, as an indication of the transition from a liquid to
a solid (more elastic) scaffold. Other authors have used this method
to establish the elastic modulus changes throughout different time
periods after cross-linking.<sup><xref ref-type="bibr" rid="ref128">128</xref></sup> From reviewing
the literature for chitosan-based cross-linked scaffolds in the last
ten years, it is evident that rheological properties of materials
have been less explored compared to mechanical and compressive studies
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B). The viscoelasticity
of a material is however an important consideration as it also affects
the osteogenic differentiation of cells and their spreading behavior.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> Rapid relaxation of the scaffold following an
applied stress encourages differentiation of the mesenchymal stem
cells.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> Therefore, although it is more
common to find studies that examine both recently, this combination
of studies should be a set standard in implementation of Diamond Concept
in bone repair, as it allows for a more concrete understanding of
the material and possible interactions with body environment and cells.</p></sec><sec id="sec3.4"><label>3.4</label><title>Influence of Chitosan Cross-linking on Structural
Architecture</title><p>The microarchitecture of scaffolds plays a vital
role in supporting various functions. Careful consideration is needed
when developing scaffolds to achieve the optimal structural architecture,
depending on the intended therapeutic application. Bone is a highly
porous structure; as such, porosity is an important parameter of a
scaffold to better mimic the native tissue.<sup><xref ref-type="bibr" rid="ref176">176</xref></sup> An interconnected porous microstructure would favor higher cell
infiltration and activity, vascularization, proper exchange of nutrients,
and diffusion of therapeutic agents.<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup></p><p>In general,
chitosan-based scaffolds demonstrate excellent porosity, with a commonly
reported range of 80&#8211;90%.<sup><xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref110">110</xref></sup> Moreover,
pore diameter sizes tend to often be &gt;100 &#956;m, which is reported
to be optimal for efficacious tissue infiltration and ingrowth.<sup><xref ref-type="bibr" rid="ref116">116</xref></sup> However, cross-linking in efforts to enhance
the mechanical properties might be detrimental to the desired scaffold
architecture, and thus, it is important to determine a right balance
between polymer and cross-linker concentrations.</p><p>Genipin is
among the most commonly used cross-linkers when fabricating
chitosan-based scaffolds. While increasing the concentration of this
cross-linker can slow down the degradation rate of the scaffold as
a consequence of higher cross-linking, Dimida <italic toggle="yes">et al.</italic> observed no significant change neither in the structural architecture
of the formed scaffolds nor in their mechanical properties (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>A).<sup><xref ref-type="bibr" rid="ref72">72</xref></sup> Similarly, increasing concentrations of glutaraldehyde,
another popular chitosan cross-linker, do not show a great effect
on the general microarchitecture but did aid in enhancing the mechanical
behavior of the scaffold. On the other hand, the compressive modulus
of sodium tripolyphosphate cross-linked chitosan scaffold showed significant
increase with higher cross-linking concentrations, but the porosity
decreased to as low as 17.2%.<sup><xref ref-type="bibr" rid="ref93">93</xref></sup> Such results
might suggest glutaraldehyde as an optimal cross-linker to combine
improved mechanical strengths with maintained porous microstructure.
However, increasing the concentrations of glutaraldehyde can risk
an increase in cytotoxic effects. Therefore, more focus should be
placed on finding a suitable cross-linker that supports all necessary
properties relevant to the Diamond Concept.</p><fig id="fig6" position="float" orientation="portrait"><label>Figure 6</label><caption><p>Characterization of structural
architecture for various modifications
of chitosan scaffold. (A) SEM images of chitosan scaffolds with increasing
concentrations of genipin (left &#8722;3.75%, right &#8722;7.5%).
Reproduced and adapted under open access conditions (Creative Commons
Attribution License) from ref (<xref ref-type="bibr" rid="ref72">72</xref>). Copyright 2017 Simona Dimida et al. and Hindawi. (B) Total
porosity measurements (T.Po), structure thickness (St.Th), and specific
surface (Sp.S) for chitosan scaffolds with increasing graphene oxide
(GO) percentages (0, 0.5, 3%). Reproduced and adapted under open access
conditions (Creative Commons Attribution License) from ref (<xref ref-type="bibr" rid="ref177">177</xref>). Copyright 2019 Sorina
Dinescu <italic toggle="yes">et al.</italic> and MDPI. (C) Percentage of porosity
for sodium alginate and chitosan composite scaffolds with and without
the addition of collagen and graphene oxide using liquid displacement
method. Reproduced and adapted with permission from ref (<xref ref-type="bibr" rid="ref138">138</xref>). Copyright 2018 American
Chemical Society.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr7" position="float" orientation="portrait" xlink:href="mt3c00108_0006.jpg"/></fig><p>To complement cross-linking with the enhancement
of mechanical
and osteogenic properties of a scaffold, the addition of apatites
and other ceramics is commonly employed. Hydroxyapatite (HA) is one
such frequent additive to chitosan-based cross-linked scaffolds.<sup><xref ref-type="bibr" rid="ref71">71</xref>,<xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref166">166</xref></sup> As a major constituent of natural bone, HA not only increases the
mechanical strength of scaffolds but also their biocompatibility and
bioactivity.<sup><xref ref-type="bibr" rid="ref101">101</xref></sup></p><p>This, however, can
often be accompanied by changes to the overall
porosity or pore size.<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref152">152</xref></sup> Compared to the control scaffold
with only tripolyphosphate (TPP) cross-linking, Shemshad <italic toggle="yes">et
al.</italic> observed a decrease in pore size following incorporation
of nanohydroxyapatite along with bioactive silicate diopside.
Nonetheless, the size remained within the range of 40 to 250 &#956;m
often recommended for bone tissue engineering applications. The incorporation
of these factors did also yield a rougher pore morphology, which can
be advantageous for better cell and tissue adhesion.<sup><xref ref-type="bibr" rid="ref94">94</xref></sup> &#946;-TCP is another ceramic that can be added to confer
to scaffolds similar properties as HA does. However, Jahan <italic toggle="yes">et al.</italic> observed that &#946;-TCP had a larger particle size
compared to HA, resulting in more occluded scaffold pores, thereby
decreasing their size.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup></p><p>To enhance
the overall morphology of chitosan-based scaffolds,
the addition of graphene oxide (GO) as an additive was attempted.
This carbon-based material can aid in cross-linking different polymer
chains together or polymers and other biomolecules, as well as increasing
the mechanical properties of a scaffold and its biocompatibility,
osteogenic properties, and in some instances, the total porosity of
chitosan scaffolds.<sup><xref ref-type="bibr" rid="ref138">138</xref></sup> Dinescu <italic toggle="yes">et al.</italic> reported enhanced porosity with the addition of 3%
wt. GO in a freeze-dried chitosan scaffold. They also observed that
the addition of GO favored the formation of larger pores (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>B).<sup><xref ref-type="bibr" rid="ref177">177</xref></sup> In other instances where chemical cross-linking was completed,
the addition of GO slightly decreased the pore size of an alginate&#8211;chitosan&#8211;collagen
composite scaffold chemically cross-linked with Ca<sup>2+</sup> (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>C).<sup><xref ref-type="bibr" rid="ref138">138</xref></sup> Nonetheless, addition of GO commonly yields a more homogeneous
architecture with more defined pores, thick pore walls, and rougher
morphology all which beneficially influence cell attachment and osteogenic
differentiation and improve the overall efficacy of the scaffold for
bone tissue engineering.<sup><xref ref-type="bibr" rid="ref80">80</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref178">178</xref></sup></p></sec><sec id="sec3.5"><label>3.5</label><title>Influence of Chitosan Cross-linking on Degradation
Rate</title><p>Since one of the expectations of bone healing in defects
is the regeneration of bone tissue over the course of time, the biodegradability
of the material is an important consideration of scaffold design.
When the scaffold is placed <italic toggle="yes">in vivo</italic>, it is expected
that its degradation rate will match that of the native bone tissue
ingrowth thus allowing the gradual transfer of mechanical load.<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref25">25</xref>&#8722;<xref ref-type="bibr" rid="ref30">30</xref></sup> The scaffold&#8217;s role is to act as a temporary bridge between
both ends of the defect helping cells, as well as acting as a platform
to create an optimal microenvironment.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> Degradation rates that are too fast or too slow result in inadequate
healing and lead to insufficiencies in mechanical support throughout
the healing process.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup></p><p>Due to the
necessity for control, assessment of this property has become a standard
practice in material design and characterization, including the design
of chitosan-based scaffolds.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> Within the
body, degradation of polymers typically occurs through a chain scission
process of the polymer induced by enzymes such as lysozymes, which
results in the hydrolysis of chitosan and the cleavage of its &#946;-(1&#8211;4)-glycosidic
bonds.<sup><xref ref-type="bibr" rid="ref26">26</xref>,<xref ref-type="bibr" rid="ref51">51</xref></sup> A study by Kim <italic toggle="yes">et al.</italic> demonstrated
this concept through the incorporation of varying concentrations of
lysozymes in a methacrylated glycol chitosan hydrogel.<sup><xref ref-type="bibr" rid="ref140">140</xref></sup> Increases in lysozyme concentration from 0.1
to 10 mg/mL resulted in accelerated degradation rates of the hydrogel
with a final degradation of around 30% left after 14 days when a lysozyme
concentration of 10 mg/mL was used.</p><p>Work within the literature
on chitosan cross-linked scaffolds has
often embraced the lysozyme technique to study <italic toggle="yes">in vitro</italic> degradation behavior.<sup><xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref72">72</xref>,<xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref138">138</xref>,<xref ref-type="bibr" rid="ref140">140</xref></sup> Formation of a composite chitosan and polycaprolactone (PCL) scaffold
with genipin cross-linking showed decreased degradation rates compared
to chitosan alone cross-linked control groups (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>A).<sup><xref ref-type="bibr" rid="ref119">119</xref></sup> The dependence
of the chitosan amount on the degradation rate was not surprising
since the lysozyme is expected to target the chitosan specifically.
Another study by Rahman <italic toggle="yes">et al.</italic> further demonstrated
chemical cross-linking&#8217;s influence on biodegradation rates
and stability using a chitosan/hydroxyapatite/collagen composite scaffold.<sup><xref ref-type="bibr" rid="ref111">111</xref></sup> This scaffold was cross-linked with either
glutaraldehyde (GTA), dehydrothermal treatment (DTH), irradiation
(IR) or 2-hydroxyethyl methacrylate (HEMA), resulting in Ha&#183;Col1&#183;Cs-GTA,
Ha&#183;Col1&#183;Cs-IR, Ha&#183;Col1&#183;Cs-DTH, and Ha&#183;Col1&#183;Cs-HEMA
composites. Results indicated that the glutaraldehyde cross-linked
scaffold exhibited a 16% degradation on day 21, whereas the scaffold
without the cross-linker was 55% degraded at this same time point
(<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>B). Interestingly,
this improvement in degradation rate using cross-linkers was not shown
when adding a fibrin coating to a chitosan scaffold.<sup><xref ref-type="bibr" rid="ref70">70</xref></sup></p><fig id="fig7" position="float" orientation="portrait"><label>Figure 7</label><caption><p>Degradation profiles of composite chitosan scaffolds in lysozyme.
(A) Chitosan (CS) and polycaprolactone (PCL) scaffolds with different
concentrations of polymers (100:0, 20:80, 40:60, 0:100) cross-linked
with genipin. Reproduced and adapted with permission from ref (<xref ref-type="bibr" rid="ref119">119</xref>). Copyright 2022 Elsevier.
(B) Chitosan/hydroxyapatite/collagen composite (Ha-Col1-CS) scaffolds
before and after cross-linking with different methodologies: (1) DHT
&#8211; dehydro-thermal treatment, (2) IR &#8211; irradiation, (3)
GTA &#8211; glutaraldehyde, and (4) HEMA &#8211; 2-hydroxyethyl
methacrylate. Reproduced and adapted under open access conditions
(Creative Commons Attribution License) from ref (<xref ref-type="bibr" rid="ref111">111</xref>). Copyright 2019 Md. Shaifur
Rahman <italic toggle="yes">et al.</italic> and Springer.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr8" position="float" orientation="portrait" xlink:href="mt3c00108_0007.jpg"/></fig><p>Since composite scaffolds are often formed with
chitosan and other
polymers such as collagen, the biodegradation of scaffolds in collagenase
solution is also sometimes assessed in the literature.<sup><xref ref-type="bibr" rid="ref107">107</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref125">125</xref>,<xref ref-type="bibr" rid="ref126">126</xref></sup> Grabska-Zielinska <italic toggle="yes">et al.</italic> examined the degradation
profile of a chitosan and fish gelatin scaffold with genipin cross-linking
and the benefits of graphene oxide incorporation. Interestingly, when
cultured in collagenase 2 solution, the scaffold without graphene
oxide mostly degraded (72%) within the first 24 h. However, the addition
of graphene oxide in doses above 1 wt % was able to withstand some
of this degradation showing percentage values around 44% to 52% depending
on concentration.<sup><xref ref-type="bibr" rid="ref107">107</xref></sup> Similarly, the addition
of amino group functionalized silica particles with alendronate served
to slow down the degradation process of chitosan scaffolds with collagen
and hyaluronic acid.<sup><xref ref-type="bibr" rid="ref121">121</xref></sup> However, the beneficial
effects of biodegradation mediators should be further explored for
better understanding of mediator-mediated biodegradation.</p><p>In
addition to the importance of the biodegradation profile itself,
the byproducts of this degradation must also be considered in aspects
of design. These should be nontoxic and nonteratogenic and do not
elicit any undesirable immunogenic response when degradation occurs.<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref179">179</xref></sup> Often, byproducts
can be beneficial in the development of an adequate microenvironment
for healing and can improve bioactivity within the defect site.<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref51">51</xref></sup></p></sec></sec><sec id="sec4"><label>4</label><title>Cell Encapsulation in Chitosan Cross-linked
Scaffolds</title><p>In addition to modifications of the scaffold material
itself, the
Diamond Concept also stresses the necessity of an encapsulated viable
cell population. Incorporation of cells is important in successful
bone regenerative therapies since bone cells such as osteoblasts,
osteoclasts, and osteocytes are responsible for the production, remodeling,
and maintenance of bone.<sup><xref ref-type="bibr" rid="ref180">180</xref></sup> Previous studies
with empty scaffolds have shown almost no cellular ingrowth from the
native tissue, which negatively affects the regenerative ability.<sup><xref ref-type="bibr" rid="ref181">181</xref></sup> With relevant cell encapsulation, both osteogenic
differentiation of the cells and angiogenesis are encouraged when
present at the target site, thereby resulting in the secretion of
varying growth factors, matrix proteins and cytokines such as vascular
endothelial growth factor and interleukin 6.<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref179">179</xref>,<xref ref-type="bibr" rid="ref182">182</xref></sup> Culmination
of these secretion activities with successful cellular differentiation
can improve the healing outcomes.</p><sec id="sec4.1"><label>4.1</label><title>Methodology for Cellular <italic toggle="yes">In Vitro</italic> Studies in Chitosan Scaffolds</title><p>The first step in designing
an encapsulated cell-based substitute is to examine the material&#8217;s
ability to support cellular activity. While cross-linking of chitosan-based
scaffolds can result in improved mechanical properties which is beneficial
in supporting loading, it can be accompanied by a decrease in porosity
and pore size. Since the functionality of cells once encapsulated
is known to be heavily dependent on their access to nutrients and
oxygen, such significant changes to the internal structure with cross-linking
can lead to drastic changes in cellular viability and activity.</p><p>Another important consideration is the effect of the method of cross-linking
itself on cellular viability and functionality. Some cross-linking
techniques, like physical cross-linking, can have low cytotoxicity
to cells however, they might require harsh conditions such as changes
in temperature or pH and do not always provide the optimal material
properties necessary for bone applications.<sup><xref ref-type="bibr" rid="ref58">58</xref>,<xref ref-type="bibr" rid="ref183">183</xref></sup> On the other hand, chemical cross-linking might be more beneficial
with respect to material properties due to stronger bonding but can
have higher costs and higher risk of cytotoxicity, especially with
cross-linkers such as glutaraldehyde.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> Genipin cross-linking, which is commonly used as a cross-linker
for chitosan-based materials, is known to be biocompatible and less
cytotoxic than other chemical cross-linkers.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup></p><p>With all the considerations of cross-linker effects on cellular
activity, this addition necessitates a thorough evaluation of cellular
functionality in chitosan-based scaffolds. For bone applications,
the <italic toggle="yes">in vitro</italic> assessment of cellular activity is thought
to be further divided into three subgroups, namely biocompatibility,
osteogenic differentiation, and mineralization (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig">8</xref></xref>).</p><fig id="fig8" position="float" orientation="portrait"><label>Figure 8</label><caption><p>Common methodologies for <italic toggle="yes">in vitro</italic> studies using
cell cultures in the literature. These steps include testing for biocompatibility,
osteogenic differentiation, and biomineralization.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr9" position="float" orientation="portrait" xlink:href="mt3c00108_0008.jpg"/></fig><p>The initial aspect of this often encompasses a
quantification of
cellular proliferation and metabolic activity using commercial assays
such as MTT/XTT/MTS (41.9%), alamarBlue (21.5%), or Cell Counting
Kits (18.3%). While these listed tend to be the most popular in terms
of quantitative assays, many other techniques encompassing a visual
assessment component have also been demonstrated in the literature.
For example, around 33.3% of recent articles have examined cellular
distribution and morphology through staining using antibodies for
phalloidin and nucleic acid. Another common staining found in the
literature is Live/Dead or calcein based assays, which stain live
and dead cells different colors making it easy to quantify cytotoxicity
and overall percentage of viability.</p><p>Furthermore, in many studies
SEM is used to visually determine
cell adhesion properties on the surface of the scaffold. All these
methods for biocompatibility provide researchers with a more thorough
understanding of whether their material can support generic cellular
activities without significant adverse effects. However, not all these
methods will provide the same information and therefore it is crucial
to understand the differences between testing methods. <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref> is presented to help differentiate
these differences and serve as a resource for experiment planning
in future studies.</p><table-wrap id="tbl3" position="float" orientation="portrait"><label>Table 3</label><caption><title>Common Methodologies for <italic toggle="yes">In
Vitro</italic> Testing in Chitosan Cross-linked Scaffolds for Bone
(<italic toggle="yes">N</italic> = 94)</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">In
Vitro</italic> Experiments</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Incorporation
in <italic toggle="yes">In Vitro</italic> Studies (%)</th><th style="border:none;" align="center" colspan="1" rowspan="1">Information
Obtained</th><th style="border:none;" align="center" colspan="1" rowspan="1">Methodology</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Usage in
Specific <italic toggle="yes">In Vitro</italic> (%)</th></tr></thead><tbody><tr><td rowspan="18" style="border:none;" align="left" colspan="1">Cellular Biocompatibility</td><td rowspan="18" style="border:none;" align="char" char="." colspan="1">98.9%</td><td rowspan="8" style="border:none;" align="left" colspan="1">Cellular Metabolic
Activity, Growth and Proliferation</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>MTT/XTT/MTS Assay</bold>(<xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref72">72</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref90">90</xref>,<xref ref-type="bibr" rid="ref93">93</xref>&#8722;<xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref108">108</xref>,<xref ref-type="bibr" rid="ref110">110</xref>,<xref ref-type="bibr" rid="ref115">115</xref>,<xref ref-type="bibr" rid="ref116">116</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref124">124</xref>,<xref ref-type="bibr" rid="ref128">128</xref>&#8722;<xref ref-type="bibr" rid="ref132">132</xref>,<xref ref-type="bibr" rid="ref135">135</xref>,<xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref138">138</xref>,<xref ref-type="bibr" rid="ref141">141</xref>,<xref ref-type="bibr" rid="ref148">148</xref>&#8722;<xref ref-type="bibr" rid="ref150">150</xref>,<xref ref-type="bibr" rid="ref152">152</xref>&#8722;<xref ref-type="bibr" rid="ref155">155</xref>,<xref ref-type="bibr" rid="ref157">157</xref>&#8722;<xref ref-type="bibr" rid="ref159">159</xref>,<xref ref-type="bibr" rid="ref170">170</xref>,<xref ref-type="bibr" rid="ref171">171</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>41.9%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">IF Staining
&#8211; DAPI
with or without Phalloidin<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref74">74</xref>&#8722;<xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref85">85</xref>&#8722;<xref ref-type="bibr" rid="ref89">89</xref>,<xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref104">104</xref>,<xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref152">152</xref>,<xref ref-type="bibr" rid="ref161">161</xref>,<xref ref-type="bibr" rid="ref166">166</xref>,<xref ref-type="bibr" rid="ref168">168</xref>,<xref ref-type="bibr" rid="ref169">169</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">33.3%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Alamar Blue Assay<sup><xref ref-type="bibr" rid="ref72">72</xref>,<xref ref-type="bibr" rid="ref76">76</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref89">89</xref>,<xref ref-type="bibr" rid="ref92">92</xref>,<xref ref-type="bibr" rid="ref107">107</xref>,<xref ref-type="bibr" rid="ref118">118</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref125">125</xref>&#8722;<xref ref-type="bibr" rid="ref127">127</xref>,<xref ref-type="bibr" rid="ref134">134</xref>,<xref ref-type="bibr" rid="ref136">136</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref143">143</xref>,<xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref152">152</xref>,<xref ref-type="bibr" rid="ref164">164</xref>,<xref ref-type="bibr" rid="ref170">170</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">21.5%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Cellular Counting Kits<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref71">71</xref>,<xref ref-type="bibr" rid="ref74">74</xref>,<xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref104">104</xref>,<xref ref-type="bibr" rid="ref114">114</xref>,<xref ref-type="bibr" rid="ref117">117</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref133">133</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref147">147</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref163">163</xref>,<xref ref-type="bibr" rid="ref166">166</xref>,<xref ref-type="bibr" rid="ref169">169</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">18.3%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">PrestoBlue Kit<sup><xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref109">109</xref>,<xref ref-type="bibr" rid="ref112">112</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.2%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">EdU and BrdU Staining<sup><xref ref-type="bibr" rid="ref161">161</xref>,<xref ref-type="bibr" rid="ref184">184</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">2.2%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Resazurin Assay<sup><xref ref-type="bibr" rid="ref68">68</xref>,<xref ref-type="bibr" rid="ref102">102</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">2.2%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">IF Staining &#8211;
Ki67<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref119">119</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">2.2%</td></tr><tr><td rowspan="6" style="border:none;" align="left" colspan="1">Cellular Cytotoxicity
and Counting of Viable Cell Numbers</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Live Dead Assay/Calcein
AM Staining</bold>(<xref ref-type="bibr" rid="ref64">64</xref>&#8722;<xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref89">89</xref>,<xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref104">104</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref117">117</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref124">124</xref>,<xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref138">138</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref147">147</xref>,<xref ref-type="bibr" rid="ref150">150</xref>,<xref ref-type="bibr" rid="ref159">159</xref>,<xref ref-type="bibr" rid="ref160">160</xref>,<xref ref-type="bibr" rid="ref163">163</xref>,<xref ref-type="bibr" rid="ref167">167</xref>&#8722;<xref ref-type="bibr" rid="ref169">169</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>25.8%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Lactic Dehydrogenase Assay<sup><xref ref-type="bibr" rid="ref124">124</xref>,<xref ref-type="bibr" rid="ref156">156</xref>,<xref ref-type="bibr" rid="ref169">169</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.2%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Trypan Blue Staining<sup><xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref165">165</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">2.2%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">FDA Staining<sup><xref ref-type="bibr" rid="ref71">71</xref>,<xref ref-type="bibr" rid="ref93">93</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">2.2%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Acridine orange/Ethidium
bromide staining<sup><xref ref-type="bibr" rid="ref151">151</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.1%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Flow Cytometry &#8211;
Annexin V,<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> Propidium Iodide<sup><xref ref-type="bibr" rid="ref64">64</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.1%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">DNA Content</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>PicoGreen total DNA
Assay</bold>(<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref162">162</xref>,<xref ref-type="bibr" rid="ref170">170</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>8.6%</bold></td></tr><tr><td rowspan="3" style="border:none;" align="left" colspan="1">Cellular Biocompatibility,
Morphology and Adhesion</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Scanning Electron
Microscopy</bold>(<xref ref-type="bibr" rid="ref64">64</xref>&#8722;<xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref73">73</xref>&#8722;<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref108">108</xref>,<xref ref-type="bibr" rid="ref115">115</xref>,<xref ref-type="bibr" rid="ref117">117</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref125">125</xref>&#8722;<xref ref-type="bibr" rid="ref127">127</xref>,<xref ref-type="bibr" rid="ref131">131</xref>,<xref ref-type="bibr" rid="ref132">132</xref>,<xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref150">150</xref>,<xref ref-type="bibr" rid="ref152">152</xref>,<xref ref-type="bibr" rid="ref157">157</xref>,<xref ref-type="bibr" rid="ref166">166</xref>,<xref ref-type="bibr" rid="ref169">169</xref>,<xref ref-type="bibr" rid="ref170">170</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>35.5%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Light
Microscopy<sup><xref ref-type="bibr" rid="ref90">90</xref>,<xref ref-type="bibr" rid="ref157">157</xref>,<xref ref-type="bibr" rid="ref165">165</xref>,<xref ref-type="bibr" rid="ref171">171</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">5.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">HE Staining<sup><xref ref-type="bibr" rid="ref73">73</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.1%</td></tr><tr><td rowspan="6" style="border:none;" align="left" colspan="1">Osteogenic
Differentiation</td><td rowspan="6" style="border:none;" align="char" char="." colspan="1">63.8%</td><td rowspan="3" style="border:none;" align="left" colspan="1">Osteoblast
Differentiation Specific Protein Secretion</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Alkaline Phosphatase
Testing</bold>(<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref64">64</xref>&#8722;<xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref69">69</xref>&#8722;<xref ref-type="bibr" rid="ref71">71</xref>,<xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref75">75</xref>&#8722;<xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref89">89</xref>,<xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref108">108</xref>,<xref ref-type="bibr" rid="ref109">109</xref>,<xref ref-type="bibr" rid="ref114">114</xref>,<xref ref-type="bibr" rid="ref118">118</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref125">125</xref>&#8722;<xref ref-type="bibr" rid="ref127">127</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref131">131</xref>,<xref ref-type="bibr" rid="ref133">133</xref>,<xref ref-type="bibr" rid="ref135">135</xref>,<xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref139">139</xref>&#8722;<xref ref-type="bibr" rid="ref141">141</xref>,<xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref155">155</xref>&#8722;<xref ref-type="bibr" rid="ref157">157</xref>,<xref ref-type="bibr" rid="ref159">159</xref>,<xref ref-type="bibr" rid="ref161">161</xref>,<xref ref-type="bibr" rid="ref163">163</xref>,<xref ref-type="bibr" rid="ref169">169</xref>,<xref ref-type="bibr" rid="ref170">170</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>84.7%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">ELISA - Osteocalcin,<sup><xref ref-type="bibr" rid="ref71">71</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref163">163</xref></sup> Type 1 Collagen,<sup><xref ref-type="bibr" rid="ref100">100</xref></sup> Osteopontin<sup><xref ref-type="bibr" rid="ref163">163</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">5.1%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Sirius Red Dye Assay<sup><xref ref-type="bibr" rid="ref112">112</xref></sup>/SirCol Collagen Assay<sup><xref ref-type="bibr" rid="ref73">73</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Osteoblast Differentiation
Related Activity Stainings</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>IHC, ICC, IF Staining
for different markers &#8211; RUNX2</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref115">115</xref>,<xref ref-type="bibr" rid="ref120">120</xref></sup><bold>OPN</bold>,<sup><xref ref-type="bibr" rid="ref120">120</xref></sup><bold>BSP</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref></sup><bold>OCN</bold>,<sup><xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref115">115</xref>,<xref ref-type="bibr" rid="ref184">184</xref></sup><bold>OSX</bold><sup><xref ref-type="bibr" rid="ref88">88</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>11.9%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Gene Expression of Osteoblast
Related Genes</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>qPCR &#8211; ALP</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref74">74</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref89">89</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref147">147</xref>,<xref ref-type="bibr" rid="ref166">166</xref>,<xref ref-type="bibr" rid="ref169">169</xref></sup><bold>BSP</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref129">129</xref></sup><bold>COL1A1</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref127">127</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref157">157</xref>,<xref ref-type="bibr" rid="ref169">169</xref></sup><bold>OCN</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref108">108</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref127">127</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref157">157</xref></sup><bold>RUNX2</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref89">89</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref108">108</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref127">127</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref147">147</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref157">157</xref>,<xref ref-type="bibr" rid="ref162">162</xref>,<xref ref-type="bibr" rid="ref169">169</xref></sup><bold>OPN</bold>,<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref130">130</xref></sup><bold>BMPs</bold>,<sup><xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup><bold>ON</bold>,<sup><xref ref-type="bibr" rid="ref70">70</xref></sup><bold>OSX</bold><sup><xref ref-type="bibr" rid="ref65">65</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>44.1%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Protein Expression of Osteoblast
Related Genes</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Western Blot &#8211;
Col1A1</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref130">130</xref></sup><bold>RUNX2</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref130">130</xref></sup><bold>ALP</bold>,<sup><xref ref-type="bibr" rid="ref130">130</xref></sup><bold>OPN</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref130">130</xref></sup><bold>BSP</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref></sup><bold>OSX</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref></sup><bold>OCN</bold>,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref119">119</xref></sup><bold>ECM Proteins</bold>,<sup><xref ref-type="bibr" rid="ref119">119</xref></sup><bold>B-Catenin</bold>,<sup><xref ref-type="bibr" rid="ref130">130</xref></sup><bold>Smad1</bold>,<sup><xref ref-type="bibr" rid="ref130">130</xref></sup><bold>p-smad</bold>1/5/8,<sup><xref ref-type="bibr" rid="ref130">130</xref></sup><bold>cell growth
factors</bold><sup><xref ref-type="bibr" rid="ref119">119</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>6.8%</bold></td></tr><tr><td rowspan="4" style="border:none;" align="left" colspan="1">Mineralization</td><td rowspan="4" style="border:none;" align="char" char="." colspan="1">36.2%</td><td rowspan="4" style="border:none;" align="left" colspan="1">Quantification
of Mineral and Calcium Deposition</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Alizarin Red Staining</bold>(<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref64">64</xref>&#8722;<xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref104">104</xref>,<xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref114">114</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref138">138</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref141">141</xref>,<xref ref-type="bibr" rid="ref143">143</xref>,<xref ref-type="bibr" rid="ref147">147</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref155">155</xref>,<xref ref-type="bibr" rid="ref156">156</xref>,<xref ref-type="bibr" rid="ref159">159</xref>,<xref ref-type="bibr" rid="ref161">161</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>45.8%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Von
Kossa Staining<sup><xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref144">144</xref>,<xref ref-type="bibr" rid="ref184">184</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">8.5%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Total Calcium Kit<sup><xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref156">156</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">6.8%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">O-Cresol phthalein complexone method<sup><xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref109">109</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.4%</td></tr></tbody></table></table-wrap><p>In addition to simply testing biocompatibility, the
ability of
a material to support osteogenic differentiation is another important
consideration to address since the target application in many of these
studies is bone regeneration. Around 63.8% of relevant literature
have included this aspect into their <italic toggle="yes">In vitro</italic> studies,
with the most common technique for studying this being the detection
of an early osteogenic marker, alkaline phosphatase (84.7%). Bone
ALP is known to regulate the mineralization process since it provides
a phosphate reservoir to the matrix through hydrolysis of the mineralization
inhibitor, pyrophosphate. Thus, it is arguably a necessary methodology
with regards to claiming successful differentiation potential. This
assay is sometimes complemented with other techniques such as qPCR,
which serves to assess gene expression of other early and late-stage
markers in a comprehensive manner.</p><p>With respect to mineralization
of the material, this is often the
least considered and evaluated aspect of <italic toggle="yes">in vitro</italic> studies, present in only around 36.2% of publications. The most
common techniques for this involve mineral staining using either Alizarin
Red or Von Kossa but a few studies have also shown promising results
using quantitative calcium assays.</p></sec><sec id="sec4.2"><label>4.2</label><title>Cell Sources for Bone Tissue Engineering in
Chitosan Scaffolds</title><p>A variety of factors need to be considered
in the decision of cell source including aspects such as the ease
of availability for harvesting, low morbidity of donor site, high
efficiency of isolation, adequate cell proliferative ability, and
sufficient osteogenic differentiation potential. While many different
options for cell sources are currently being explored in chitosan-based
cross-linked scaffolds for bone tissue engineering, the focus remains
on finding a reliable cell source that will meet many of the criteria
listed above. Currently, these consist of either osteogenic cells
that are already lineage committed or stem cells, which allow for
control of differentiation (<xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref>).</p><table-wrap id="tbl4" position="float" orientation="portrait"><label>Table 4</label><caption><title>Common Cell Lineages and Lines Presented
in the Literature for Chitosan-Based Scaffolds</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">Category</th><th style="border:none;" align="center" colspan="1" rowspan="1">Cells in
Literature</th><th style="border:none;" align="center" colspan="1" rowspan="1">Scaffold</th></tr></thead><tbody><tr><td rowspan="16" style="border:none;" align="left" colspan="1">Lineage committed</td><td rowspan="9" style="border:none;" align="left" colspan="1">MC3T3 preosteoblast
cells (murine)</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref137">137</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/gelatin<sup><xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref109">109</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref124">124</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/collagen<sup><xref ref-type="bibr" rid="ref135">135</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/collagen/alginate<sup><xref ref-type="bibr" rid="ref138">138</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan-cysteine conjugate<sup><xref ref-type="bibr" rid="ref100">100</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Methacrylic anhydride
modified
chitosan<sup><xref ref-type="bibr" rid="ref169">169</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Methacrylic anhydride modified
chitosan/poly(acrylamide)<sup><xref ref-type="bibr" rid="ref130">130</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Carboxymethyl chitosan/alginate<sup><xref ref-type="bibr" rid="ref139">139</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/hyaluronic acid<sup><xref ref-type="bibr" rid="ref129">129</xref></sup></td></tr><tr><td rowspan="2" style="border:none;" align="left" colspan="1">7F2 osteoblast
cells (murine)</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref73">73</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Carboxymethyl chitosan/fucoidan<sup><xref ref-type="bibr" rid="ref141">141</xref></sup></td></tr><tr><td rowspan="5" style="border:none;" align="left" colspan="1">MG-63 osteoblast
like cells from osteosarcoma (murine)</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref98">98</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/collagen/hyaluronic
acid<sup><xref ref-type="bibr" rid="ref118">118</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref125">125</xref>,<xref ref-type="bibr" rid="ref126">126</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/gelatin<sup><xref ref-type="bibr" rid="ref143">143</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/polyvinyl
alcohol<sup><xref ref-type="bibr" rid="ref131">131</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/polycaprolactone<sup><xref ref-type="bibr" rid="ref170">170</xref></sup></td></tr><tr><td rowspan="12" style="border:none;" align="left" colspan="1">Stem cells</td><td rowspan="12" style="border:none;" align="left" colspan="1">Mesenchymal
stem cells (MSCs) &#8211; attained from multiple sources</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref66">66</xref>,<xref ref-type="bibr" rid="ref75">75</xref>&#8722;<xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref156">156</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/gelatin<sup><xref ref-type="bibr" rid="ref115">115</xref>,<xref ref-type="bibr" rid="ref133">133</xref>,<xref ref-type="bibr" rid="ref147">147</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/agarose/gelatin<sup><xref ref-type="bibr" rid="ref114">114</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/collagen<sup><xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref127">127</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Thiolated chitosan/gelatin<sup><xref ref-type="bibr" rid="ref151">151</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Carboxymethyl chitosan<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref71">71</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/gelatin<sup><xref ref-type="bibr" rid="ref108">108</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Methylacrylylated
chitosan/hyaluronic
acid<sup><xref ref-type="bibr" rid="ref104">104</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/polycaprolactone<sup><xref ref-type="bibr" rid="ref119">119</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Fatty
acid modified chitosan/decellularized
bone ECM<sup><xref ref-type="bibr" rid="ref123">123</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Methacrylated glycol chitosan<sup><xref ref-type="bibr" rid="ref140">140</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/fibrin<sup><xref ref-type="bibr" rid="ref70">70</xref></sup></td></tr><tr><td rowspan="2" style="border:none;" align="left" colspan="1">Others</td><td rowspan="2" style="border:none;" align="left" colspan="1">C2C12 myoblasts
(murine)</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/alginate<sup><xref ref-type="bibr" rid="ref161">161</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/lactide<sup><xref ref-type="bibr" rid="ref155">155</xref></sup></td></tr></tbody></table></table-wrap><sec id="sec4.2.1"><label>4.2.1</label><title>Osteogenic Lineage Committed Cells in Chitosan
Scaffolds</title><p>The first category often discussed when addressing
this challenge is osteogenic cells such as osteo-progenitor cells,
osteoblasts, and osteocytes.<sup><xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> Although these cells
are still derived from mesenchymal cells, their previous commitment
to the osteogenic lineage allows them to begin secreting bone matrix
components almost immediately upon implantation.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup> Thus, osteogenic markers such as type 1 collagen and alkaline phosphatase
are expected to be present sooner into the regenerative process, therefore
improving the rate of bone healing.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> In
recent years, the MC3T3 preosteoblastic cell line has become a standard
model regarding lineage committed cells for applications in bone tissue
engineering.<sup><xref ref-type="bibr" rid="ref185">185</xref>,<xref ref-type="bibr" rid="ref186">186</xref></sup> In many studies with chitosan-based
cross-linked scaffolds, these cells have thus been included for evaluation
of osteogenic differentiation and mineralization potential in the
materials. For example, in a genipin cross-linked chitosan-gelatin
scaffold with GO incorporated, Selaru <italic toggle="yes">et al.</italic> were
able to use MC3T3 cells to demonstrate enhanced osteogenic differentiation
and mineral deposition compared to scaffolds without GO.<sup><xref ref-type="bibr" rid="ref120">120</xref></sup> Similarly, Karake&#231;ili <italic toggle="yes">et al.</italic> observed enhanced MC3T3 mineralization aided by the addition of
n-HA.<sup><xref ref-type="bibr" rid="ref101">101</xref></sup> While these committed lineage
cells provide many benefits in the healing cascade, they are often
time-consuming with regard to the culturing process and their potential
for expansion is limited <italic toggle="yes">in vitro</italic>.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> Furthermore, collection and harvesting processes for primary
cells are invasive by nature, therefore encouraging scientists to
commonly look at alternatives for cell types such as the incorporation
of stem cells.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup></p><p>Another common category
of cells for various <italic toggle="yes">in vitro</italic> osteogenic models includes
osteosarcomas such as MG-63 and Saos-2. These cell lines are derived
from bone tumors and can display similar properties as osteogenic
cells like alkaline phosphatase (ALP) production and mineral deposition.<sup><xref ref-type="bibr" rid="ref187">187</xref></sup> Osteosarcomas have been widely used to investigate
the osteogenic suitability of a various range of chitosan-based cross-linked
scaffolds.<sup><xref ref-type="bibr" rid="ref92">92</xref>,<xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref128">128</xref>,<xref ref-type="bibr" rid="ref132">132</xref>,<xref ref-type="bibr" rid="ref152">152</xref>,<xref ref-type="bibr" rid="ref154">154</xref>,<xref ref-type="bibr" rid="ref164">164</xref></sup> In the study by Shemshad <italic toggle="yes">et al.</italic>, osteogenic differentiation
of MG-63 cells seeded on a TPP cross-linked chitosan scaffold with
addition of hydroxyapatite and bioactive silicate diopside is reported.<sup><xref ref-type="bibr" rid="ref94">94</xref></sup> By adding the osteogenic factor strontium to
their scaffold, Rodr&#237;guez-M&#233;ndez <italic toggle="yes">et al.</italic> observed increased ALP activity of MG-63 cells, whereas Pati <italic toggle="yes">et al</italic>. demonstrated the benefits of cross-linking with an
increase in mineralization (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig">9</xref></xref>).<sup><xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref170">170</xref></sup> However, while osteosarcomas
can be useful in providing valuable information regarding biocompatibility
and osteogenic potential <italic toggle="yes">in vitro</italic>, their clinical
translatability is hindered by their tumoral nature. Therefore, it
can be argued that these cells are not ideal within the scope of the
Diamond Concept and an alternative source should be considered or
tested simultaneously with these cells.</p><fig id="fig9" position="float" orientation="portrait"><label>Figure 9</label><caption><p>Assessment of (A) osteoblastic
differentiation (ALP activity) and
(B) mineralization potential (Alizarin Red Staining) from MG-63 cells
over 21 days for chitosan scaffolds with and without tripolyphosphate
cross-linker. Reproduced and adapted with permission from ref (<xref ref-type="bibr" rid="ref98">98</xref>). Copyright 2012 Wiley
Periodicals, Inc.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr10" position="float" orientation="portrait" xlink:href="mt3c00108_0009.jpg"/></fig></sec><sec id="sec4.2.2"><label>4.2.2</label><title>Stem Cells in Chitosan-Based Scaffolds</title><p>Stem cells present many advantages for use, since they have self-renewal
capabilities and can easily be induced to differentiate into various
lineages.<sup><xref ref-type="bibr" rid="ref179">179</xref>,<xref ref-type="bibr" rid="ref188">188</xref>,<xref ref-type="bibr" rid="ref189">189</xref></sup> Although this broad categorization encompasses several different
types, adult mesenchymal stem cells (MSCs) are most extensively used
in the literature for bone regeneration application as they are not
associated with ethical or safety constraints.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup> Adult MSCs can be isolated from tissues such as bone marrow and
adipose, which are vascularized.<sup><xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref179">179</xref>,<xref ref-type="bibr" rid="ref182">182</xref></sup> They possess beneficial properties including multilineage
potential for differentiation (adipogenic, chondrogenic, and osteogenic),
high proliferative abilities, and immunomodulatory capabilities.<sup><xref ref-type="bibr" rid="ref179">179</xref>,<xref ref-type="bibr" rid="ref180">180</xref>,<xref ref-type="bibr" rid="ref182">182</xref></sup> Bone marrow derived stem cells
are the frequent cell choice for bone tissue engineering applications
and treatment of bone disease since they have demonstrated the highest
potential for osteogenic differentiation and bone repair.<sup><xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref181">181</xref>,<xref ref-type="bibr" rid="ref182">182</xref></sup> These cells are harvested during
bone marrow biopsies, often from the iliac crest, sternum, or proximal
tibia, which all are rich in marrow and are induced for differentiation
through exposure of cells to a high phosphate environment.<sup><xref ref-type="bibr" rid="ref181">181</xref>,<xref ref-type="bibr" rid="ref182">182</xref>,<xref ref-type="bibr" rid="ref190">190</xref></sup></p><p>Although bone marrow derived
stem cells are commonly employed and have been extensively characterized,
they only compose around 0.001 to 0.1% of cells present in the marrow,
which make their isolation in large quantities very difficult.<sup><xref ref-type="bibr" rid="ref181">181</xref></sup> The cell number for isolation is dependent
on various parameters including the donor&#8217;s age and associated
donor site morbidity and their limited quantity is a significant disadvantage
to their use.<sup><xref ref-type="bibr" rid="ref188">188</xref></sup></p><p>An alternative cell
source for osteogenic applications includes
adipose derived stem cells (ADSCs). These cells are attained from
adipose tissue through minimally invasive surgical procedures such
as liposuction.<sup><xref ref-type="bibr" rid="ref182">182</xref>,<xref ref-type="bibr" rid="ref188">188</xref>,<xref ref-type="bibr" rid="ref190">190</xref></sup> They can be retrieved in high abundance from harvesting, and their
differentiation from fibroblast-like morphology makes them very interesting
for rapid formation of connective tissue.<sup><xref ref-type="bibr" rid="ref42">42</xref>,<xref ref-type="bibr" rid="ref181">181</xref>,<xref ref-type="bibr" rid="ref182">182</xref>,<xref ref-type="bibr" rid="ref188">188</xref>,<xref ref-type="bibr" rid="ref191">191</xref>,<xref ref-type="bibr" rid="ref192">192</xref></sup> However, their osteogenic ability has been questioned since some
studies have shown lower capability for differentiation compared to
bone marrow derived stem cells.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref188">188</xref></sup> Others have demonstrated
that their differentiation potential is adequate and can be enhanced
in this cell type through culture with osteogenic medium.<sup><xref ref-type="bibr" rid="ref181">181</xref></sup></p></sec></sec></sec><sec id="sec5"><label>5</label><title>Osteoinductive Mediators&#8217; Encapsulation
in Cross-linked Chitosan Scaffolds</title><p>The third major aspect
in the design of biological substitutes
for bone tissue regeneration involves the incorporation of bioactive
molecules, drugs, and growth factors with osteoinductive properties.
These components are responsible for influencing cellular functionality
including the attraction of cells to the injured site, and stimulation
of cells to undergo osteogenic differentiation in turn resulting in
bone regeneration.<sup><xref ref-type="bibr" rid="ref193">193</xref>&#8722;<xref ref-type="bibr" rid="ref196">196</xref></sup> While in cell cultures growth factors can be added to media, it
is often more effective to encapsulate them in the scaffold or conjugate
them to the polymer backbone through chemical modification.<sup><xref ref-type="bibr" rid="ref194">194</xref>,<xref ref-type="bibr" rid="ref197">197</xref></sup> Within the scaffold, factors can be locally delivered to the injury
site in a controlled release manner, allowing for the creation of
a similar microenvironment to the natural healing cascade.<sup><xref ref-type="bibr" rid="ref193">193</xref>,<xref ref-type="bibr" rid="ref198">198</xref>,<xref ref-type="bibr" rid="ref199">199</xref></sup></p><p>Many studies have been
conducted within the literature examining
the application of different osteoinductive mediators with respect
to cross-linked chitosan scaffolds including growth factors, mediators,
enzymes, drugs, compounds, and nanoparticles (<xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig">10</xref></xref>).</p><fig id="fig10" position="float" orientation="portrait"><label>Figure 10</label><caption><p>Common osteoinductive mediators in the literature
for chitosan-based
cross-linked scaffolds.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr11" position="float" orientation="portrait" xlink:href="mt3c00108_0010.jpg"/></fig><sec id="sec5.1"><label>5.1</label><title>Encapsulation of Growth Factors in Cross-linked
Chitosan Scaffolds</title><p>Traditional growth factors, such as BMPs,
have great potential in bone regeneration applications since they
are known to have a physiological role in the fracture healing cascade.<sup><xref ref-type="bibr" rid="ref199">199</xref></sup> BMPs residing within the transforming growth
factor-beta (TGF-&#946;) family are one of the most popular osteogenic
growth factors currently. These factors encourage bone formation through
downstream events that occur due to receptor binding.<sup><xref ref-type="bibr" rid="ref193">193</xref>&#8722;<xref ref-type="bibr" rid="ref195">195</xref>,<xref ref-type="bibr" rid="ref199">199</xref></sup> BMPs 2 and 7 specifically are
known to be responsible for bone regeneration and have been demonstrated
in the literature for controlled delivery both alone and in conjunction
with other mediators from chitosan-based scaffolds.<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref114">114</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref161">161</xref>,<xref ref-type="bibr" rid="ref169">169</xref>,<xref ref-type="bibr" rid="ref193">193</xref>&#8722;<xref ref-type="bibr" rid="ref195">195</xref></sup> A study by Nath <italic toggle="yes">et al.</italic> demonstrated the osteogenic
effects of BMP2 incorporation into a chitosan and hyaluronic acid
scaffold cross-linked with 3 mg of genipin. Results showed that MC3T3
preosteoblast cells in the scaffolds coencapsulated with BMP2 exhibited
higher expression levels of early differentiation markers ALP and
osteopontin (OPN) at day 7 compared to control groups, as well as
significantly higher late-stage expression of OPN at day 28. While
this study showed the benefits of coencapsulation, the osteogenic
effect of sustained release of BMP2 was not considered for cells outside
the scaffold.<sup><xref ref-type="bibr" rid="ref129">129</xref></sup> This missing aspect was
however explored in the scope of a chitosan-agarose-gelatin scaffold
with chitosan oligosaccharide/heparin nanoparticles. Through
indirect culture of MSCs, Wang <italic toggle="yes">et al.</italic> demonstrated
that the loading of BMP2 within the nanoparticles resulted in a sustained
release over time leading to increased ALP activity and osteogenic
induction throughout 21 days. These BMP2 loaded nanoparticles in the
chitosan-agarose-gelatin scaffold showed significantly higher ALP
levels compared to the nanoparticles or scaffold alone and demonstrated
similar levels to the group with BMP2 alone at early time points.
At later stages, this BMP2 loaded test group also exhibited more positive
alizarin red calcium staining compared to the BMP2 alone control group.<sup><xref ref-type="bibr" rid="ref114">114</xref></sup> Interestingly, while BMPs are present in a
variety of studies in the literature for chitosan-based scaffolds
due to their demonstrated beneficial effects, other alternatives are
considered due to their high cost and possible side effects.</p></sec><sec id="sec5.2"><label>5.2</label><title>Encapsulation of Bioactive Compounds in Cross-linked
Chitosan Scaffolds</title><p>In addition to traditional growth factors,
studies within the bone tissue engineering domain heavily rely on
the incorporation of osteoinductive mediators such as bioceramics,
namely HA<sup><xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref69">69</xref>,<xref ref-type="bibr" rid="ref71">71</xref>,<xref ref-type="bibr" rid="ref76">76</xref>,<xref ref-type="bibr" rid="ref81">81</xref>,<xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref94">94</xref>,<xref ref-type="bibr" rid="ref101">101</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref136">136</xref>,<xref ref-type="bibr" rid="ref141">141</xref>,<xref ref-type="bibr" rid="ref145">145</xref>,<xref ref-type="bibr" rid="ref146">146</xref>,<xref ref-type="bibr" rid="ref152">152</xref>,<xref ref-type="bibr" rid="ref164">164</xref>&#8722;<xref ref-type="bibr" rid="ref166">166</xref></sup> and &#946;-TCP.<sup><xref ref-type="bibr" rid="ref70">70</xref>,<xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref92">92</xref>,<xref ref-type="bibr" rid="ref145">145</xref></sup> Both ceramics
contain calcium and phosphate, which make up the main components of
mineralized bone.<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref200">200</xref>&#8722;<xref ref-type="bibr" rid="ref203">203</xref></sup> Many studies have included HA within their designed chitosan-based
scaffolds due to its biocompatibility with cells and its known bioactivity
both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>.<sup><xref ref-type="bibr" rid="ref204">204</xref></sup> Recent work has explored the combination of
HA with other compounds for added promotion of osteogenic activities.
Lu <italic toggle="yes">et al.</italic> incorporated n-HA with fucoidan into a
hydroxypropyl chitosan scaffold cross-linked with genipin.<sup><xref ref-type="bibr" rid="ref69">69</xref></sup> While the incorporation of n-HA alone in these
scaffolds resulted in a marked concentration-dependent increase in
ALP activity for 7F2 osteoblasts compared to controls, the combination
of n-HA with fucoidan produced an even higher ALP activity. The influence
of HA incorporation either alone or in combination with fucoidan also
showed increased calcium deposition in alizarin red staining, signifying
its benefits in mineralization induction. Combination of HA and &#946;-TCP
in varying ratios has also been tested in chitosan-based scaffolds<sup><xref ref-type="bibr" rid="ref68">68</xref> ,<xref ref-type="bibr" rid="ref81">81</xref> ,<xref ref-type="bibr" rid="ref95">95</xref> ,<xref ref-type="bibr" rid="ref133">133</xref></sup> since this biphasic calcium phosphate composite is expected to have
increased osteoconductivity to HA alone.</p><p>More recently, studies
have focused on this criterial element by incorporating enzymes, natural
compounds, and drugs in their chitosan-based scaffolds. A few studies
used pyrophosphatase in combination with the purine cross-linker guanosine
diphosphate to promote mineralization.<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref86">86</xref>,<xref ref-type="bibr" rid="ref88">88</xref></sup> Nayef <italic toggle="yes">et al.</italic> have shown that due
to the enzymatic cleavage of the purine during the degradation process,
a large quantity of pyrophosphate is found in the culture media.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Incorporation of pyrophosphatase served to cleave
observed pyrophosphates into phosphate ions allowing for an increased
ratio of phosphate to pyrophosphate, thus producing mineralization
at levels similar to those treated with direct BMP7 injection in MC3T3
cell cultures.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Additional studies have
expanded the pyrophosphatase encapsulation in conjunction with adipose
derived stem cells<sup><xref ref-type="bibr" rid="ref86">86</xref></sup> in the chitosan scaffold
and reported on its beneficial effect <italic toggle="yes">in vivo</italic> using
mouse tibial defect models.<sup><xref ref-type="bibr" rid="ref88">88</xref></sup></p><p>The
loading of bisphosphonate drugs such as Alendronate have also
been explored for promoting osteogenic activity in chitosan cross-linked
scaffolds.<sup><xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref121">121</xref></sup> Alendronate has been shown to
increase BMP2 expression, thereby stimulating osteogenic differentiation
and mineralization. A recent study by Shi <italic toggle="yes">et al.</italic> examined
these possible beneficial effects in a chitosan and polycaprolactone
scaffold cross-linked with genipin.<sup><xref ref-type="bibr" rid="ref119">119</xref></sup> Through
seeding of ectomesenchyme cells, they demonstrated increased osteogenic
induction (ALP activity) and calcium deposition with Alendronate compared
to the control scaffolds. Additionally, results showed an increased
level of BMP2 proteins within this test group, which could suggest
Alendronate as a possible lower-cost alternative to BMP2 growth factor.
Since bisphosphonate drugs are often more commonly associated with
their roles in osteoclast activity inhibition, their usage proves
beneficial in diseases such as osteoporosis or Paget&#8217;s disease
where additional bone turnover is observed.</p><p>Natural medicinal
compounds derived from herbs and minerals have
also been considered as an alternate option for promotion of osteogenic
differentiation to mitigate high costs and long-lasting side effects.<sup><xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref148">148</xref></sup> Two flavonoid compounds, Quercetin
and Icariin, have been explored recently with encapsulation into chitosan-based
cross-linked scaffolds as possible agents for promotion of bone regeneration
and formation. Both compounds exhibit similar effects in bone metabolism
to estrogen, thus inhibiting osteoclast differentiation and promoting
osteoblast formation. A study by Min <italic toggle="yes">et al.</italic> showed
a synergistic osteogenic effect of amino-functionalized mesoporous
bioglass nanoparticles loaded with Quercetin in a chitosan cysteine
conjugate composite (CH&#8211;CY) with difunctionalized PEG cross-linkers.<sup><xref ref-type="bibr" rid="ref100">100</xref></sup> Hydrogels with loaded nanoparticles exhibited
increased ALP activity and Collagen I content at 14 days compared
to CH&#8211;CY gels alone. The authors suggested that the synergistic
effect was a result of both Si and Ca ions released due to nanoparticle
degradation as well as quercetin release. While these encouraging
results of natural compounds are outlined clearly in the literature,
their tested incorporation in the scaffolds serves to design a drug
delivery system whereby drug release can be carefully controlled.
Often, loading of these compounds relies on the usage of nano or microparticles
within the scaffold as can be seen in the previous example.</p></sec><sec id="sec5.3"><label>5.3</label><title>Inorganic Mediators Encapsulation in Micro-
and Nanoparticles</title><p>Nanoparticle encapsulation in chitosan-based
cross-linked scaffolds has incorporated the usage of mostly inorganic
materials including silica,<sup><xref ref-type="bibr" rid="ref90">90</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref118">118</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref122">122</xref>,<xref ref-type="bibr" rid="ref125">125</xref>,<xref ref-type="bibr" rid="ref127">127</xref></sup> copper,<sup><xref ref-type="bibr" rid="ref139">139</xref></sup> zinc oxide,<sup><xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref148">148</xref></sup> strontium,<sup><xref ref-type="bibr" rid="ref170">170</xref></sup> and titanium oxide.<sup><xref ref-type="bibr" rid="ref128">128</xref></sup> Silica is one of the components that make up
bioactive glass, thus making its incorporation in studies popular.
Unlike the previous compounds and additives, silica has been shown
to promote apatite formation in cultures of simulated body fluid as
well as osteogenic differentiation. Filipowska <italic toggle="yes">et al.</italic> demonstrates both effects using hBMSCs in a chitosan and collagen
composite scaffold.<sup><xref ref-type="bibr" rid="ref127">127</xref></sup> In groups with silica
particles, the mRNA expression levels of osteogenic related genes
(RUNX2, COL-1, and osteocalcin) were significantly higher than the
control group at day 14. Interestingly, results demonstrated a dependency
of the mRNA expression on the size of the particles at this early
stage where the smaller particles exhibited higher levels. In addition,
SEM micrographs of both silica particle groups showed aggregation
on the surface of the cell as a sign of mineralization and apatite
formation compared to the smooth surface found in the control collagen
and chitosan scaffold. EDS analysis for calcium and phosphorus on
these surfaces illustrated silica&#8217;s effect on calcium and phosphate
production. These two test groups had Ca/P ratios around 1.65, which
is similar to that of native crystalline hydroxyapatite. Other inorganic
materials listed above have also been tested within these scaffolds,
however to a much lesser extent. Copper is one of these less explored
elements but has been shown to promote bone formation in the literature.
A study by Lu <italic toggle="yes">et al.</italic> demonstrated that the incorporation
of copper nanoparticles in a carboxymethyl chitosan and alginate scaffold
resulted in increased ALP activity at day 7, and increased COL-1 and
osteocalcin mRNA expression at day 14.<sup><xref ref-type="bibr" rid="ref139">139</xref></sup> Interestingly, the copper nanoparticles were used in place of Cu<sup>2+</sup> ions in this study to slow down the cross-linking process
of the carboxymethyl chitosan and alginate scaffold. It has been shown
that the Cu<sup>2+</sup> ion alone can serve as a cross-linker, thus
allowing the scaffold to cross-link slowly as ions are released.</p></sec><sec id="sec5.4"><label>5.4</label><title>Investigation of Release Kinetics of Encapsulated
Compounds</title><p>Since one of the main challenges in the design
of biological substitutes with mediators, growth factors, or drugs
is the achievement of a sustained release profile, kinetic release
studies are often conducted <italic toggle="yes">in vitro</italic> as part of scaffold
characterization.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref205">205</xref>&#8722;<xref ref-type="bibr" rid="ref207">207</xref></sup> To perform these tests, scaffolds are loaded with a model component
and its concentration in the supernatant is measured over a certain
amount of time (<xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig">11</xref></xref>, <xref rid="tbl5" ref-type="other">Table <xref rid="tbl5" ref-type="other">5</xref></xref>).
The most common method to assess the release kinetics includes UV&#8211;vis
spectrophotometry and absorbance readings, with half of the relevant
articles having reported on this methodology. Other techniques like
enzyme linked immunosorbent assays, HPLC, or protein assays can also
be used. Ideally, the release of growth factors and mediators for
osteogenic promotion needs to be sustained throughout the healing
process. Thus, research incorporating compounds such as BMPs, bisphosphonates,
or inorganic materials in chitosan scaffolds often tests this kinetics
throughout a designated period. Some studies have examined a short
duration of time up to 2 weeks,<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref91">91</xref>,<xref ref-type="bibr" rid="ref135">135</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref155">155</xref></sup> while others have examined release past 4 or 5 weeks<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref96">96</xref>,<xref ref-type="bibr" rid="ref130">130</xref></sup> enabling a more comprehensive
understanding of the mediator&#8217;s possible effect over time.</p><fig id="fig11" position="float" orientation="portrait"><label>Figure 11</label><caption><p>General
mechanisms that mediate the release of factors from scaffolds
and common methodologies used to assess this release.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr12" position="float" orientation="portrait" xlink:href="mt3c00108_0011.jpg"/></fig><table-wrap id="tbl5" position="float" orientation="portrait"><label>Table 5</label><caption><title>Common Methodologies for Encapsulation
Efficiency and Release Kinetic Studies in Chitosan Cross-linked Scaffolds
for Bone (<italic toggle="yes">N</italic> = 31)</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">Growth Factor
Properties</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Incorporation
in Growth Factor Studies (%)</th><th style="border:none;" align="center" colspan="1" rowspan="1">Information
Obtained</th><th style="border:none;" align="center" colspan="1" rowspan="1">Methodology</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Usage in
Specific Property Category testing (%)</th></tr></thead><tbody><tr><td rowspan="6" style="border:none;" align="left" colspan="1">Encapsulation
efficiency</td><td rowspan="6" style="border:none;" align="char" char="." colspan="1">45.2%</td><td rowspan="4" style="border:none;" align="left" colspan="1">Drug loading
rate encapsulation efficiency</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>UV&#8211;vis/ spectrophotometer&#8211;absorbance
readings</bold>(<xref ref-type="bibr" rid="ref67">67</xref>,<xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref121">121</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>35.7%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">ELISA<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref96">96</xref>,<xref ref-type="bibr" rid="ref114">114</xref>,<xref ref-type="bibr" rid="ref167">167</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">28.6%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">HPLC<sup><xref ref-type="bibr" rid="ref119">119</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">7.1%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Weight measurements
of drug<sup><xref ref-type="bibr" rid="ref105">105</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">7.1%</td></tr><tr><td rowspan="2" style="border:none;" align="left" colspan="1">Drug specific
testing</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>BCA
protein assay&#8211;used
commonly for BSA loading</bold>(<xref ref-type="bibr" rid="ref91">91</xref>,<xref ref-type="bibr" rid="ref129">129</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>14.3%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Toluidine Blue staining
(presence of heparin)</bold>(<xref ref-type="bibr" rid="ref96">96</xref>,<xref ref-type="bibr" rid="ref146">146</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>14.3%</bold></td></tr><tr><td rowspan="7" style="border:none;" align="left" colspan="1">Release kinetics</td><td rowspan="7" style="border:none;" align="char" char="." colspan="1">96.7%</td><td rowspan="5" style="border:none;" align="left" colspan="1">Release rate
of drug percentage of drug released</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>UV&#8211;vis/ spectrophotometer&#8211;absorbance
readings</bold>(<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref68">68</xref>,<xref ref-type="bibr" rid="ref73">73</xref>,<xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref100">100</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref132">132</xref>,<xref ref-type="bibr" rid="ref147">147</xref>,<xref ref-type="bibr" rid="ref153">153</xref>,<xref ref-type="bibr" rid="ref157">157</xref>,<xref ref-type="bibr" rid="ref161">161</xref>,<xref ref-type="bibr" rid="ref169">169</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>50%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">ELISA<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref96">96</xref>,<xref ref-type="bibr" rid="ref114">114</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref167">167</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">26.7%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Inductively coupled
plasma
mass spectrometry<sup><xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref139">139</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">6.7%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Aluminum trichloride method<sup><xref ref-type="bibr" rid="ref158">158</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.3%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">HPLC<sup><xref ref-type="bibr" rid="ref135">135</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.3%</td></tr><tr><td rowspan="2" style="border:none;" align="left" colspan="1">Drug specific
testing</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>BCA
protein assay&#8211;used
commonly for BSA loading</bold>(<xref ref-type="bibr" rid="ref91">91</xref>,<xref ref-type="bibr" rid="ref155">155</xref>,<xref ref-type="bibr" rid="ref162">162</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>10%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Toluidine
Blue Assay (concentration
of Heparin)<sup><xref ref-type="bibr" rid="ref146">146</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.3%</td></tr></tbody></table></table-wrap><p>Osteogenic mediators and factors can be added to chitosan
scaffolds
mainly through covalent or noncovalent binding.<sup><xref ref-type="bibr" rid="ref208">208</xref>,<xref ref-type="bibr" rid="ref209">209</xref></sup> The latter is more prominent in bone-oriented applications and involves
the adsorption of the factors onto the scaffolds or their entrapment
within the scaffold mesh.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref210">210</xref></sup> Electrostatic interactions,
hydrophobic interactions, hydrogen bonding, or van der Waals forces
play a major role in immobilizing factors noncovalently onto the scaffolds,
and disruption of these interactions can influence the release kinetics.<sup><xref ref-type="bibr" rid="ref208">208</xref>,<xref ref-type="bibr" rid="ref209">209</xref></sup> Generally, different mechanisms mediate the release of factors from
scaffolds including desorption and diffusion of factors outside of
the scaffold, swelling of the scaffold, or degradation of the scaffold&#8217;s
structure, and they have been previously reviewed in a publication
by Herdiana <italic toggle="yes">et al</italic>.<sup><xref ref-type="bibr" rid="ref211">211</xref></sup> In
addition to the type of factor added, the release mechanism also depends
on how the factor interacts with and is bound to the scaffold as well
as the properties of the scaffold itself. Thus, changes in the composition
of the scaffold can allow for the rate of release to be tuned and
controlled more precisely.<sup><xref ref-type="bibr" rid="ref210">210</xref></sup></p><p>As
discussed in the previous sections, cross-linking of chitosan
greatly influences the material properties of the formed scaffold,
which in turn can affect the release of factors depending on the cross-linker
used and its concentration (<xref rid="tbl6" ref-type="other">Table <xref rid="tbl6" ref-type="other">6</xref></xref>). Therefore, it is necessary to take that into consideration
when developing cross-linked chitosan scaffolds in order to yield
optimal kinetics. As an example, the addition of a model drug, Pentoxifylline,
was examined in multiple chitosan scaffold formulations with either
genipin (CG) or pectin cross-linkers (CP).<sup><xref ref-type="bibr" rid="ref73">73</xref></sup> Results indicated a significant difference in release kinetics among
all tested groups with the genipin cross-linker showing the most promise
with a lower cumulative release percentage after 6 h (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>A). However, the high percentage
values at 6 h (around 80% in CG scaffolds) seems to indicate an initial
burst release, which has been demonstrated in other studies in the
literature.<sup><xref ref-type="bibr" rid="ref77">77</xref>,<xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref93">93</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref114">114</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref129">129</xref>,<xref ref-type="bibr" rid="ref155">155</xref>,<xref ref-type="bibr" rid="ref167">167</xref></sup> However, it would be interesting in this scenario to determine whether
the kinetics becomes more gradual at later points. A study by Ji <italic toggle="yes">et al.</italic> has indicated that while this burst trend is often
observed, it is usually accompanied by two additional stages: a line
and slow stage. This was evident in the results of their study, where
the release of BMP2 from composite chitosan scaffolds with mineralized
COL-I and poly lactic-co-glycolic acid (plga) microspheres was high
at day 3 (162.8 pg rhbmp2 per mg) but gradually reached 361.06 pg
at the 28th day of culture (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>B).<sup><xref ref-type="bibr" rid="ref135">135</xref></sup> This notion of stages
for release profiles was also found in other studies where an initial
burst release occurred.<sup><xref ref-type="bibr" rid="ref87">87</xref></sup></p><table-wrap id="tbl6" position="float" orientation="portrait"><label>Table 6</label><caption><title>Common Osteogenic Mediators Examined
in the Literature for Release Kinetics from Chitosan-Based Scaffolds</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">Mediator
in Literature</th><th style="border:none;" align="center" colspan="1" rowspan="1">Scaffold
Tested</th><th style="border:none;" align="center" colspan="1" rowspan="1">Cross-linking
Method</th><th style="border:none;" align="center" colspan="1" rowspan="1">Observed
Outcomes</th></tr></thead><tbody><tr><td rowspan="5" style="border:none;" align="left" colspan="1">BMP-2</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/alginate</td><td style="border:none;" align="left" colspan="1" rowspan="1">EDC/NHS</td><td style="border:none;" align="left" colspan="1" rowspan="1">Lower cross-linking levels
showed higher initial burst release, as well as absolute amount of BMP-2 released over 1 month<sup><xref ref-type="bibr" rid="ref161">161</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/hyaluronic
acid</td><td style="border:none;" align="left" colspan="1" rowspan="1">Genipin</td><td style="border:none;" align="left" colspan="1" rowspan="1">Initial burst release was
observed that became more gradual and sustained after 3 days and lasted
over 4 weeks<sup><xref ref-type="bibr" rid="ref129">129</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/collagen</td><td style="border:none;" align="left" colspan="1" rowspan="1">Sodium tripolyphosphate
(STPP)</td><td style="border:none;" align="left" colspan="1" rowspan="1">Initial burst
release followed
by a linear stage for 3 days after which the kinetics reached a slow-release
stage<sup><xref ref-type="bibr" rid="ref135">135</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan</td><td style="border:none;" align="left" colspan="1" rowspan="1">Sodium tripolyphosphate
(STPP)</td><td style="border:none;" align="left" colspan="1" rowspan="1">No initial
burst release
was observed. Release was sustained over 45 days, after which 90%
of BMP-2 was released<sup><xref ref-type="bibr" rid="ref96">96</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/agarose/gelatin</td><td style="border:none;" align="left" colspan="1" rowspan="1">Glutaraldehyde</td><td style="border:none;" align="left" colspan="1" rowspan="1">Zero-order-like release
sustained over 15 days<sup><xref ref-type="bibr" rid="ref114">114</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Alendronate</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/polycaprolactone</td><td style="border:none;" align="left" colspan="1" rowspan="1">Genipin</td><td style="border:none;" align="left" colspan="1" rowspan="1">Addition of polycaprolactone
to the scaffold demonstrated a more sustained release of alendronate
compared to the control which had faster release. More than 90% of
the drug was released from either scaffold after 7 days<sup><xref ref-type="bibr" rid="ref119">119</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Icariin</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan</td><td style="border:none;" align="left" colspan="1" rowspan="1">Glutaraldehyde</td><td style="border:none;" align="left" colspan="1" rowspan="1">50% of icariin was released
after 8 h. By the 24 h mark, 73% of loaded icariin was released, after
which the rate of release became slow and sustained<sup><xref ref-type="bibr" rid="ref83">83</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Ascorbic acid</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan</td><td style="border:none;" align="left" colspan="1" rowspan="1">Guanosine diphosphate</td><td style="border:none;" align="left" colspan="1" rowspan="1">A burst release was observed
in the first 5 h, in which 50% of ascorbic acid was released. Afterward,
the release became more gradual up to 6 days<sup><xref ref-type="bibr" rid="ref87">87</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Gentamicin</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#914;-Glycerophosphate</td><td style="border:none;" align="left" colspan="1" rowspan="1">100% of the drug
was released
in 4&#160;h<sup><xref ref-type="bibr" rid="ref153">153</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Levofloxacin</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/biphasic calcium
phosphates</td><td style="border:none;" align="left" colspan="1" rowspan="1">Genipin</td><td style="border:none;" align="left" colspan="1" rowspan="1">Initial fast release that
begins to plateau after 10 min. This burst release is more pronounced
with a higher Ca/P ratio. More than half the drug is released after
30 min, regardless of Ca/P ratio<sup><xref ref-type="bibr" rid="ref68">68</xref></sup></td></tr></tbody></table></table-wrap><fig id="fig12" position="float" orientation="portrait"><label>Figure 12</label><caption><p>Cumulative release profiles of different encapsulants from scaffolds.
(A) Release percentage of pentoxifylline at the 6 h time point for
chitosan scaffolds cross-linked with genipin, pectin, or freeze-dried.
Reproduced and adapted with permission from ref (<xref ref-type="bibr" rid="ref73">73</xref>). Copyright 2015 IOP Publishing.
(B) Cumulative release of rhBMP2 from PLGA microspheres, which will
be placed in composite chitosan scaffolds with mineralized collagen
I. Reproduced and adapted with permission from ref (<xref ref-type="bibr" rid="ref135">135</xref>). Copyright 2017 Wiley
Periodicals, Inc. (C) Release patterns of rhBMP-2 and vancomycin (VAN)
from methacrylated chitosan photo-cross-linked scaffolds with or without
PLGA microspheres. Reproduced and adapted with permission from ref (<xref ref-type="bibr" rid="ref169">169</xref>). Copyright 2021 Elsevier.
(D) Cumulative release percentage of tetracycline hydrochloride from
carboxymethyl chitosan/oxidized gellan gum gels with hydroxyapatite
(HAp/gel) and gels with magnetic hydroxyapatite/gelatin microspheres
(MHGMs). Reproduced and adapted with permission from ref (<xref ref-type="bibr" rid="ref103">103</xref>). Copyright 2022 Elsevier.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr13" position="float" orientation="portrait" xlink:href="mt3c00108_0012.jpg"/></fig><p>In other instances, authors have focused their
drug delivery studies
to the encapsulation of antibacterial or anti-inflammatory agents
rather than those to promote bone healing.<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref68">68</xref>,<xref ref-type="bibr" rid="ref103">103</xref>,<xref ref-type="bibr" rid="ref169">169</xref></sup> Incorporation
of these drugs, while not directly influencing osteogenic differentiation
and mineralization, still can have a beneficial effect in these applications
since inflammation can hinder successful bone regeneration. Since
fracture healing starts with a preliminary inflammatory phase, it
could potentially be more useful to deliver these drugs faster such
as in the Pentoxifylline study mentioned above. Song et al. also showed
early burst release patterns of an antibacterial agent, Vancomycin,
with more than 80% released in the first 2 days in a chitosan hydrogel
with a coencapsulation of PLGA microparticles loaded with rhBMP2 (<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>C).<sup><xref ref-type="bibr" rid="ref169">169</xref></sup> While this quick release was expected based
on other studies, authors suggested that this rate needs to be further
tuned to match that of the antibacterial stage.</p><p>Loading of drugs
within nano or micro spheres or particles prior
to encapsulation into a chitosan scaffold could serve to delay the
release of drugs or compounds and encourage a more gradual release.
The control of release for antibacterial agents, silver sulfadiazine
and tetracycline hydrochloride, has recently been explored using magnetic
hydroxyapatite and gelatin microspheres cross-linked with glutaraldehyde.<sup><xref ref-type="bibr" rid="ref103">103</xref></sup> Chen <italic toggle="yes">et al.</italic> demonstrated that
due to the solubility of tetracycline hydrochloride in water, the
release rate tends to be accelerated by diffusion in the aqueous environment
(<xref rid="fig12" ref-type="fig">Figure <xref rid="fig12" ref-type="fig">12</xref></xref>D). While
release kinetics from the microspheres and carboxymethyl chitosan
and oxidized gellan gum gel alone resulted in a burst release, the
incorporation of the nanoparticles within the gel was shown to provide
a more sustained release rate. At the 21-day time point, cumulative
release was 16.1%, which was decreased compared to the gel alone.
Similarly, Dorati <italic toggle="yes">et al.</italic> observed complete release
of gentamicin from a &#946;-glycerophosphate cross-linked chitosan
scaffold within only 4 h, which extended to 80 days following the
loading of the drugs within PLGA&#8211;PEG microparticles.<sup><xref ref-type="bibr" rid="ref153">153</xref></sup></p></sec></sec><sec id="sec6"><label>6</label><title>Vascularization in Bone Tissue Engineering</title><p>The fifth element of the diamond concept for proper bone healing
is the development of an adequate vascular network throughout.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> Osteogenesis and angiogenesis are closely associated
processes, sharing some essential mediators. Skeletal vasculature
plays a significant role in the process of bone development (endochondral
and intramembranous ossification), regeneration, and remodeling.<sup><xref ref-type="bibr" rid="ref212">212</xref>,<xref ref-type="bibr" rid="ref213">213</xref></sup> As known, bone is highly vascular tissue and the presence of a vascular
network aids in providing oxygen and nutrients to cells, calcium and
phosphate for mineralization as well as removing waste products from
the site.<sup><xref ref-type="bibr" rid="ref212">212</xref>,<xref ref-type="bibr" rid="ref214">214</xref>&#8722;<xref ref-type="bibr" rid="ref216">216</xref></sup> Formation of these vascular networks within biomaterial substitutes
has been one of the main challenges in the bone tissue engineering
domain and is often overlooked in literature studies. Lack of sufficient
vascularization in tested scaffolds has been shown to result in cell
hypoxia and death since nutrients and oxygen can only travel around
150 &#956;m from surrounding networks.<sup><xref ref-type="bibr" rid="ref215">215</xref>,<xref ref-type="bibr" rid="ref217">217</xref>&#8722;<xref ref-type="bibr" rid="ref219">219</xref></sup></p><p>Vasculogenesis and angiogenesis are
thought to be the main mechanisms
for vascular network formation in bone. While the vasculogenesis mechanism
relies on progenitor cells forming the vasculature without an existing
network, angiogenesis builds off pre-existing networks surrounding
the defect site.<sup><xref ref-type="bibr" rid="ref212">212</xref>,<xref ref-type="bibr" rid="ref220">220</xref></sup> Assessment of vascular formation
within the scaffold <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> relies on measurement of vascular markers.<sup><xref ref-type="bibr" rid="ref221">221</xref></sup> These can include vascular endothelial growth factor, von Willebrand
factor, vascular endothelial cadherin, and the platelet endothelial
cell adhesion molecule among others.<sup><xref ref-type="bibr" rid="ref221">221</xref></sup></p><p>Recent studies of chitosan-based scaffolds have incorporated
a
chicken chorioallantois membrane (CAM) assay to examine the induction
of angiogenesis. Through this method, Zhang <italic toggle="yes">et al.</italic> were able to demonstrate that the addition of sphingosine 1-phosphate
(S1P) loaded silica nanoparticles (MSNs) to N,O-carboxymethyl chitosan
(NOCC) and aldehyde hyaluronic acid (aHa) nanocomposite hydrogels
resulted in the formation of a dense capillary network compared to
control scaffolds (<xref rid="fig13" ref-type="fig">Figure <xref rid="fig13" ref-type="fig">13</xref></xref>A,B).<sup><xref ref-type="bibr" rid="ref105">105</xref></sup> The difference between
these groups was shown to be significant with respect to the area
of vessels counted from 30.03% in S1P loaded hydrogels to 16.26% in
control. This significant effect of S1P addition was also confirmed <italic toggle="yes">in vivo</italic> subcutaneously in mice (<xref rid="fig13" ref-type="fig">Figure <xref rid="fig13" ref-type="fig">13</xref></xref>C,D). Another chitosan-based composite scaffold
was assessed for vascularization potential <italic toggle="yes">in vivo</italic> as well, but this time using a critical size defect model in the
femoral head of a rabbit.<sup><xref ref-type="bibr" rid="ref133">133</xref></sup> This study
only examined one configuration of their scaffold (2:1:3 mass ratio
of chitosan, gelatin, and biphasic calcium phosphate nanoparticles),
but hematoxylin and eosin (HE) staining results demonstrated improved
vascularity over the course of time from one to three months. No clear
pattern emerges from the literature regarding which encapsulants significantly
improve vascularization of the scaffold, but some publications have
proposed the incorporation of a coculture system to overcome this
aspect.<sup><xref ref-type="bibr" rid="ref87">87</xref>,<xref ref-type="bibr" rid="ref215">215</xref>,<xref ref-type="bibr" rid="ref220">220</xref>,<xref ref-type="bibr" rid="ref222">222</xref></sup> This involves the coencapsulation of an osteoblast
precursor in direct or indirect contact with endothelial cells, allowing
for the regeneration of a tissue more similar to the native environment.<sup><xref ref-type="bibr" rid="ref223">223</xref></sup> However, the specifics of a coculture platform
for healing, while important, are considered to be outside of the
scope of this review.</p><fig id="fig13" position="float" orientation="portrait"><label>Figure 13</label><caption><p>Effect of sphingosine 1-phosphate (S1P) loaded silica
nanoparticles
(MSNs) addition to N,O-carboxymethyl chitosan (NOCC) and aldehyde
hyaluronic acid (aHa) nanocomposite hydrogels on capillary network
formation <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>.
(A, B) Results of CAM assay for examination of angiogenesis and quantification
of vascular area. (C, D) HE staining images at the 2-week time point
after implantation into a mouse. Arrows present the blood vessels.
D presents the counted number of vessels shown. Reproduced and adapted
with permission from ref (<xref ref-type="bibr" rid="ref105">105</xref>). Copyright 2022 Royal Society of Chemistry.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr14" position="float" orientation="portrait" xlink:href="mt3c00108_0013.jpg"/></fig></sec><sec id="sec7"><label>7</label><title>Pre-clinical Implementation of Diamond Concept
Using Chitosan-Based Cross-linked Scaffolds</title><p>While <italic toggle="yes">in vitro</italic> experiments are a necessary step
in the assessment of osteogenic differentiation and regeneration potential
for designed substitutes, the clinical translation of <italic toggle="yes">in vitro</italic> findings require preclinical <italic toggle="yes">in vivo</italic> validations.
Often, the <italic toggle="yes">in vitro</italic> models are not convoluted enough
to accurately represent the complexity of the <italic toggle="yes">in vivo</italic> healing environment.<sup><xref ref-type="bibr" rid="ref224">224</xref></sup> As such, incorporating
animal studies is an essential part of biological substitute development
and evaluation in the framework of the Diamond Concept.<sup><xref ref-type="bibr" rid="ref225">225</xref></sup> Within the literature, this has included studies
of fracture healing models on many mammals, both large and small,
with implantation or injection of chitosan-based cross-linked scaffolds
(<xref rid="tbl7" ref-type="other">Table <xref rid="tbl7" ref-type="other">7</xref></xref>).<sup><xref ref-type="bibr" rid="ref225">225</xref>,<xref ref-type="bibr" rid="ref226">226</xref></sup></p><table-wrap id="tbl7" position="float" orientation="portrait"><label>Table 7</label><caption><title>Cross-linked Chitosan-Based Scaffold
Formulations That Demonstrated Beneficial Bone Regeneration <italic toggle="yes">In Vivo</italic></title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">Species</th><th style="border:none;" align="center" colspan="1" rowspan="1">Defect Model</th><th style="border:none;" align="center" colspan="1" rowspan="1">Scaffold</th><th style="border:none;" align="center" colspan="1" rowspan="1">Additions
Tested</th></tr></thead><tbody><tr><td rowspan="8" style="border:none;" align="left" valign="middle" colspan="1">Rats</td><td rowspan="6" style="border:none;" align="left" valign="middle" colspan="1">Cranial/mandible
defect model</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref80">80</xref>,<xref ref-type="bibr" rid="ref99">99</xref></sup></td><td rowspan="6" style="border:none;" align="left" colspan="1">Carbon nanotubes
and BMP-2,<sup><xref ref-type="bibr" rid="ref64">64</xref></sup>, Alendronate,<sup><xref ref-type="bibr" rid="ref119">119</xref></sup> Graphene oxide and titanium
oxide,<sup><xref ref-type="bibr" rid="ref80">80</xref></sup> Bisphosphonates and BMP-2,<sup><xref ref-type="bibr" rid="ref130">130</xref></sup> Magnesium ions and polyhedral oligomeric silsesquioxane
(POSS) nanoparticles,<sup><xref ref-type="bibr" rid="ref151">151</xref></sup> Graphene oxide
and nanohydroxyapatite,<sup><xref ref-type="bibr" rid="ref65">65</xref></sup> Copper<sup><xref ref-type="bibr" rid="ref99">99</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Carboxymethyl&#160;chitosan<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/polycaprolactone<sup><xref ref-type="bibr" rid="ref119">119</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Methacrylic&#160;modified&#160;chitosan<sup><xref ref-type="bibr" rid="ref130">130</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/collagen<sup><xref ref-type="bibr" rid="ref72">72</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Thiolated&#160;chitosan/gelatin<sup><xref ref-type="bibr" rid="ref151">151</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td style="border:none;" align="left" valign="middle" colspan="1" rowspan="1">Subcutaneous
insertion</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref96">96</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Silicon-substituted calcium
phosphate, rhBMP-2 and heparin<sup><xref ref-type="bibr" rid="ref96">96</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td rowspan="10" style="border:none;" align="left" valign="middle" colspan="1">Mice</td><td rowspan="3" style="border:none;" align="left" valign="middle" colspan="1">Cranial/mandible defect model</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref76">76</xref></sup></td><td rowspan="3" style="border:none;" align="left" colspan="1">Lysozyme,<sup><xref ref-type="bibr" rid="ref140">140</xref></sup> Hydroxyapatite<sup><xref ref-type="bibr" rid="ref76">76</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Methacrylated&#160;glycol&#160;chitosan<sup><xref ref-type="bibr" rid="ref140">140</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Phenol&#160;conjugated&#160;glycol<sup><xref ref-type="bibr" rid="ref167">167</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td style="border:none;" align="left" valign="middle" colspan="1" rowspan="1">Tibial model</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref88">88</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Hydroxyapatite and pyrophosphatase<sup><xref ref-type="bibr" rid="ref88">88</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td rowspan="4" style="border:none;" align="left" valign="middle" colspan="1">Subcutaneous insertion</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref120">120</xref></sup></td><td rowspan="4" style="border:none;" align="left" colspan="1">Graphene oxide,<sup><xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref124">124</xref></sup> Bioglass
nanoparticles and BMP-2,<sup><xref ref-type="bibr" rid="ref79">79</xref></sup> Hydroxyapatite
-decorated silica beads with alendronate,<sup><xref ref-type="bibr" rid="ref121">121</xref></sup> BMP-2<sup><xref ref-type="bibr" rid="ref161">161</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/collagen/hyaluronic&#160;acid<sup><xref ref-type="bibr" rid="ref121">121</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/gelatin<sup><xref ref-type="bibr" rid="ref124">124</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/alginate<sup><xref ref-type="bibr" rid="ref161">161</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td><td style="border:none;" align="left" colspan="1" rowspan="1">&#160;</td></tr><tr><td rowspan="4" style="border:none;" align="left" valign="middle" colspan="1">Rabbits</td><td style="border:none;" align="left" valign="middle" colspan="1" rowspan="1">Cranial/mandible
defect model</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/collagen<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Hydroxyapatite<sup><xref ref-type="bibr" rid="ref111">111</xref></sup></td></tr><tr><td style="border:none;" align="left" valign="middle" colspan="1" rowspan="1">Femoral
model</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan/gelatin<sup><xref ref-type="bibr" rid="ref133">133</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Biphasic calcium phosphate
nanoparticles<sup><xref ref-type="bibr" rid="ref133">133</xref></sup></td></tr><tr><td rowspan="2" style="border:none;" align="left" valign="middle" colspan="1">Tibial
model</td><td style="border:none;" align="left" colspan="1" rowspan="1">Chitosan<sup><xref ref-type="bibr" rid="ref85">85</xref></sup></td><td rowspan="2" style="border:none;" align="left" colspan="1">Citric acid<sup><xref ref-type="bibr" rid="ref85">85</xref></sup></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Oleyol&#160;chitosan/decellularized&#160;bone&#160;matrix<sup><xref ref-type="bibr" rid="ref123">123</xref></sup></td></tr></tbody></table></table-wrap><p>As large animal models, rabbits are used in multiple
studies for
chitosan-based cross-linked scaffolds&#8217; evaluation <italic toggle="yes">in
vivo</italic>.<sup><xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref133">133</xref></sup> These studies have included
examinations of both the cross-linking mechanisms and the necessity
for cell encapsulation for <italic toggle="yes">in vivo</italic> studies. Datta <italic toggle="yes">et al.</italic> examined the influence of human amnion derived MSC
encapsulation using a combinatorial genipin cross-linked fatty acid
modified chitosan and decellularized bone ECM hydrogel in a rabbit
tibial defect model.<sup><xref ref-type="bibr" rid="ref123">123</xref></sup> Results demonstrated
the positive effect of cellular addition, as cell encapsulated scaffolds
produced highly mineralized tissue densities compared to cell free
groups. In addition, staining showed that this incorporation of cells
resulted in similar morphological features to that of the native bone
tissue. This reinforces the notion of osteogenic cells as a crucial
subcategory of the Diamond Concept. Another study using a similar
rabbit tibial defect model provided a thorough understanding of cross-linking&#8217;s
role in bone formation. By comparing two types of chitosan-based fibers
treated with either a citric acid bath for cross-linking or a dual
cross-linking using a citric acid bath and NHS/EDC, the authors were
able to demonstrate that the dual cross-linked chitosan fibers showed
more collagen and mineral deposition.<sup><xref ref-type="bibr" rid="ref85">85</xref></sup> This finding indicated better osteogenic activity and bone regeneration
with higher amounts of cross-linking. In addition to tibial defects,
other studies in rabbits with chitosan scaffolds have used mandible
defects<sup><xref ref-type="bibr" rid="ref111">111</xref></sup> and femoral head<sup><xref ref-type="bibr" rid="ref133">133</xref></sup> defects models, but these models tend to be
less common in both large and small animals.</p><p>Use of small animal
models such as rat and mouse, is significantly
more common than large animal studies since these animals are low
cost and can be kept in large quantities, allowing for more groups
to be tested and more statistically relevant information to be obtained
on differences.<sup><xref ref-type="bibr" rid="ref225">225</xref>,<xref ref-type="bibr" rid="ref226">226</xref></sup> In addition, many of the commercially
available monoclonal antibodies used to conduct a more comprehensive
evaluation of healing are targeted for rat and mouse.<sup><xref ref-type="bibr" rid="ref226">226</xref></sup> Within these rat and mouse models, fracture
healing is completed within 4 to 6 weeks, which is faster than the
timeline for healing in large animal models.<sup><xref ref-type="bibr" rid="ref225">225</xref>,<xref ref-type="bibr" rid="ref226">226</xref></sup> Assessment of healing in these models is conducted at an early phase
(1&#8211;2 weeks) and a late phase (3&#8211;5 weeks in mice, 4&#8211;6
weeks in rats).<sup><xref ref-type="bibr" rid="ref226">226</xref></sup></p><p>Among these murine
models, researchers tend to examine their material&#8217;s
effect on osteogenic differentiation and bone healing through usage
of cranial defects<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref76">76</xref>,<xref ref-type="bibr" rid="ref80">80</xref>,<xref ref-type="bibr" rid="ref82">82</xref>,<xref ref-type="bibr" rid="ref99">99</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref135">135</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref167">167</xref></sup> or subcutaneous incorporation.<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref96">96</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref161">161</xref></sup> However, a few studies have
instead chosen to use tibial<sup><xref ref-type="bibr" rid="ref88">88</xref></sup> or femoral
defect<sup><xref ref-type="bibr" rid="ref112">112</xref></sup> models to better understand the
fate of their scaffold for a load bearing bone application. Often,
incorporation of chitosan-based scaffolds in these cases is done in
combination with a fixator or mechanical stabilizer to bear the load
while the bone is healing. Jahan <italic toggle="yes">et al.</italic> demonstrated
the potential of a chitosan-based GDP cross-linked scaffold with hydroxyapatite
and pyrophosphatase incorporation <italic toggle="yes">in vivo</italic> using a
rod fixated tibia fracture model of mice (<xref rid="fig14" ref-type="fig">Figure <xref rid="fig14" ref-type="fig">14</xref></xref>A).<sup><xref ref-type="bibr" rid="ref88">88</xref></sup> However,
although tibial fracture models are well-established in murine models,
often, femur fracture models are more beneficial since they provide
more consistent results with respect to biomechanical evaluation.<sup><xref ref-type="bibr" rid="ref225">225</xref></sup></p><fig id="fig14" position="float" orientation="portrait"><label>Figure 14</label><caption><p><italic toggle="yes">In vivo</italic> studies using (A&#8211;C)
MicroCT and
(D) HE staining. (A) Images of mouse tibial fractures treated with
nothing (SHAM) or chitosan scaffolds with hydroxyapatite (HA) and
pyrophosphatase (P). Reproduced and adapted under open access conditions
(Creative Commons Attribution License) from ref (<xref ref-type="bibr" rid="ref88">88</xref>). Copyright 2020 Kaushar
Jahan <italic toggle="yes">et al.</italic> and Springer Nature. (B, C) Imaging
and quantitative analysis of a rat cranial defect model at 12 weeks
postsurgery treated with control, chitosan and PCL composite scaffolds,
and composite scaffolds with Alendronate. (C) Quantification of the
mature bone area, bone volume/tissue volume, and bone mineral density
for these samples. Both B and C were reproduced and adapted with permission
from ref (<xref ref-type="bibr" rid="ref119">119</xref>). Copyright
2022 Elsevier. (D) Staining for new bone formation in defects treated
with nothing (top), chitosan scaffold (middle), or a chitosan scaffold
loaded with copper (bottom). Within this figure, the new bone (NB)
and old bone (OB) are distinguished. Reproduced and adapted with permission
from ref (<xref ref-type="bibr" rid="ref99">99</xref>). Copyright
2014 Wiley Periodicals, Inc.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr15" position="float" orientation="portrait" xlink:href="mt3c00108_0014.jpg"/></fig><sec id="sec7.1"><label>7.1</label><title>Methodology of <italic toggle="yes">In Vivo</italic> Bone
Healing Assessment in Chitosan-Based Scaffolds</title><p>Assessment
of the scaffold&#8217;s capability for healing <italic toggle="yes">in vivo</italic> commonly involves three different components: bone imaging, histological
staining and quantitative assays<sup><xref ref-type="bibr" rid="ref225">225</xref>,<xref ref-type="bibr" rid="ref226">226</xref></sup> (<xref rid="fig15" ref-type="fig">Figure <xref rid="fig15" ref-type="fig">15</xref></xref>). <xref rid="tbl8" ref-type="other">Table <xref rid="tbl8" ref-type="other">8</xref></xref> serves to demonstrate the available
techniques for each of these components, as well as the percentage
of use within recent work on chitosan-based scaffolds for bone.</p><fig id="fig15" position="float" orientation="portrait"><label>Figure 15</label><caption><p>Common methodologies
for <italic toggle="yes">in vivo</italic> studies using
animal models in the literature. These are divided into 3 components:
imaging studies, histological staining, and quantitative assays.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr16" position="float" orientation="portrait" xlink:href="mt3c00108_0015.jpg"/></fig><table-wrap id="tbl8" position="float" orientation="portrait"><label>Table 8</label><caption><title>Common Methodologies for <italic toggle="yes">In
Vivo</italic> Testing in Chitosan Cross-linked Scaffolds for Bone
(<italic toggle="yes">N</italic> = 33)</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">In
Vivo</italic> Experiments</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Incorporation
in <italic toggle="yes">In Vivo</italic> Studies (%)</th><th style="border:none;" align="center" colspan="1" rowspan="1">Methodology</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Usage in
Specific <italic toggle="yes">In Vivo</italic> Testing (%)</th></tr></thead><tbody><tr><td rowspan="5" style="border:none;" align="left" colspan="1">Imaging techniques</td><td rowspan="5" style="border:none;" align="char" char="." colspan="1">57.6%</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>MicroCT and CT imaging</bold>(<xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref76">76</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref99">99</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref135">135</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref161">161</xref>,<xref ref-type="bibr" rid="ref163">163</xref>,<xref ref-type="bibr" rid="ref184">184</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>78.9%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">X-ray
imaging<sup><xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref167">167</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">10.5%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Radiography<sup><xref ref-type="bibr" rid="ref82">82</xref>,<xref ref-type="bibr" rid="ref135">135</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">10.5%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Scanning electron microscopy<sup><xref ref-type="bibr" rid="ref80">80</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">5.3%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Stereoscopic
imaging<sup><xref ref-type="bibr" rid="ref80">80</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">5.3%</td></tr><tr><td rowspan="19" style="border:none;" align="left" colspan="1">Staining techniques</td><td rowspan="19" style="border:none;" align="char" char="." colspan="1">87.9%</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>H</bold><bold>E staining</bold>(<xref ref-type="bibr" rid="ref76">76</xref>,<xref ref-type="bibr" rid="ref79">79</xref>,<xref ref-type="bibr" rid="ref80">80</xref>,<xref ref-type="bibr" rid="ref82">82</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref96">96</xref>,<xref ref-type="bibr" rid="ref99">99</xref>,<xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref119">119</xref>&#8722;<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref133">133</xref>,<xref ref-type="bibr" rid="ref135">135</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref158">158</xref>,<xref ref-type="bibr" rid="ref163">163</xref>,<xref ref-type="bibr" rid="ref168">168</xref>,<xref ref-type="bibr" rid="ref170">170</xref>,<xref ref-type="bibr" rid="ref184">184</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>86.2%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Masson&#8217;s
trichrome
staining<sup><xref ref-type="bibr" rid="ref76">76</xref>,<xref ref-type="bibr" rid="ref80">80</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref112">112</xref>,<xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref133">133</xref>,<xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref140">140</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref163">163</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">44.8%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">IHC/IF osteocalcin (OCN)<sup><xref ref-type="bibr" rid="ref119">119</xref>,<xref ref-type="bibr" rid="ref130">130</xref>,<xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref163">163</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">13.8%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Alizarin Red staining<sup><xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref96">96</xref>,<xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref121">121</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">13.8%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Von Kossa staining<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref88">88</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">10.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">CD31 Staining<sup><xref ref-type="bibr" rid="ref105">105</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">10.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Toluidine Blue/Alcian
Blue
staining<sup><xref ref-type="bibr" rid="ref88">88</xref>,<xref ref-type="bibr" rid="ref123">123</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">10.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Gomori&#8217;s Trichrome
staining<sup><xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref124">124</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">6.9%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">IHC/IF RUNX2<sup><xref ref-type="bibr" rid="ref120">120</xref>,<xref ref-type="bibr" rid="ref151">151</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">6.9%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">IHC/IF Collagen 1<sup><xref ref-type="bibr" rid="ref151">151</xref>,<xref ref-type="bibr" rid="ref163">163</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">6.9%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">IHC/IF osteopontin (OPN)<sup><xref ref-type="bibr" rid="ref65">65</xref>,<xref ref-type="bibr" rid="ref120">120</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">6.9%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">ALP staining<sup><xref ref-type="bibr" rid="ref163">163</xref>,<xref ref-type="bibr" rid="ref167">167</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">6.9%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Giemsa staining<sup><xref ref-type="bibr" rid="ref139">139</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Von Willebrand factor staining<sup><xref ref-type="bibr" rid="ref105">105</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Alpha smooth muscle actin
staining<sup><xref ref-type="bibr" rid="ref151">151</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Calcein staining<sup><xref ref-type="bibr" rid="ref64">64</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">TRAP staining<sup><xref ref-type="bibr" rid="ref167">167</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">Tetracycline
staining<sup><xref ref-type="bibr" rid="ref64">64</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.4%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">IHC/IF bone sialo protein
(BSP)<sup><xref ref-type="bibr" rid="ref65">65</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.4%</td></tr><tr><td rowspan="3" style="border:none;" align="left" colspan="1">Assays and
quantitative assessments</td><td rowspan="3" style="border:none;" align="char" char="." colspan="1">9.1%</td><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Quantification of
inflammatory cytokines</bold>(<xref ref-type="bibr" rid="ref121">121</xref>,<xref ref-type="bibr" rid="ref168">168</xref>)</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1"><bold>66.7%</bold></td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">ALP quantification in serum<sup><xref ref-type="bibr" rid="ref120">120</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">33.3%</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">qPCR for gene expression<sup><xref ref-type="bibr" rid="ref120">120</xref></sup></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">33.3%</td></tr></tbody></table></table-wrap><p>Scanning techniques are implemented around 57.6% of
the time in
the literature and are known to aid researchers in fully assessing
newly formed bone tissue prior to sectioning. Micro-CT imaging has
been shown to be the most popular of the available imaging techniques
since it allows for the quantification different parameter values
including bone volume to tissue volume or trabecular spacing, among
others. These scans are typically performed <italic toggle="yes">ex vivo</italic> to encourage the examination of newly formed tissue in a higher
resolution but the technique could also be adapted for monitoring <italic toggle="yes">in vivo</italic> throughout the healing process.<sup><xref ref-type="bibr" rid="ref225">225</xref>,<xref ref-type="bibr" rid="ref227">227</xref></sup> Other scanning techniques have also been found in recent literature
including X-ray imaging (10.5%) or SEM (5.3%); however, these are
significantly less common compared to MicroCT imaging (78.9%).</p><p>Histomorphometry of samples by different staining methods is another
technique that can be applied to acquire specific desired information
on the role of the scaffold on the bone healing process.<sup><xref ref-type="bibr" rid="ref225">225</xref></sup> For example, Georgopoulou <italic toggle="yes">et al.</italic> used HE and Masson Trichrome stainings to assess the ability of
a glutaraldehyde cross-linked chitosan and gelatin scaffold to support
bone regeneration and formation of the extracellular matrix.<sup><xref ref-type="bibr" rid="ref228">228</xref></sup> HE staining is one of the primary methods for
assessing bone healing <italic toggle="yes">in vivo</italic>, with a reported usage
of 86.2% in publications with some sort of staining technique. While
used for histology of many different tissues, the bone structure in
HE-stained images tends to have a dark pink color, whereas connective
tissue will be a noticeably lighter shade of pink. Use of other stains
such as Masson Trichrome and Movat Pentachrome have become a more
set standard in the literature recently since they allow for a more
in-depth observation of the callus tissue composition with only one
required staining.<sup><xref ref-type="bibr" rid="ref229">229</xref>,<xref ref-type="bibr" rid="ref230">230</xref></sup> Other less common staining options
include Von Kossa/Van Gieson which aims to look at mineralization
and Alcian Blue to examine cartilage.</p><p>Quantification of different
parameters using assays does not appear
to be an increasingly common trend with respect to <italic toggle="yes">in vivo</italic> studies as it is with <italic toggle="yes">in vitro</italic> studies (9.1%).
A few studies have used ELISA or kits to measure the production of
inflammatory cytokines, which could in future be an important test
to further understanding the full biocompatibility of the designed
material.</p></sec><sec id="sec7.2"><label>7.2</label><title>Influence of Chitosan Cross-linking on <italic toggle="yes">In Vivo</italic> Studies</title><p>The combination of these techniques
provides a more accurate representation of the full healing process.
Within the literature in the past ten years, very few studies have
examined the effect of scaffold formulation, such as polymer addition
or cross-linker concentration geared toward improving the material
properties, in the <italic toggle="yes">in vivo</italic> osteogenic potential experiments.
Often, the number of tested groups are minimized based on prior investigation
of material properties and <italic toggle="yes">in vitro</italic> cell experiments
to reduce the cost for animal studies. This means that only the optimal
groups, per se, are considered for <italic toggle="yes">in vivo</italic> experiments,
to determine what encapsulants, or factors play a promotional osteogenic
role.</p><p>Incorporation of the bisphosphonate, Alendronate, into
a Chitosan/polylactic acid scaffold was demonstrated to support bony
bridging within the cranial defect model compared to the scaffold
alone in micro-CT images (<xref rid="fig15" ref-type="fig">Figure <xref rid="fig15" ref-type="fig">15</xref></xref>B,C).<sup><xref ref-type="bibr" rid="ref119">119</xref></sup> This beneficial
trend in growth factor addition was also evident with the incorporation
of BMP2 in carboxymethyl chitosan scaffolds with carbon nanotubes.
While the initial intention of this <italic toggle="yes">in vivo</italic> study
was to assess specifically at the carbon nanotube effect, the addition
of BMP2 resulted in a nearly fully covered defect at week 8, whereas
the carbon nanotubes alone in the scaffold had significantly reduced
bone tissue production.<sup><xref ref-type="bibr" rid="ref64">64</xref></sup> The influence
of inorganic materials as mediators was also established in a rat
critical size defect model using a chitosan scaffold with copper cross-linking.<sup><xref ref-type="bibr" rid="ref99">99</xref></sup> Results showed improved mineralized tissue formation
in groups with copper compared to controls and chitosan alone (<xref rid="fig15" ref-type="fig">Figure <xref rid="fig15" ref-type="fig">15</xref></xref>D). This supportive
effect was also confirmed using HE staining. Generally, results presented
here illustrate the necessity of osteogenic compounds in the designed
scaffold and encourage the development of additional and alternative
growth factors for these applications.</p></sec></sec><sec id="sec8"><label>8</label><title>Future Perspectives and Conclusion</title><p>This review serves to provide a thorough comparison of modifications
made to cross-linked chitosan-based scaffolds with respect to the
Diamond Concept including changes of cross-linkers, cell types and
growth factors. Based on the research results in the development of
these scaffolds within the last ten years, it is evident that the
synergistic combination of all aspects of the Diamond Concept are
necessary to achieving successful bone healing. However, consideration
for all these aspects in literature studies of cross-linked chitosan
materials remains lacking hence why no clinically relevant chitosan
scaffold-based solution has been achieved. The base polymer chitosan,
often found in many different variations commercially, should be the
preliminary consideration in the design process with emphasis placed
on chitosan solutions with high DD and molecular weight (MW). Chitosan
has been demonstrated in the literature to have sufficient biocompatibility
with cells and presents many beneficial properties with regards to
osteogenic activities.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> The large DD allows
for the prominence of positive charges in the amine groups throughout
the structure thus improving the interaction of the material with
the cells.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> Both chitosan parameters have
shown an inverse correlation with degradation thus necessitating precise
control of these to tune the rate of scaffold degradation as new bone
formation occurs.<sup><xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref231">231</xref></sup> With respect to the use of chemically
modified chitosan derivatives for bone specific applications, no clear
trend has emerged thus far and further analysis on this should be
conducted.</p><p>Studies have adequately demonstrated the importance
of cross-linking,
with many publications using genipin or glutaraldehyde, yet no clear
cross-linking agent has emerged as optimal with respect to material
properties. Future studies should therefore focus on eliciting a clear
trend between different cross-linkers. Concerns within the literature
have been raised regarding the usage of synthetic chemical cross-linkers
such as glutaraldehyde with respect to cytotoxicity. Thus, a balance
should be struck between benefits to material properties and effects
on cellular functionality. Cross-linking alone however has not been
shown to be sufficient for bone healing and the encapsulation of bioceramics
such as hydroxyapatite can be argued as an integral component to meet
necessary mechanical and osteogenic properties for bone engineering
applications.</p><p>There has been no set standardized methodology
regarding the assessment
of material properties for chitosan-based cross-linked materials,
with many studies using varying techniques that may not necessarily
yield the same information. This, in turn, makes comparisons between
studies significantly more challenging. Future work in this domain
should investigate the material properties of the designed scaffold
in the following presented manner. First, mechanical properties should
be assessed using compression testing since it resembles the experience
of the scaffold in the native tissue environment.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> This method should be supplemented with rheological testing
as viscoelasticity plays an important role in promoting differentiation
of encapsulated cells.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> Second, the structural
architecture examination should be completed scanning electron microscopy
for surface morphology and complemented with micro-CT for internal
structure parameters. While liquid displacement is more popular for
porosity assessment, it can be argued that, if not inhibited by cost
and availability, micro-CT provides a more comprehensive evaluation
of this internal architecture. Finally, biodegradation rates of the
chitosan-based scaffolds should be assessed through incubations in
solutions of PBS or water with enzymes. This method more accurately
serves to simulate the natural body conditions experienced by implanted
scaffolds. Although these degradation patterns have been extensively
characterized within the literature for various scaffold fabrications
in different buffers such as PBS, water, simulated body fluid,<sup><xref ref-type="bibr" rid="ref75">75</xref>,<xref ref-type="bibr" rid="ref95">95</xref>,<xref ref-type="bibr" rid="ref116">116</xref>,<xref ref-type="bibr" rid="ref133">133</xref>,<xref ref-type="bibr" rid="ref145">145</xref></sup> or culture media<sup><xref ref-type="bibr" rid="ref71">71</xref>,<xref ref-type="bibr" rid="ref150">150</xref></sup> no clear standard has been established with regard to the appropriate
degradation timeline needed for striking a balance with the rate of
new bone tissue formation. A more precise timeline for material degradation
should be explored further in future work to allow for the design
of optimal chitosan-based biomaterials.</p><p>With respect to cellular
encapsulation, research should focus on
using more clinically relevant cell lines such as stem cells. The
last 10 years of chitosan-based scaffold studies demonstrate good
advancement in this regard. Assignment of a standardized methodology
for cellular biocompatibility assessment is challenging since many
techniques have been proven effective for attaining similar information
regarding metabolic activity, cytotoxicity, and adhesion. However,
the addition of a cross-linker to scaffolds makes the necessity for
this assessment evident in all future work. Techniques for studying
the potential for cellular differentiation and mineralization should
include an evaluation of both early and late stage markers and would
benefit greatly from gene expression studies on top of secretion and
staining techniques.</p><p>Few studies of cellular activity <italic toggle="yes">in vitro</italic> have
sought to regenerate the complex aspects of the bone structure such
as vascularization. This aspect is known to be important for successful
bone tissue engineering since it serves to provide oxygen and nutrient
to cells within the injured sites, but its success <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> remains a challenge in terms of achievement.<sup><xref ref-type="bibr" rid="ref217">217</xref>,<xref ref-type="bibr" rid="ref232">232</xref></sup> The coculture of osteoblastic lineage cells with endothelial cells
is a seemingly promising method for this endeavor. Future studies
on chitosan-based bone tissue engineering scaffolds can benefit from
a comprehensive evaluation of all aspects of the Diamond Concept including
vascularization instead of only focusing on osteogenic differentiation
and mineralization.</p><p>While research examining the combination
of the different aspects
of the Diamond Concept is prominent <italic toggle="yes">in vitro</italic>, its
application has been lacking <italic toggle="yes">in vivo</italic>. As previously
discussed, <italic toggle="yes">in vivo</italic> studies in the literature incorporate
3 main components including imaging, staining, and quantitative assays.
Micro-CT imaging of the regenerated bone should become the gold standard
for imaging methodologies since it provides an abundance of qualitative
and quantitative information and can be nondestructive. This property
is beneficial as it allows for scanning of the same bones at multiple
time points without the addition of more groups, thereby following
the reduction principle of animal work (the 3Rs). Imaging of the samples
should, in turn, be sequentially followed by sectioning and staining
to assess specific aspects of healing. Recent studies have demonstrated
the clear benefit of both HE and Masson&#8217;s Trichrome since they
stain multiple tissue types with only one necessary staining. Thus,
the implementation of these stains in animal samples should become
standard practice but could be complemented with additional ones if
a particular aspect of healing is of specific interest.</p><p>Studies
exploring the use of quantitative assays within <italic toggle="yes">in vivo</italic> studies has been sufficiently lacking in recent
publications but are recommended to be added in the future. Incorporation
of assays and tests such as qPCR for osteogenic gene expression or
serum secretion levels of markers such as ALP could be beneficial
in conjunction with imaging and staining in attaining a more complete
profile of <italic toggle="yes">in vivo</italic> healing. In addition to this,
future studies of chitosan cross-linked scaffolds should also focus
on exploring more comprehensively their capabilities <italic toggle="yes">in vivo</italic> for aiding in bone formation with biomechanical testing including
torsional and 3-point bending. This determination of the newly formed
bone&#8217;s mechanical properties can help to design a detailed
therapeutic option for future clinical testing and usage.</p></sec></body><back><notes notes-type="COI-statement" id="NOTES-d14e5838-autogenerated"><p>The authors declare no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The authors acknowledge the financial support of
CIHR and NSERC via the Collaborative Health Research Program, Canada
Research Chair &#8211; Tier 1 in Regenerative Medicine and Nanomedicine,
as well as FRQ-S funding. All schematic figures were created using
the Biorender software under paid subscription, and graphs were created
using Graphpad Prism.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name name-style="western"><surname>Marsell</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Einhorn</surname><given-names>T. A.</given-names></name><article-title>The biology of fracture healing</article-title>. <source>Injury</source><year>2011</year>, <volume>42</volume> (<issue>6</issue>), <fpage>551</fpage>&#8211;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1016/j.injury.2011.03.031</pub-id>.<pub-id pub-id-type="pmid">21489527</pub-id><pub-id pub-id-type="pmcid">PMC3105171</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name name-style="western"><surname>Claes</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Recknagel</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ignatius</surname><given-names>A.</given-names></name><article-title>Fracture healing under
healthy and
inflammatory conditions</article-title>. <source>Nature Reviews Rheumatology</source><year>2012</year>, <volume>8</volume> (<issue>3</issue>), <fpage>133</fpage>&#8211;<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2012.1</pub-id>.<pub-id pub-id-type="pmid">22293759</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name name-style="western"><surname>Pereira</surname><given-names>H. F.</given-names></name>; <name name-style="western"><surname>Cengiz</surname><given-names>I. F.</given-names></name>; <name name-style="western"><surname>Silva</surname><given-names>F. S.</given-names></name>; <name name-style="western"><surname>Reis</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Oliveira</surname><given-names>J. M.</given-names></name><article-title>Scaffolds
and coatings for bone regeneration</article-title>. <source>J. Mater.
Sci.: Mater. Med.</source><year>2020</year>, <volume>31</volume> (<issue>3</issue>), <fpage>1</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s10856-020-06364-y</pub-id>.<pub-id pub-id-type="pmid">32124052</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name name-style="western"><surname>Nayef</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Mekhail</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Benameur</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Rendon</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Hamdy</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name><article-title>A combinatorial approach towards
achieving an injectable,
self-contained, phosphate-releasing scaffold for promoting biomineralization
in critical size bone defects</article-title>. <source>Acta biomaterialia</source><year>2016</year>, <volume>29</volume>, <fpage>389</fpage>&#8211;<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2015.10.020</pub-id>.<pub-id pub-id-type="pmid">26478471</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name name-style="western"><surname>Lutolf</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hubbell</surname><given-names>J.</given-names></name><article-title>Synthetic biomaterials
as instructive extracellular
microenvironments for morphogenesis in tissue engineering</article-title>. <source>Nature biotechnology</source><year>2005</year>, <volume>23</volume> (<issue>1</issue>), <elocation-id>47</elocation-id><pub-id pub-id-type="doi">10.1038/nbt1055</pub-id>.<pub-id pub-id-type="pmid">15637621</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name name-style="western"><surname>Schemitsch</surname><given-names>E. H.</given-names></name><article-title>Size matters:
defining critical in bone defect size!</article-title>. <source>Journal
of orthopaedic trauma</source><year>2017</year>, <volume>31</volume>, <fpage>S20</fpage>&#8211;<lpage>S22</lpage>. <pub-id pub-id-type="doi">10.1097/BOT.0000000000000978</pub-id>.<pub-id pub-id-type="pmid">28938386</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name name-style="western"><surname>Petite</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Viateau</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Bensaid</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Meunier</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>de Pollak</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Bourguignon</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Oudina</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sedel</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Guillemin</surname><given-names>G.</given-names></name><article-title>Tissue-engineered
bone regeneration</article-title>. <source>Nature biotechnology</source><year>2000</year>, <volume>18</volume> (<issue>9</issue>), <elocation-id>959</elocation-id><pub-id pub-id-type="doi">10.1038/79449</pub-id>.<pub-id pub-id-type="pmid">10973216</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name name-style="western"><surname>Mauffrey</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Barlow</surname><given-names>B. T.</given-names></name>; <name name-style="western"><surname>Smith</surname><given-names>W.</given-names></name><article-title>Management
of segmental bone defects</article-title>. <source>JAAOS-Journal of
the American Academy of Orthopaedic Surgeons</source><year>2015</year>, <volume>23</volume> (<issue>3</issue>), <fpage>143</fpage>&#8211;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.5435/JAAOS-D-14-00018</pub-id>.<pub-id pub-id-type="pmid">25716002</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name name-style="western"><surname>Jahan</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name><article-title>Composite
biopolymers for bone regeneration enhancement
in bony defects</article-title>. <source>Biomaterials science</source><year>2016</year>, <volume>4</volume> (<issue>1</issue>), <fpage>25</fpage>&#8211;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1039/C5BM00163C</pub-id>.<pub-id pub-id-type="pmid">26317131</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name name-style="western"><surname>Roddy</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>DeBaun</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Daoud-Gray</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>Y. P.</given-names></name>; <name name-style="western"><surname>Gardner</surname><given-names>M. J.</given-names></name><article-title>Treatment
of critical-sized bone defects: clinical and tissue engineering perspectives</article-title>. <source>European Journal of Orthopaedic Surgery &amp; Traumatology</source><year>2018</year>, <volume>28</volume> (<issue>3</issue>), <fpage>351</fpage>&#8211;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1007/s00590-017-2063-0</pub-id>.<pub-id pub-id-type="pmid">29080923</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name name-style="western"><surname>Andrzejowski</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Giannoudis</surname><given-names>P. V.</given-names></name><article-title>The &#8216;diamond concept&#8217;for long bone non-union
management</article-title>. <source>Journal of Orthopaedics and Traumatology</source><year>2019</year>, <volume>20</volume> (<issue>1</issue>), <elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1186/s10195-019-0528-0</pub-id>.<pub-id pub-id-type="pmid">30976944</pub-id><pub-id pub-id-type="pmcid">PMC6459453</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name name-style="western"><surname>Dorozhkin</surname><given-names>S. V.</given-names></name><article-title>Calcium
Orthophosphate (capo4) Scaffolds For Bone Tissue Engineering Applications</article-title>. <source>Journal of Biotechnology and Biomedical Science</source><year>2018</year>, <volume>1</volume> (<issue>3</issue>), <elocation-id>25</elocation-id><pub-id pub-id-type="doi">10.14302/issn.2576-6694.jbbs-18-2143</pub-id>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name name-style="western"><surname>Lobb</surname><given-names>D. C.</given-names></name>; <name name-style="western"><surname>DeGeorge</surname><given-names>B. R.</given-names><suffix>Jr</suffix></name>; <name name-style="western"><surname>Chhabra</surname><given-names>A. B.</given-names></name><article-title>Bone graft substitutes:
current concepts and future expectations</article-title>. <source>Journal
of hand surgery</source><year>2019</year>, <volume>44</volume> (<issue>6</issue>), <fpage>497</fpage>&#8211;<lpage>505.e2</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhsa.2018.10.032</pub-id>.<pub-id pub-id-type="pmid">30704784</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name name-style="western"><surname>Black</surname><given-names>C. R.</given-names></name>; <name name-style="western"><surname>Goriainov</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Gibbs</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kanczler</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Tare</surname><given-names>R. S.</given-names></name>; <name name-style="western"><surname>Oreffo</surname><given-names>R. O.</given-names></name><article-title>Bone tissue
engineering</article-title>. <source>Current
molecular biology reports</source><year>2015</year>, <volume>1</volume> (<issue>3</issue>), <fpage>132</fpage>&#8211;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1007/s40610-015-0022-2</pub-id>.<pub-id pub-id-type="pmid">26618105</pub-id><pub-id pub-id-type="pmcid">PMC4654432</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="book" id="cit15"><person-group person-group-type="allauthors"><name name-style="western"><surname>Akter</surname><given-names>F.</given-names></name></person-group><article-title>Chapter 1 - What
is Tissue Engineering?</article-title> In <source>Tissue Engineering
Made Easy</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Akter</surname><given-names>F.</given-names></name></person-group>, Ed.; <publisher-name>Academic Press</publisher-name>, <year>2016</year>; pp <fpage>1</fpage>&#8211;<lpage>2</lpage>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name name-style="western"><surname>Vacanti</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Langer</surname><given-names>R.</given-names></name><article-title>Tissue engineering: the design and fabrication of living
replacement devices for surgical reconstruction and transplantation</article-title>. <source>lancet</source><year>1999</year>, <volume>354</volume>, <fpage>S32</fpage>&#8211;<lpage>S34</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(99)90247-7</pub-id>.<pub-id pub-id-type="pmid">10437854</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name name-style="western"><surname>O&#8217;Brien</surname><given-names>F. J.</given-names></name><article-title>Biomaterials
&amp; scaffolds for tissue engineering</article-title>. <source>Mater.
Today</source><year>2011</year>, <volume>14</volume> (<issue>3</issue>), <fpage>88</fpage>&#8211;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/S1369-7021(11)70058-X</pub-id>.</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="book" id="cit18"><person-group person-group-type="allauthors"><name name-style="western"><surname>Carletti</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Motta</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Migliaresi</surname><given-names>C.</given-names></name></person-group><article-title>Scaffolds for tissue engineering
and 3D cell culture</article-title>. In <source>3D cell culture</source>; <publisher-name>Springer</publisher-name>, <year>2011</year>; pp <fpage>17</fpage>&#8211;<lpage>39</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-1-60761-984-0_2</pub-id><pub-id pub-id-type="pmid">21042963</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>P. X.</given-names></name><article-title>Polymeric
scaffolds for bone tissue engineering</article-title>. <source>Annals
of biomedical engineering</source><year>2004</year>, <volume>32</volume> (<issue>3</issue>), <fpage>477</fpage>&#8211;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1023/B:ABME.0000017544.36001.8e</pub-id>.<pub-id pub-id-type="pmid">15095822</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="book" id="cit20"><person-group person-group-type="allauthors"><name name-style="western"><surname>Wiraja</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chong</surname><given-names>M.
S.</given-names></name>; <name name-style="western"><surname>Liao</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Chew</surname><given-names>S. W.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>C.</given-names></name></person-group><article-title>Multi-Functional Biomaterials for
Bone Tissue Engineering</article-title>. In <source>Smart Materials
for Tissue Engineering</source>; <publisher-name>Royal Society of
Chemistry</publisher-name>: <publisher-loc>London, UK</publisher-loc>, <year>2017</year>; pp <fpage>169</fpage>&#8211;<lpage>193</lpage>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name name-style="western"><surname>Eltom</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Zhong</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Muhammad</surname><given-names>A.</given-names></name><article-title>Scaffold Techniques
and Designs in
Tissue Engineering Functions and Purposes: A Review</article-title>. <source>Advances in Materials Science and Engineering</source><year>2019</year>, <volume>2019</volume>, <elocation-id>3429527</elocation-id><pub-id pub-id-type="doi">10.1155/2019/3429527</pub-id>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name name-style="western"><surname>Levengood</surname><given-names>S. K. L.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><article-title>Chitosan-based scaffolds
for bone tissue engineering</article-title>. <source>J. Mater. Chem.
B</source><year>2014</year>, <volume>2</volume> (<issue>21</issue>), <fpage>3161</fpage>&#8211;<lpage>3184</lpage>. <pub-id pub-id-type="doi">10.1039/c4tb00027g</pub-id>.<pub-id pub-id-type="pmid">24999429</pub-id><pub-id pub-id-type="pmcid">PMC4078888</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name name-style="western"><surname>Bose</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Roy</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bandyopadhyay</surname><given-names>A.</given-names></name><article-title>Recent advances in bone tissue engineering
scaffolds</article-title>. <source>Trends Biotechnol.</source><year>2012</year>, <volume>30</volume> (<issue>10</issue>), <fpage>546</fpage>&#8211;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2012.07.005</pub-id>.<pub-id pub-id-type="pmid">22939815</pub-id><pub-id pub-id-type="pmcid">PMC3448860</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name name-style="western"><surname>Vining</surname><given-names>K. H.</given-names></name>; <name name-style="western"><surname>Mooney</surname><given-names>D. J.</given-names></name><article-title>Mechanical forces direct stem cell behaviour in development
and regeneration</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source><year>2017</year>, <volume>18</volume> (<issue>12</issue>), <fpage>728</fpage>&#8211;<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2017.108</pub-id>.<pub-id pub-id-type="pmid">29115301</pub-id><pub-id pub-id-type="pmcid">PMC5803560</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name name-style="western"><surname>Wei</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>J.-X.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Gu</surname><given-names>X.-S.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>X.-L.</given-names></name><article-title>Biodegradable
materials for bone defect repair</article-title>. <source>Military Medical
Research</source><year>2020</year>, <volume>7</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1186/s40779-020-00280-6</pub-id>.<pub-id pub-id-type="pmid">33172503</pub-id><pub-id pub-id-type="pmcid">PMC7653714</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><article-title>Control of scaffold
degradation in
tissue engineering: a review</article-title>. <source>Tissue Engineering
Part B: Reviews</source><year>2014</year>, <volume>20</volume> (<issue>5</issue>), <fpage>492</fpage>&#8211;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2013.0452</pub-id>.<pub-id pub-id-type="pmid">24547761</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name name-style="western"><surname>Collins</surname><given-names>M. N.</given-names></name>; <name name-style="western"><surname>Ren</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Young</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Pina</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Reis</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Oliveira</surname><given-names>J. M.</given-names></name><article-title>Scaffold
fabrication technologies and structure/function properties in bone
tissue engineering</article-title>. <source>Adv. Funct. Mater.</source><year>2021</year>, <volume>31</volume> (<issue>21</issue>), <elocation-id>2010609</elocation-id><pub-id pub-id-type="doi">10.1002/adfm.202010609</pub-id>.</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Goh</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Shrestha</surname><given-names>A.</given-names></name><article-title>Biomaterial Properties Modulating Bone Regeneration</article-title>. <source>Macromol. Biosci.</source><year>2021</year>, <volume>21</volume> (<issue>4</issue>), <elocation-id>2000365</elocation-id><pub-id pub-id-type="doi">10.1002/mabi.202000365</pub-id>.<pub-id pub-id-type="pmid">33615702</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name name-style="western"><surname>Abbasi</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Hamlet</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Love</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Nguyen</surname><given-names>N.-T.</given-names></name><article-title>Porous scaffolds
for bone regeneration</article-title>. <source>Journal of Science: Advanced
Materials and Devices</source><year>2020</year>, <volume>5</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsamd.2020.01.007</pub-id>.</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name name-style="western"><surname>Salgado</surname><given-names>A. J.</given-names></name>; <name name-style="western"><surname>Coutinho</surname><given-names>O. P.</given-names></name>; <name name-style="western"><surname>Reis</surname><given-names>R. L.</given-names></name><article-title>Bone tissue engineering:
state of
the art and future trends</article-title>. <source>Macromol. Biosci.</source><year>2004</year>, <volume>4</volume> (<issue>8</issue>), <fpage>743</fpage>&#8211;<lpage>765</lpage>. <pub-id pub-id-type="doi">10.1002/mabi.200400026</pub-id>.<pub-id pub-id-type="pmid">15468269</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name name-style="western"><surname>Afewerki</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Sheikhi</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kannan</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ahadian</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Khademhosseini</surname><given-names>A.</given-names></name><article-title>Gelatin-polysaccharide
composite scaffolds for 3D cell culture and tissue engineering: towards
natural therapeutics</article-title>. <source>Bioengineering &amp; translational
medicine</source><year>2019</year>, <volume>4</volume> (<issue>1</issue>), <fpage>96</fpage>&#8211;<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1002/btm2.10124</pub-id>.<pub-id pub-id-type="pmid">30680322</pub-id><pub-id pub-id-type="pmcid">PMC6336672</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="book" id="cit32"><person-group person-group-type="allauthors"><name name-style="western"><surname>Buttery</surname><given-names>L. D.</given-names></name>; <name name-style="western"><surname>Bishop</surname><given-names>A. E.</given-names></name></person-group><article-title>Introduction
to Tissue Engineering</article-title>. In <source>Biomaterials, Artificial
Organs and Tissue Engineering</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Hench</surname><given-names>L. L.</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>J. R.</given-names></name></person-group>, Eds.; <publisher-name>Woodhead
Publishing Series in Biomaterials</publisher-name>, <year>2005</year>; pp <fpage>193</fpage>&#8211;<lpage>200</lpage>.</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name name-style="western"><surname>Kargozar</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Mozafari</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hamzehlou</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Brouki Milan</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>H.-W.</given-names></name>; <name name-style="western"><surname>Baino</surname><given-names>F.</given-names></name><article-title>Bone tissue engineering using human
cells: a comprehensive review on recent trends, current prospects,
and recommendations</article-title>. <source>Applied Sciences</source><year>2019</year>, <volume>9</volume> (<issue>1</issue>), <elocation-id>174</elocation-id><pub-id pub-id-type="doi">10.3390/app9010174</pub-id>.</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name name-style="western"><surname>Florencio-Silva</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Sasso</surname><given-names>G. R. d. S.</given-names></name>; <name name-style="western"><surname>Sasso-Cerri</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Sim&#245;es</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Cerri</surname><given-names>P. S.</given-names></name><article-title>Biology of bone
tissue: structure, function, and factors
that influence bone cells</article-title>. <source>BioMed. research
international</source><year>2015</year>, <volume>2015</volume>, <elocation-id>421746</elocation-id><pub-id pub-id-type="doi">10.1155/2015/421746</pub-id>.<pub-id pub-id-type="pmid">26247020</pub-id><pub-id pub-id-type="pmcid">PMC4515490</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name name-style="western"><surname>Karoichan</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Baudequin</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Al-Jallad</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name><article-title>Encapsulation
and differentiation of adipose-derived mesenchymal stem cells in a
biomimetic purine cross-linked chitosan sponge</article-title>. <source>J. Biomed. Mater. Res., Part A</source><year>2022</year>, <volume>110</volume> (<issue>3</issue>), <fpage>585</fpage>&#8211;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.37311</pub-id>.<pub-id pub-id-type="pmid">34545996</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name name-style="western"><surname>Roberts</surname><given-names>T. T.</given-names></name>; <name name-style="western"><surname>Rosenbaum</surname><given-names>A. J.</given-names></name><article-title>Bone grafts,
bone substitutes and orthobiologics: the
bridge between basic science and clinical advancements in fracture
healing</article-title>. <source>Organogenesis</source><year>2012</year>, <volume>8</volume> (<issue>4</issue>), <fpage>114</fpage>&#8211;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.4161/org.23306</pub-id>.<pub-id pub-id-type="pmid">23247591</pub-id><pub-id pub-id-type="pmcid">PMC3562252</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="book" id="cit37"><person-group person-group-type="allauthors"><name name-style="western"><surname>Dahiya</surname><given-names>U. R.</given-names></name>; <name name-style="western"><surname>Mishra</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Bano</surname><given-names>S.</given-names></name></person-group><article-title>Application of Bone Substitutes
and Its Future Prospective in Regenerative Medicine</article-title>. In <source>Biomaterial-supported Tissue Reconstruction or Regeneration</source>; <publisher-name>IntechOpen</publisher-name>, <year>2019</year>;
p <elocation-id>85092</elocation-id>.</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name name-style="western"><surname>Khan</surname><given-names>W. S.</given-names></name>; <name name-style="western"><surname>Rayan</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Dhinsa</surname><given-names>B. S.</given-names></name>; <name name-style="western"><surname>Marsh</surname><given-names>D.</given-names></name><article-title>An osteoconductive,
osteoinductive, and osteogenic tissue-engineered product for trauma
and orthopaedic surgery: how far are we?</article-title>. <source>Stem
cells international</source><year>2012</year>, <volume>2012</volume>, <elocation-id>236231</elocation-id><pub-id pub-id-type="doi">10.1155/2012/236231</pub-id>.<pub-id pub-id-type="pmid">25098363</pub-id><pub-id pub-id-type="pmcid">PMC3205731</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name name-style="western"><surname>Albrektsson</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Johansson</surname><given-names>C.</given-names></name><article-title>Osteoinduction, osteoconduction and osseointegration</article-title>. <source>European spine journal</source><year>2001</year>, <volume>10</volume> (<issue>2</issue>), <fpage>S96</fpage>&#8211;<lpage>S101</lpage>. <pub-id pub-id-type="doi">10.1007/s005860100282</pub-id>.<pub-id pub-id-type="pmid">11716023</pub-id><pub-id pub-id-type="pmcid">PMC3611551</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name name-style="western"><surname>Garg</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Singh</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Arora</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Murthy</surname><given-names>R.</given-names></name><article-title>Scaffold: a novel carrier
for cell and drug delivery</article-title>. <source>Crit. Rev. Ther.
Drug Carrier Syst.</source><year>2012</year>, <volume>29</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1615/CritRevTherDrugCarrierSyst.v29.i1.10</pub-id>.<pub-id pub-id-type="pmid">22356721</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name name-style="western"><surname>Mishra</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Bishop</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Valerio</surname><given-names>I. L.</given-names></name>; <name name-style="western"><surname>Fisher</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Dean</surname><given-names>D.</given-names></name><article-title>The potential
impact of bone tissue engineering in the clinic</article-title>. <source>Regenerative medicine</source><year>2016</year>, <volume>11</volume> (<issue>6</issue>), <fpage>571</fpage>&#8211;<lpage>587</lpage>. <pub-id pub-id-type="doi">10.2217/rme-2016-0042</pub-id>.<pub-id pub-id-type="pmid">27549369</pub-id><pub-id pub-id-type="pmcid">PMC5007661</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name name-style="western"><surname>Shi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Tian</surname><given-names>W.</given-names></name><article-title>Current advances
for bone regeneration based on tissue engineering strategies</article-title>. <source>Frontiers of medicine</source><year>2019</year>, <volume>13</volume> (<issue>2</issue>), <fpage>160</fpage>&#8211;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1007/s11684-018-0629-9</pub-id>.<pub-id pub-id-type="pmid">30047029</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name name-style="western"><surname>Willie</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Petersen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Schmidt-Bleek</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Cipitria</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mehta</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Strube</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lienau</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wildemann</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Fratzl</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Duda</surname><given-names>G.</given-names></name><article-title>Designing biomimetic
scaffolds for
bone regeneration: why aim for a copy of mature tissue properties
if nature uses a different approach?</article-title>. <source>Soft Matter</source><year>2010</year>, <volume>6</volume> (<issue>20</issue>), <fpage>4976</fpage>&#8211;<lpage>4987</lpage>. <pub-id pub-id-type="doi">10.1039/c0sm00262c</pub-id>.</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="book" id="cit44"><person-group person-group-type="allauthors"><name name-style="western"><surname>Hayashi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yamada</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Guchi</surname><given-names>K.
Y.</given-names></name>; <name name-style="western"><surname>Koyama</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Ikeda</surname><given-names>T.</given-names></name></person-group><article-title>Chitosan and fish collagen as biomaterials
for regenerative medicine</article-title>. In <source>Advances in
food and nutrition research</source>; <publisher-name>Elsevier</publisher-name>, <year>2012</year>; Vol. <volume>65</volume>, pp <fpage>107</fpage>&#8211;<lpage>120</lpage>.<pub-id pub-id-type="pmid">22361182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/B978-0-12-416003-3.00006-8</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="book" id="cit45"><person-group person-group-type="allauthors"><name name-style="western"><surname>Jiang</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>James</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Kumbar</surname><given-names>S. G.</given-names></name>; <name name-style="western"><surname>Laurencin</surname><given-names>C. T.</given-names></name></person-group><article-title>Chitosan as a biomaterial:
structure, properties, and applications in tissue engineering and
drug delivery</article-title>. In <source>Natural and synthetic biomedical
polymers</source>; <publisher-name>Elsevier</publisher-name>, <year>2014</year>; pp <fpage>91</fpage>&#8211;<lpage>113</lpage>.</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name name-style="western"><surname>Ahmed</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ali</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Sheikh</surname><given-names>J.</given-names></name>; et al. <article-title>A review
on chitosan centred scaffolds and
their applications in tissue engineering</article-title>. <source>Int.
J. Biol. Macromol.</source><year>2018</year>, <volume>116</volume>, <fpage>849</fpage>&#8211;<lpage>862</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.04.176</pub-id>.<pub-id pub-id-type="pmid">29730001</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="book" id="cit47"><person-group person-group-type="allauthors"><name name-style="western"><surname>Ibrahim</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>El-Zairy</surname><given-names>E.</given-names></name></person-group><article-title>Chitosan as a
biomaterial&#8212;structure, properties, and electrospun nanofibers</article-title>. In <source>Concepts, Compounds, and the Alternatives of Antibacterials</source>; <publisher-name>IntechOpen</publisher-name>, <year>2015</year>;
p <elocation-id>61300</elocation-id>.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="book" id="cit48"><person-group person-group-type="allauthors"><name name-style="western"><surname>Dutta</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Rinki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Dutta</surname><given-names>J.</given-names></name></person-group><article-title>Chitosan: A promising biomaterial
for tissue engineering scaffolds</article-title>. In <source>Chitosan
for biomaterials II</source>; <publisher-name>Springer</publisher-name>, <year>2011</year>; pp <fpage>45</fpage>&#8211;<lpage>79</lpage>.</mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name name-style="western"><surname>Benameur</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Baudequin</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Mekhail</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name><article-title>The bioconjugation
mechanism of purine cross-linkers affects microstructure and cell
response to ultra rapidly gelling purine&#8211;chitosan sponges</article-title>. <source>J. Mater. Chem. B</source><year>2018</year>, <volume>6</volume> (<issue>4</issue>), <fpage>602</fpage>&#8211;<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1039/C7TB02968C</pub-id>.<pub-id pub-id-type="pmid">32254489</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name name-style="western"><surname>Mekhail</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Jahan</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name><article-title>Genipin-crosslinked
chitosan/poly-l-lysine
gels promote fibroblast adhesion and proliferation</article-title>. <source>Carbohydr. Polym.</source><year>2014</year>, <volume>108</volume>, <fpage>91</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2014.03.021</pub-id>.<pub-id pub-id-type="pmid">24751251</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name name-style="western"><surname>Jahan</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Mekhail</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name><article-title>One-step fabrication
of apatite-chitosan
scaffold as a potential injectable construct for bone tissue engineering</article-title>. <source>Carbohydr. Polym.</source><year>2019</year>, <volume>203</volume>, <fpage>60</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2018.09.017</pub-id>.<pub-id pub-id-type="pmid">30318236</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name name-style="western"><surname>Croisier</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>J&#233;r&#244;me</surname><given-names>C.</given-names></name><article-title>Chitosan-based biomaterials
for tissue engineering</article-title>. <source>Eur. Polym. J.</source><year>2013</year>, <volume>49</volume> (<issue>4</issue>), <fpage>780</fpage>&#8211;<lpage>792</lpage>. <pub-id pub-id-type="doi">10.1016/j.eurpolymj.2012.12.009</pub-id>.</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name name-style="western"><surname>Ahsan</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Thomas</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Reddy</surname><given-names>K. K.</given-names></name>; <name name-style="western"><surname>Sooraparaju</surname><given-names>S. G.</given-names></name>; <name name-style="western"><surname>Asthana</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bhatnagar</surname><given-names>I.</given-names></name><article-title>Chitosan as biomaterial in drug delivery
and tissue engineering</article-title>. <source>Int. J. Biol. Macromol.</source><year>2018</year>, <volume>110</volume>, <fpage>97</fpage>&#8211;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.08.140</pub-id>.<pub-id pub-id-type="pmid">28866015</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name name-style="western"><surname>LogithKumar</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>KeshavNarayan</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Dhivya</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Chawla</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Saravanan</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Selvamurugan</surname><given-names>N.</given-names></name><article-title>A review of chitosan and its derivatives in bone tissue
engineering</article-title>. <source>Carbohydr. Polym.</source><year>2016</year>, <volume>151</volume>, <fpage>172</fpage>&#8211;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2016.05.049</pub-id>.<pub-id pub-id-type="pmid">27474556</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name name-style="western"><surname>Dash</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Chiellini</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Ottenbrite</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Chiellini</surname><given-names>E.</given-names></name><article-title>Chitosan&#8212;A
versatile semi-synthetic polymer in biomedical applications</article-title>. <source>Prog. Polym. Sci.</source><year>2011</year>, <volume>36</volume> (<issue>8</issue>), <fpage>981</fpage>&#8211;<lpage>1014</lpage>. <pub-id pub-id-type="doi">10.1016/j.progpolymsci.2011.02.001</pub-id>.</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name name-style="western"><surname>P&#233;rez-&#193;lvarez</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ruiz-Rubio</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Vilas-Vilela</surname><given-names>J. L.</given-names></name><article-title>Determining the Deacetylation Degree
of Chitosan: Opportunities To Learn Instrumental Techniques</article-title>. <source>J. Chem. Educ.</source><year>2018</year>, <volume>95</volume> (<issue>6</issue>), <fpage>1022</fpage>&#8211;<lpage>1028</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jchemed.7b00902</pub-id>.</mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="book" id="cit57"><person-group person-group-type="allauthors"><name name-style="western"><surname>Lv</surname><given-names>S. H.</given-names></name></person-group><article-title>7 - High-performance
superplasticizer based on chitosan</article-title>. In <source>Biopolymers
and Biotech Admixtures for Eco-Efficient Construction Materials</source>; <person-group person-group-type="editor"><name name-style="western"><surname>Pacheco-Torgal</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Ivanov</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Karak</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Jonkers</surname><given-names>H.</given-names></name></person-group>, Eds.; <publisher-name>Woodhead
Publishing</publisher-name>, <year>2016</year>; pp <fpage>131</fpage>&#8211;<lpage>150</lpage>.</mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name name-style="western"><surname>Oryan</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kamali</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Moshiri</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Baharvand</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Daemi</surname><given-names>H.</given-names></name><article-title>Chemical crosslinking of biopolymeric scaffolds: Current knowledge
and future directions of crosslinked engineered bone scaffolds</article-title>. <source>Int. J. Biol. Macromol.</source><year>2018</year>, <volume>107</volume>, <fpage>678</fpage>&#8211;<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.08.184</pub-id>.<pub-id pub-id-type="pmid">28919526</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name name-style="western"><surname>Acevedo</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Olgu&#237;n</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Brice&#241;o</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Forero</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Osses</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>D&#237;az-Calder&#243;n</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Jaques</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ortiz</surname><given-names>R.</given-names></name><article-title>Design of
a biodegradable UV-irradiated gelatin-chitosan/nanocomposed membrane
with osteogenic ability for application in bone regeneration</article-title>. <source>Materials Science and Engineering: C</source><year>2019</year>, <volume>99</volume>, <fpage>875</fpage>&#8211;<lpage>886</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2019.01.135</pub-id>.<pub-id pub-id-type="pmid">30889762</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name name-style="western"><surname>Krishnakumar</surname><given-names>G. S.</given-names></name>; <name name-style="western"><surname>Sampath</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Muthusamy</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>John</surname><given-names>M. A.</given-names></name><article-title>Importance of crosslinking
strategies in designing smart biomaterials for bone tissue engineering:
A systematic review</article-title>. <source>Materials Science and Engineering:
C</source><year>2019</year>, <volume>96</volume>, <fpage>941</fpage>&#8211;<lpage>954</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2018.11.081</pub-id>.<pub-id pub-id-type="pmid">30606606</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Ramay</surname><given-names>H. R.</given-names></name>; <name name-style="western"><surname>Hauch</surname><given-names>K. D.</given-names></name>; <name name-style="western"><surname>Xiao</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><article-title>Chitosan&#8211;alginate
hybrid scaffolds for bone tissue engineering</article-title>. <source>Biomaterials</source><year>2005</year>, <volume>26</volume> (<issue>18</issue>), <fpage>3919</fpage>&#8211;<lpage>3928</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2004.09.062</pub-id>.<pub-id pub-id-type="pmid">15626439</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name name-style="western"><surname>Calori</surname><given-names>I. R.</given-names></name>; <name name-style="western"><surname>Braga</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>de Jesus</surname><given-names>P. d. C. C.</given-names></name>; <name name-style="western"><surname>Bi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Tedesco</surname><given-names>A. C.</given-names></name><article-title>Polymer
scaffolds as drug delivery systems</article-title>. <source>Eur. Polym.
J.</source><year>2020</year>, <volume>129</volume>, <elocation-id>109621</elocation-id><pub-id pub-id-type="doi">10.1016/j.eurpolymj.2020.109621</pub-id>.</mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name name-style="western"><surname>Fang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>W.</given-names></name><article-title>Assessment of various
crosslinking agents on collagen/chitosan scaffolds for myocardial
tissue engineering</article-title>. <source>Biomedical Materials</source><year>2020</year>, <volume>15</volume> (<issue>4</issue>), <elocation-id>045003</elocation-id><pub-id pub-id-type="doi">10.1088/1748-605X/ab452d</pub-id>.<pub-id pub-id-type="pmid">31530754</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ji</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Deng</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Long</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ge</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Su</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Chan</surname><given-names>S. Y.</given-names></name>; <name name-style="western"><surname>Loh</surname><given-names>X. J.</given-names></name>; <name name-style="western"><surname>Zhuang</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ruan</surname><given-names>J.</given-names></name><article-title>A non-invasive smart scaffold for bone repair and monitoring</article-title>. <source>Bioactive Materials</source><year>2023</year>, <volume>19</volume>, <fpage>499</fpage>&#8211;<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioactmat.2022.04.034</pub-id>.<pub-id pub-id-type="pmid">35600976</pub-id><pub-id pub-id-type="pmcid">PMC9097555</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name name-style="western"><surname>Yu</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Xiao</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wei</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Bi</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ruan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Fan</surname><given-names>X.</given-names></name><article-title>Enhanced bioactivity
and osteoinductivity
of carboxymethyl chitosan/nanohydroxyapatite/graphene oxide nanocomposites</article-title>. <source>RSC Adv.</source><year>2018</year>, <volume>8</volume> (<issue>32</issue>), <fpage>17860</fpage>&#8211;<lpage>17877</lpage>. <pub-id pub-id-type="doi">10.1039/C8RA00383A</pub-id>.<pub-id pub-id-type="pmid">35542061</pub-id><pub-id pub-id-type="pmcid">PMC9080497</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name name-style="western"><surname>Tang</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Luo</surname><given-names>B.</given-names></name><article-title>Dual-Cross-linked
Liquid Crystal
Hydrogels with Controllable Viscoelasticity for Regulating Cell Behaviors</article-title>. <source>ACS Appl. Mater. Interfaces</source><year>2022</year>, <volume>14</volume>, <fpage>21966</fpage>&#8211;<lpage>21977</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.2c02689</pub-id>.<pub-id pub-id-type="pmid">35503918</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name name-style="western"><surname>Vukajlovic</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Bretcanu</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Novakovic</surname><given-names>K.</given-names></name><article-title>Fabrication
and characterization
of two types of bone composites made of chitosan-genipin hydrogel
and Bioglass 45S5</article-title>. <source>Open Ceramics</source><year>2021</year>, <volume>8</volume>, <elocation-id>100174</elocation-id><pub-id pub-id-type="doi">10.1016/j.oceram.2021.100174</pub-id>.</mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name name-style="western"><surname>Marques</surname><given-names>C. F.</given-names></name>; <name name-style="western"><surname>Olhero</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Torres</surname><given-names>P. M. C.</given-names></name>; <name name-style="western"><surname>Abrantes</surname><given-names>J. C. C.</given-names></name>; <name name-style="western"><surname>Fateixa</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Nogueira</surname><given-names>H. I. S.</given-names></name>; <name name-style="western"><surname>Ribeiro</surname><given-names>I. A. C.</given-names></name>; <name name-style="western"><surname>Bettencourt</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Sousa</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Granja</surname><given-names>P. L.</given-names></name>; <name name-style="western"><surname>Ferreira</surname><given-names>J. M. F.</given-names></name><article-title>Novel sintering-free
scaffolds obtained by additive manufacturing for concurrent bone regeneration
and drug delivery: Proof of concept</article-title>. <source>Materials
Science and Engineering C</source><year>2019</year>, <volume>94</volume>, <fpage>426</fpage>&#8211;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2018.09.050</pub-id>.<pub-id pub-id-type="pmid">30423726</pub-id></mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name name-style="western"><surname>Lu</surname><given-names>H. T.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>T. W.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>C. H.</given-names></name>; <name name-style="western"><surname>Mi</surname><given-names>F. L.</given-names></name><article-title>Development
of genipin-crosslinked
and fucoidan-adsorbed nano-hydroxyapatite/hydroxypropyl chitosan composite
scaffolds for bone tissue engineering</article-title>. <source>Int.
J. Biol. Macromol.</source><year>2019</year>, <volume>128</volume>, <fpage>973</fpage>&#8211;<lpage>984</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.02.010</pub-id>.<pub-id pub-id-type="pmid">30738901</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name name-style="western"><surname>Siddiqui</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Pramanik</surname><given-names>K.</given-names></name><article-title>Improvement of cellular
responses of genipin cross-linked
chitosan/nano &#946;-TCP composite scaffolds by surface modification
with fibrin</article-title>. <source>Biomedical Physics and Engineering
Express</source><year>2018</year>, <volume>4</volume> (<issue>4</issue>), <elocation-id>045034</elocation-id><pub-id pub-id-type="doi">10.1088/2057-1976/aacad1</pub-id>.</mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Yao</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Guo</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Meng</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>F.</given-names></name><article-title>Modulation
of osteogenic and haemostatic activities by tuning cationicity of
genipin-crosslinked chitosan hydrogels</article-title>. <source>Colloids
Surf., B</source><year>2018</year>, <volume>166</volume>, <fpage>29</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2018.02.056</pub-id>.<pub-id pub-id-type="pmid">29529506</pub-id></mixed-citation></ref><ref id="ref500"><mixed-citation publication-type="journal" id="cit500"><name name-style="western"><surname>Dimida</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Barca</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Cancelli</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>De Benedictis</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Raucci</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Demitri</surname><given-names>C.</given-names></name><article-title>Effects of genipin concentration
on cross-linked chitosan scaffolds for bone tissue engineering: Structural
characterization and evidence of biocompatibility features</article-title>. <source>International Journal of Polymer Science</source><year>2017</year>, <volume>2017</volume>, <fpage>8410750</fpage><pub-id pub-id-type="doi">10.1155/2017/8410750</pub-id>.</mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name name-style="western"><surname>Dimida</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Barca</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Cancelli</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>De Benedictis</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Raucci</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Demitri</surname><given-names>C.</given-names></name><article-title>Effects of genipin concentration
on cross-linked chitosan scaffolds for bone tissue engineering: Structural
characterization and evidence of biocompatibility features</article-title>. <source>International Journal of Polymer Science</source><year>2017</year>, <volume>2017</volume>, <elocation-id>8410750</elocation-id><pub-id pub-id-type="doi">10.1155/2017/8410750</pub-id>.</mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal" id="cit73"><name name-style="western"><surname>Liu</surname><given-names>I. H.</given-names></name>; <name name-style="western"><surname>Chang</surname><given-names>S. H.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>H. Y.</given-names></name><article-title>Chitosan-based
hydrogel tissue scaffolds
made by 3D plotting promotes osteoblast proliferation and mineralization</article-title>. <source>Biomedical Materials (Bristol)</source><year>2015</year>, <volume>10</volume> (<issue>3</issue>), <elocation-id>035004</elocation-id><pub-id pub-id-type="doi">10.1088/1748-6041/10/3/035004</pub-id>.<pub-id pub-id-type="pmid">25970802</pub-id></mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal" id="cit74"><name name-style="western"><surname>Beringer</surname><given-names>L. T.</given-names></name>; <name name-style="western"><surname>Kiechel</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Komiya</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Donius</surname><given-names>A. E.</given-names></name>; <name name-style="western"><surname>Habas</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Wegst</surname><given-names>U. G. K.</given-names></name>; <name name-style="western"><surname>Schauer</surname><given-names>C. L.</given-names></name><article-title>Osteoblast
biocompatibility of novel
chitosan crosslinker, hexamethylene-1,6-diaminocarboxysulfonate</article-title>. <source>Journal of Biomedical Materials Research - Part A</source><year>2015</year>, <volume>103</volume> (<issue>9</issue>), <fpage>3026</fpage>&#8211;<lpage>3033</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.35438</pub-id>.<pub-id pub-id-type="pmid">25689675</pub-id></mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name name-style="western"><surname>Siddiqui</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Pramanik</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Jabbari</surname><given-names>E.</given-names></name><article-title>Osteogenic differentiation of human
mesenchymal stem cells in freeze-gelled chitosan/nano &#946;-tricalcium
phosphate porous scaffolds crosslinked with genipin</article-title>. <source>Materials Science and Engineering C</source><year>2015</year>, <volume>54</volume>, <fpage>76</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2015.05.005</pub-id>.<pub-id pub-id-type="pmid">26046270</pub-id><pub-id pub-id-type="pmcid">PMC4457941</pub-id></mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal" id="cit76"><name name-style="western"><surname>Frohbergh</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Katsman</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mondrinos</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Stabler</surname><given-names>C. T.</given-names></name>; <name name-style="western"><surname>Hankenson</surname><given-names>K. D.</given-names></name>; <name name-style="western"><surname>Oristaglio</surname><given-names>J. T.</given-names></name>; <name name-style="western"><surname>Lelkes</surname><given-names>P. I.</given-names></name><article-title>Osseointegrative properties of electrospun
hydroxyapatite-containing nanofibrous chitosan scaffolds</article-title>. <source>Tissue Engineering - Part A</source><year>2015</year>, <volume>21</volume> (<issue>5&#8211;6</issue>), <fpage>970</fpage>&#8211;<lpage>981</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tea.2013.0789</pub-id>.<pub-id pub-id-type="pmid">25336062</pub-id><pub-id pub-id-type="pmcid">PMC4356216</pub-id></mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal" id="cit77"><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Qiu</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ren</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Miao</surname><given-names>J.</given-names></name><article-title>Sustained delivery
of BMP-2 enhanced osteoblastic differentiation
of BMSCs based on surface hydroxyapatite nanostructure in chitosan-HAp
scaffold</article-title>. <source>Journal of Biomaterials Science, Polymer
Edition</source><year>2014</year>, <volume>25</volume> (<issue>16</issue>), <fpage>1813</fpage>&#8211;<lpage>1827</lpage>. <pub-id pub-id-type="doi">10.1080/09205063.2014.951244</pub-id>.<pub-id pub-id-type="pmid">25166866</pub-id></mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal" id="cit78"><name name-style="western"><surname>Su</surname><given-names>W. T.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Y. T.</given-names></name>; <name name-style="western"><surname>Chou</surname><given-names>C. M.</given-names></name><article-title>Optimal fluid flow
enhanced mineralization
of MG-63 cells in porous chitosan scaffold</article-title>. <source>Journal of the Taiwan Institute of Chemical Engineers</source><year>2014</year>, <volume>45</volume> (<issue>4</issue>), <fpage>1111</fpage>&#8211;<lpage>1118</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtice.2013.10.016</pub-id>.</mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal" id="cit79"><name name-style="western"><surname>Hu</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Miszuk</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lansakara</surname><given-names>T. I.</given-names></name>; <name name-style="western"><surname>Tivanski</surname><given-names>A. V.</given-names></name>; <name name-style="western"><surname>Banas</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>H.</given-names></name><article-title>Vanillin-bioglass cross-linked
3D porous chitosan scaffolds with strong osteopromotive and antibacterial
abilities for bone tissue engineering</article-title>. <source>Carbohydr.
Polym.</source><year>2021</year>, <volume>271</volume>, <elocation-id>118440</elocation-id><pub-id pub-id-type="doi">10.1016/j.carbpol.2021.118440</pub-id>.<pub-id pub-id-type="pmid">34364578</pub-id><pub-id pub-id-type="pmcid">PMC8353169</pub-id></mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal" id="cit80"><name name-style="western"><surname>Valencia-Llano</surname><given-names>C. H.</given-names></name>; <name name-style="western"><surname>Solano</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Grande-Tovar</surname><given-names>C. D.</given-names></name><article-title>Nanocomposites of chitosan/graphene
oxide/titanium dioxide nanoparticles/blackberry waste extract as potential
bone substitutes</article-title>. <source>Polymers</source><year>2021</year>, <volume>13</volume> (<issue>22</issue>), <elocation-id>3877</elocation-id><pub-id pub-id-type="doi">10.3390/polym13223877</pub-id>.<pub-id pub-id-type="pmid">34833175</pub-id><pub-id pub-id-type="pmcid">PMC8618967</pub-id></mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal" id="cit81"><name name-style="western"><surname>Pinto</surname><given-names>R. V.</given-names></name>; <name name-style="western"><surname>Gomes</surname><given-names>P. S.</given-names></name>; <name name-style="western"><surname>Fernandes</surname><given-names>M. H.</given-names></name>; <name name-style="western"><surname>Costa</surname><given-names>M. E. V.</given-names></name>; <name name-style="western"><surname>Almeida</surname><given-names>M. M.</given-names></name><article-title>Glutaraldehyde-crosslinking
chitosan scaffolds reinforced with calcium phosphate spray-dried granules
for bone tissue applications</article-title>. <source>Materials Science
and Engineering C</source><year>2020</year>, <volume>109</volume>, <elocation-id>110557</elocation-id><pub-id pub-id-type="doi">10.1016/j.msec.2019.110557</pub-id>.<pub-id pub-id-type="pmid">32228952</pub-id></mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal" id="cit82"><name name-style="western"><surname>Chen</surname><given-names>C. K.</given-names></name>; <name name-style="western"><surname>Chang</surname><given-names>N. J.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>Y. T.</given-names></name>; <name name-style="western"><surname>Fu</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Shen</surname><given-names>E. C.</given-names></name>; <name name-style="western"><surname>Feng</surname><given-names>C. W.</given-names></name>; <name name-style="western"><surname>Wen</surname><given-names>Z. H.</given-names></name><article-title>Bone formation using
cross-linked
chitosan scaffolds in rat calvarial defects</article-title>. <source>Implant Dentistry</source><year>2018</year>, <volume>27</volume> (<issue>1</issue>), <fpage>15</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1097/ID.0000000000000670</pub-id>.<pub-id pub-id-type="pmid">29189415</pub-id></mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal" id="cit83"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name><article-title>Glutaraldehyde-crosslinked
chitosan/hydroxyapatite
bone repair scaffold and its application as drug carrier for icariin</article-title>. <source>J. Appl. Polym. Sci.</source><year>2013</year>, <volume>130</volume> (<issue>3</issue>), <fpage>1539</fpage>&#8211;<lpage>1547</lpage>. <pub-id pub-id-type="doi">10.1002/app.39339</pub-id>.</mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal" id="cit84"><name name-style="western"><surname>Zeng</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Mamitimin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Qi</surname><given-names>X.</given-names></name><article-title>Chairside
administrated antibacterial hydrogels containing berberine
as dental temporary stopping for alveolar ridge preservation</article-title>. <source>Eur. Polym. J.</source><year>2021</year>, <volume>160</volume>, <elocation-id>110808</elocation-id><pub-id pub-id-type="doi">10.1016/j.eurpolymj.2021.110808</pub-id>.</mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal" id="cit85"><name name-style="western"><surname>Ghosh</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Rameshbabu</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Das</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Francis</surname><given-names>N. K.</given-names></name>; <name name-style="western"><surname>Pawar</surname><given-names>H. S.</given-names></name>; <name name-style="western"><surname>Subramanian</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Pal</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Dhara</surname><given-names>S.</given-names></name><article-title>Covalent cross-links
in polyampholytic chitosan fibers enhances bone regeneration in a
rabbit model</article-title>. <source>Colloids Surf., B</source><year>2015</year>, <volume>125</volume>, <fpage>160</fpage>&#8211;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2014.11.031</pub-id>.<pub-id pub-id-type="pmid">25483844</pub-id></mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal" id="cit86"><name name-style="western"><surname>Karoichan</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Baudequin</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Al-Jallad</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name><article-title>Encapsulation
and differentiation of adipose-derived mesenchymal stem cells in a
biomimetic purine cross-linked chitosan sponge</article-title>. <source>Journal of Biomedical Materials Research - Part A</source><year>2022</year>, <volume>110</volume> (<issue>3</issue>), <fpage>585</fpage>&#8211;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.37311</pub-id>.<pub-id pub-id-type="pmid">34545996</pub-id></mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="journal" id="cit87"><name name-style="western"><surname>Baudequin</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Agnes</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name><article-title>A core-shell
guanosine diphosphate
crosslinked chitosan scaffold as a potential co-encapsulation platform</article-title>. <source>Carbohydr. Polym.</source><year>2021</year>, <volume>256</volume>, <elocation-id>117499</elocation-id><pub-id pub-id-type="doi">10.1016/j.carbpol.2020.117499</pub-id>.<pub-id pub-id-type="pmid">33483026</pub-id></mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal" id="cit88"><name name-style="western"><surname>Jahan</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Manickam</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Murshed</surname><given-names>M.</given-names></name><article-title>In vitro and in vivo
investigation of osteogenic properties of self-contained phosphate-releasing
injectable purine-crosslinked chitosan-hydroxyapatite constructs</article-title>. <source>Sci. Rep.</source><year>2020</year>, <volume>10</volume>, <elocation-id>11603</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-67886-7</pub-id>.<pub-id pub-id-type="pmid">32665560</pub-id><pub-id pub-id-type="pmcid">PMC7360623</pub-id></mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal" id="cit89"><name name-style="western"><surname>Agnes</surname><given-names>C. J.</given-names></name>; <name name-style="western"><surname>Murshed</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Takada</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Willie</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name><article-title>A 6-bromoindirubin-3&#8242;-oxime
incorporated chitosan-based hydrogel scaffold for potential osteogenic
differentiation: Investigation of material properties in vitro</article-title>. <source>Int. J. Biol. Macromol.</source><year>2023</year>, <volume>227</volume>, <fpage>71</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.12.130</pub-id>.<pub-id pub-id-type="pmid">36535349</pub-id></mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal" id="cit90"><name name-style="western"><surname>Lewandowska-&#321;A&#324;cucka</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Fiejdasz</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Rodzik</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Kozie&#322;</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nowakowska</surname><given-names>M.</given-names></name><article-title>Bioactive hydrogel-nanosilica hybrid materials: A potential
injectable scaffold for bone tissue engineering</article-title>. <source>Biomedical Materials (Bristol)</source><year>2015</year>, <volume>10</volume> (<issue>1</issue>), <elocation-id>015020</elocation-id><pub-id pub-id-type="doi">10.1088/1748-6041/10/1/015020</pub-id>.<pub-id pub-id-type="pmid">25668107</pub-id></mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal" id="cit91"><name name-style="western"><surname>Yasmeen</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Lo</surname><given-names>M. K.</given-names></name>; <name name-style="western"><surname>Bajracharya</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Roldo</surname><given-names>M.</given-names></name><article-title>Injectable scaffolds
for bone regeneration</article-title>. <source>Langmuir</source><year>2014</year>, <volume>30</volume> (<issue>43</issue>), <fpage>12977</fpage>&#8211;<lpage>12985</lpage>. <pub-id pub-id-type="doi">10.1021/la503057w</pub-id>.<pub-id pub-id-type="pmid">25296391</pub-id></mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal" id="cit92"><name name-style="western"><surname>Dess&#236;</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Borzacchiello</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mohamed</surname><given-names>T. H. A.</given-names></name>; <name name-style="western"><surname>Abdel-Fattah</surname><given-names>W. I.</given-names></name>; <name name-style="western"><surname>Ambrosio</surname><given-names>L.</given-names></name><article-title>Novel biomimetic thermosensitive
&#946;-tricalcium
phosphate/chitosan-based hydrogels for bone tissue engineering</article-title>. <source>Journal of Biomedical Materials Research - Part A</source><year>2013</year>, <volume>101</volume> (<issue>10</issue>), <fpage>2984</fpage>&#8211;<lpage>2993</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.34592</pub-id>.<pub-id pub-id-type="pmid">23873836</pub-id></mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal" id="cit93"><name name-style="western"><surname>Goh</surname><given-names>C. Y.</given-names></name>; <name name-style="western"><surname>Lim</surname><given-names>S. S.</given-names></name>; <name name-style="western"><surname>Tshai</surname><given-names>K. Y.</given-names></name>; <name name-style="western"><surname>El Azab</surname><given-names>A. W. Z. Z.</given-names></name>; <name name-style="western"><surname>Loh</surname><given-names>H. S.</given-names></name><article-title>Fabrication and
in vitro biocompatibility of sodium
tripolyphosphate-crosslinked chitosan&#8211;hydroxyapatite scaffolds
for bone regeneration</article-title>. <source>J. Mater. Sci.</source><year>2019</year>, <volume>54</volume> (<issue>4</issue>), <fpage>3403</fpage>&#8211;<lpage>3420</lpage>. <pub-id pub-id-type="doi">10.1007/s10853-018-3087-5</pub-id>.</mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="journal" id="cit94"><name name-style="western"><surname>Shemshad</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kamali</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Khavandi</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Azari</surname><given-names>S.</given-names></name><article-title>Synthesis, characterization
and in-vitro behavior of natural chitosan-hydroxyapatite-diopside
nanocomposite scaffold for bone tissue engineering</article-title>. <source>International Journal of Polymeric Materials and Polymeric
Biomaterials</source><year>2019</year>, <volume>68</volume> (<issue>9</issue>), <fpage>516</fpage>&#8211;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1080/00914037.2018.1466138</pub-id>.</mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal" id="cit95"><name name-style="western"><surname>Shavandi</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bekhit</surname><given-names>A. E. D. A.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Ali</surname><given-names>M. A.</given-names></name><article-title>Bio-scaffolds
produced
from irradiated squid pen and crab chitosan with hydroxyapatite/&#946;-tricalcium
phosphate for bone-tissue engineering</article-title>. <source>Int.
J. Biol. Macromol.</source><year>2016</year>, <volume>93</volume>, <fpage>1446</fpage>&#8211;<lpage>1456</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2016.04.046</pub-id>.<pub-id pub-id-type="pmid">27126171</pub-id></mixed-citation></ref><ref id="ref96"><mixed-citation publication-type="journal" id="cit96"><name name-style="western"><surname>Thanyaphoo</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kaewsrichan</surname><given-names>J.</given-names></name><article-title>A new biocompatible
delivery scaffold containing heparin
and bone morphogenetic protein 2</article-title>. <source>Acta Pharmaceutica</source><year>2016</year>, <volume>66</volume> (<issue>3</issue>), <fpage>373</fpage>&#8211;<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1515/acph-2016-0026</pub-id>.<pub-id pub-id-type="pmid">27383886</pub-id></mixed-citation></ref><ref id="ref97"><mixed-citation publication-type="journal" id="cit97"><name name-style="western"><surname>Aryaei</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jayatissa</surname><given-names>A. H.</given-names></name>; <name name-style="western"><surname>Champa Jayasuriya</surname><given-names>A.</given-names></name><article-title>Cross-linked chitosan improves the
mechanical properties of calcium phosphate-chitosan cement</article-title>. <source>Materials Science and Engineering C</source><year>2015</year>, <volume>54</volume>, <fpage>14</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2015.04.024</pub-id>.<pub-id pub-id-type="pmid">26046262</pub-id><pub-id pub-id-type="pmcid">PMC4466097</pub-id></mixed-citation></ref><ref id="ref98"><mixed-citation publication-type="journal" id="cit98"><name name-style="western"><surname>Pati</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Kalita</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Adhikari</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Dhara</surname><given-names>S.</given-names></name><article-title>Osteoblastic cellular
responses on ionically crosslinked chitosan-tripolyphosphate fibrous
3-D mesh scaffolds</article-title>. <source>Journal of Biomedical Materials
Research - Part A</source><year>2013</year>, <volume>101A</volume> (<issue>9</issue>), <fpage>2526</fpage>&#8211;<lpage>2537</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.34559</pub-id>.<pub-id pub-id-type="pmid">23359556</pub-id></mixed-citation></ref><ref id="ref99"><mixed-citation publication-type="journal" id="cit99"><name name-style="western"><surname>D&#8217;Mello</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Elangovan</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hong</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ross</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Sumner</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Salem</surname><given-names>A. K.</given-names></name><article-title>Incorporation
of copper into chitosan scaffolds promotes
bone regeneration in rat calvarial defects</article-title>. <source>Journal of Biomedical Materials Research - Part B Applied Biomaterials</source><year>2015</year>, <volume>103</volume> (<issue>5</issue>), <fpage>1044</fpage>&#8211;<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.b.33290</pub-id>.<pub-id pub-id-type="pmid">25230382</pub-id><pub-id pub-id-type="pmcid">PMC4363304</pub-id></mixed-citation></ref><ref id="ref100"><mixed-citation publication-type="journal" id="cit100"><name name-style="western"><surname>Min</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Tan</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wan</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><article-title>Multi-Crosslinked
Strong and Elastic Bioglass/Chitosan-Cysteine Hydrogels
with Controlled Quercetin Delivery for Bone Tissue Engineering</article-title>. <source>Pharmaceutics</source><year>2022</year>, <volume>14</volume> (<issue>10</issue>), <elocation-id>2048</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics14102048</pub-id>.<pub-id pub-id-type="pmid">36297483</pub-id><pub-id pub-id-type="pmcid">PMC9608773</pub-id></mixed-citation></ref><ref id="ref101"><mixed-citation publication-type="journal" id="cit101"><name name-style="western"><surname>Karake&#231;ili</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Korpayev</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Orhan</surname><given-names>K.</given-names></name><article-title>Optimizing
Chitosan/Collagen
Type I/Nanohydroxyapatite Cross-linked Porous Scaffolds for Bone Tissue
Engineering</article-title>. <source>Appl. Biochem. Biotechnol.</source><year>2022</year>, <volume>194</volume> (<issue>9</issue>), <fpage>3843</fpage>&#8211;<lpage>3859</lpage>. <pub-id pub-id-type="doi">10.1007/s12010-022-03962-0</pub-id>.<pub-id pub-id-type="pmid">35543856</pub-id></mixed-citation></ref><ref id="ref102"><mixed-citation publication-type="journal" id="cit102"><name name-style="western"><surname>Grabska-Zieli&#324;ska</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Sionkowska</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Carvalho</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Monteiro</surname><given-names>F. J.</given-names></name><article-title>Biomaterials with
potential use in
bone tissue regeneration-collagen/chitosan/silk fibroin scaffolds
cross-linked by EDC/NHS</article-title>. <source>Materials</source><year>2021</year>, <volume>14</volume> (<issue>5</issue>), <fpage>1</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.3390/ma14051105</pub-id>.<pub-id pub-id-type="pmcid">PMC7956200</pub-id><pub-id pub-id-type="pmid">33652959</pub-id></mixed-citation></ref><ref id="ref103"><mixed-citation publication-type="journal" id="cit103"><name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tan</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>li</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Niu</surname><given-names>X.</given-names></name><article-title>A self-healing, magnetic and injectable biopolymer
hydrogel generated
by dual cross-linking for drug delivery and bone repair</article-title>. <source>Acta Biomaterialia</source><year>2022</year>, <volume>153</volume>, <fpage>159</fpage>&#8211;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2022.09.036</pub-id>.<pub-id pub-id-type="pmid">36152907</pub-id></mixed-citation></ref><ref id="ref104"><mixed-citation publication-type="journal" id="cit104"><name name-style="western"><surname>An</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Wei</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Niu</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><article-title>A mechanically
adaptive &#8220;all-sugar&#8221;
hydrogel for cell-laden injection</article-title>. <source>Eur. Polym.
J.</source><year>2022</year>, <volume>174</volume>, <elocation-id>111328</elocation-id><pub-id pub-id-type="doi">10.1016/j.eurpolymj.2022.111328</pub-id>.</mixed-citation></ref><ref id="ref105"><mixed-citation publication-type="journal" id="cit105"><name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Pei</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Guo</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Qian</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Feng</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Lv</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>C.</given-names></name><article-title>Vascularized nanocomposite hydrogel
mechanically reinforced by polyelectrolyte-modified nanoparticles</article-title>. <source>J. Mater. Chem. B</source><year>2022</year>, <volume>10</volume> (<issue>28</issue>), <fpage>5439</fpage>&#8211;<lpage>5453</lpage>. <pub-id pub-id-type="doi">10.1039/D2TB00735E</pub-id>.<pub-id pub-id-type="pmid">35781484</pub-id></mixed-citation></ref><ref id="ref106"><mixed-citation publication-type="journal" id="cit106"><name name-style="western"><surname>Nair</surname><given-names>P. R.</given-names></name>; <name name-style="western"><surname>Sreeja</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Sailaja</surname><given-names>G. S.</given-names></name><article-title>Early biomineralizing
chitosan-collagen hybrid scaffold withCissus quadrangularisextract
for regenerative bone tissue engineering</article-title>. <source>New
J. Chem.</source><year>2021</year>, <volume>45</volume> (<issue>42</issue>), <fpage>19733</fpage>&#8211;<lpage>19745</lpage>. <pub-id pub-id-type="doi">10.1039/D1NJ03687D</pub-id>.</mixed-citation></ref><ref id="ref107"><mixed-citation publication-type="journal" id="cit107"><name name-style="western"><surname>Grabska-Zieli&#324;ska</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Sionkowska</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Coelho</surname><given-names>C. C.</given-names></name>; <name name-style="western"><surname>Monteiro</surname><given-names>F. J.</given-names></name><article-title>Silk fibroin/collagen/chitosan
scaffolds
cross-linked by a glyoxal solution as biomaterials toward bone tissue
regeneration</article-title>. <source>Materials</source><year>2020</year>, <volume>13</volume> (<issue>15</issue>), <fpage>1</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.3390/ma13153433</pub-id>.<pub-id pub-id-type="pmcid">PMC7436058</pub-id><pub-id pub-id-type="pmid">32759746</pub-id></mixed-citation></ref><ref id="ref108"><mixed-citation publication-type="journal" id="cit108"><name name-style="western"><surname>Banafati Zadeh</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Zamanian</surname><given-names>A.</given-names></name><article-title>Glutaraldehyde: Introducing
Optimum
Condition for Cross-linking the Chitosan/Gelatin Scaffolds for Bone
Tissue Engineering</article-title>. <source>International Journal of
Engineering, Transactions A: Basics</source><year>2022</year>, <volume>35</volume> (<issue>10</issue>), <fpage>1967</fpage>&#8211;<lpage>1980</lpage>. <pub-id pub-id-type="doi">10.5829/IJE.2022.35.10A.15</pub-id>.</mixed-citation></ref><ref id="ref109"><mixed-citation publication-type="journal" id="cit109"><name name-style="western"><surname>Loukelis</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Papadogianni</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Chatzinikolaidou</surname><given-names>M.</given-names></name><article-title>Kappa-carrageenan/chitosan/gelatin
scaffolds enriched with potassium chloride for bone tissue engineering</article-title>. <source>Int. J. Biol. Macromol.</source><year>2022</year>, <volume>209</volume>, <fpage>1720</fpage>&#8211;<lpage>1730</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.04.129</pub-id>.<pub-id pub-id-type="pmid">35461864</pub-id></mixed-citation></ref><ref id="ref110"><mixed-citation publication-type="journal" id="cit110"><name name-style="western"><surname>Doustdar</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Olad</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ghorbani</surname><given-names>M.</given-names></name><article-title>Effect of
glutaraldehyde
and calcium chloride as different crosslinking agents on the characteristics
of chitosan/cellulose nanocrystals scaffold</article-title>. <source>Int. J. Biol. Macromol.</source><year>2022</year>, <volume>208</volume>, <fpage>912</fpage>&#8211;<lpage>924</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.03.193</pub-id>.<pub-id pub-id-type="pmid">35367272</pub-id></mixed-citation></ref><ref id="ref111"><mixed-citation publication-type="journal" id="cit111"><name name-style="western"><surname>Rahman</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Rana</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Spitzhorn</surname><given-names>L. S.</given-names></name>; <name name-style="western"><surname>Akhtar</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Hasan</surname><given-names>M. Z.</given-names></name>; <name name-style="western"><surname>Choudhury</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Fehm</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Czernuszka</surname><given-names>J. T.</given-names></name>; <name name-style="western"><surname>Adjaye</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Asaduzzaman</surname><given-names>S. M.</given-names></name><article-title>Fabrication
of biocompatible porous scaffolds based on hydroxyapatite/collagen/chitosan
composite for restoration of defected maxillofacial mandible bone</article-title>. <source>Progress in Biomaterials</source><year>2019</year>, <volume>8</volume> (<issue>3</issue>), <fpage>137</fpage>&#8211;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1007/s40204-019-0113-x</pub-id>.<pub-id pub-id-type="pmid">31144260</pub-id><pub-id pub-id-type="pmcid">PMC6825626</pub-id></mixed-citation></ref><ref id="ref112"><mixed-citation publication-type="journal" id="cit112"><name name-style="western"><surname>Georgopoulou</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Papadogiannis</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Batsali</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Marakis</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Alpantaki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Eliopoulos</surname><given-names>A. G.</given-names></name>; <name name-style="western"><surname>Pontikoglou</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chatzinikolaidou</surname><given-names>M.</given-names></name><article-title>Chitosan/gelatin
scaffolds support bone regeneration</article-title>. <source>J. Mater.
Sci.: Mater. Med.</source><year>2018</year>, <volume>29</volume> (<issue>5</issue>), <elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.1007/s10856-018-6064-2</pub-id>.<pub-id pub-id-type="pmid">29730855</pub-id></mixed-citation></ref><ref id="ref113"><mixed-citation publication-type="journal" id="cit113"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Fang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Yin</surname><given-names>J.</given-names></name><article-title>Homologous
Sodium Alginate/Chitosan-Based Scaffolds, but Contrasting Effect on
Stem Cell Shape and Osteogenesis</article-title>. <source>ACS Appl.
Mater. Interfaces</source><year>2018</year>, <volume>10</volume> (<issue>8</issue>), <fpage>6930</fpage>&#8211;<lpage>6941</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.7b18859</pub-id>.<pub-id pub-id-type="pmid">29392929</pub-id></mixed-citation></ref><ref id="ref114"><mixed-citation publication-type="journal" id="cit114"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Zeng</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Yin</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Xie</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>F.</given-names></name><article-title>Nanoparticle-modified
chitosan-agarose-gelatin
scaffold for sustained release of SDF-1 and BMP-2</article-title>. <source>Int. J. Nanomed.</source><year>2018</year>, <volume>13</volume>, <fpage>7395</fpage>&#8211;<lpage>7408</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S180859</pub-id>.<pub-id pub-id-type="pmcid">PMC6237249</pub-id><pub-id pub-id-type="pmid">30519022</pub-id></mixed-citation></ref><ref id="ref115"><mixed-citation publication-type="journal" id="cit115"><name name-style="western"><surname>Maji</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Dasgupta</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Pramanik</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Bissoyi</surname><given-names>A.</given-names></name><article-title>Preparation
and Evaluation of Gelatin-Chitosan-Nanobioglass 3D Porous Scaffold
for Bone Tissue Engineering</article-title>. <source>International Journal
of Biomaterials</source><year>2016</year>, <volume>2016</volume>, <elocation-id>9825659</elocation-id><pub-id pub-id-type="doi">10.1155/2016/9825659</pub-id>.<pub-id pub-id-type="pmid">26884764</pub-id><pub-id pub-id-type="pmcid">PMC4738941</pub-id></mixed-citation></ref><ref id="ref116"><mixed-citation publication-type="journal" id="cit116"><name name-style="western"><surname>Da Silva</surname><given-names>A. R. P.</given-names></name>; <name name-style="western"><surname>Macedo</surname><given-names>T. L.</given-names></name>; <name name-style="western"><surname>Coletta</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Feldman</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Pereira</surname><given-names>M. M.</given-names></name><article-title>Synthesis, characterization and cytotoxicity of Chitosan/Polyvinyl
alcohol/bioactive glass hybrid scaffolds obtained by Lyophilization</article-title>. <source>Revista Materia</source><year>2016</year>, <volume>21</volume> (<issue>4</issue>), <fpage>964</fpage>&#8211;<lpage>973</lpage>. <pub-id pub-id-type="doi">10.1590/s1517-707620160004.0089</pub-id>.</mixed-citation></ref><ref id="ref117"><mixed-citation publication-type="journal" id="cit117"><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Xie</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><article-title>The root-like
chitosan nanofiber porous scaffold cross-linked by genipin with type
I collagen and its osteoblast compatibility</article-title>. <source>Carbohydr. Polym.</source><year>2022</year>, <volume>285</volume>, <elocation-id>119255</elocation-id><pub-id pub-id-type="doi">10.1016/j.carbpol.2022.119255</pub-id>.<pub-id pub-id-type="pmid">35287869</pub-id></mixed-citation></ref><ref id="ref118"><mixed-citation publication-type="journal" id="cit118"><name name-style="western"><surname>Krajcer</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Klara</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Horak</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Lewandowska-&#321;a&#324;cucka</surname><given-names>J.</given-names></name><article-title>Bioactive
injectable composites based on insulin-functionalized silica particles
reinforced polymeric hydrogels for potential applications in bone
tissue engineering</article-title>. <source>Journal of Materials Science
and Technology</source><year>2022</year>, <volume>105</volume>, <fpage>153</fpage>&#8211;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmst.2021.08.003</pub-id>.</mixed-citation></ref><ref id="ref119"><mixed-citation publication-type="journal" id="cit119"><name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Bian</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Dai</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name><article-title>Alendronate
crosslinked
chitosan/polycaprolactone scaffold for bone defects repairing</article-title>. <source>Int. J. Biol. Macromol.</source><year>2022</year>, <volume>204</volume>, <fpage>441</fpage>&#8211;<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.02.007</pub-id>.<pub-id pub-id-type="pmid">35151707</pub-id></mixed-citation></ref><ref id="ref120"><mixed-citation publication-type="journal" id="cit120"><name name-style="western"><surname>S&#808;elaru</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Herman</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Vl&#259;sceanu</surname><given-names>G. M.</given-names></name>; <name name-style="western"><surname>Dinescu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Gharbia</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Balt&#259;</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ro&#351;u</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Mihali</surname><given-names>C. V.</given-names></name>; <name name-style="western"><surname>Ionit&#259;</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Serafim</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Iovu</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hermenean</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Costache</surname><given-names>M.</given-names></name><article-title>Graphene&#8211;oxide porous biopolymer hybrids enhance
in vitro osteogenic differentiation and promote ectopic osteogenesis
in vivo</article-title>. <source>International Journal of Molecular
Sciences</source><year>2022</year>, <volume>23</volume> (<issue>1</issue>), <elocation-id>491</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23010491</pub-id>.<pub-id pub-id-type="pmid">35008918</pub-id><pub-id pub-id-type="pmcid">PMC8745160</pub-id></mixed-citation></ref><ref id="ref121"><mixed-citation publication-type="journal" id="cit121"><name name-style="western"><surname>Gilarska</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Hinz</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bzowska</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Dyduch</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Kami&#324;ski</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nowakowska</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lewandowska-&#321;A&#324;cucka</surname><given-names>J.</given-names></name><article-title>Addressing
the Osteoporosis Problem-Multifunctional Injectable Hybrid Materials
for Controlling Local Bone Tissue Remodeling</article-title>. <source>ACS Appl. Mater. Interfaces</source><year>2021</year>, <volume>13</volume> (<issue>42</issue>), <fpage>49762</fpage>&#8211;<lpage>49779</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.1c17472</pub-id>.<pub-id pub-id-type="pmid">34643364</pub-id><pub-id pub-id-type="pmcid">PMC8554765</pub-id></mixed-citation></ref><ref id="ref122"><mixed-citation publication-type="journal" id="cit122"><name name-style="western"><surname>Yu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Tian</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Wan</surname><given-names>Y.</given-names></name><article-title>Thermo-responsive
chitosan/silk fibroin/amino-functionalized mesoporous silica hydrogels
with strong and elastic characteristics for bone tissue engineering</article-title>. <source>Int. J. Biol. Macromol.</source><year>2021</year>, <volume>182</volume>, <fpage>1746</fpage>&#8211;<lpage>1758</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2021.05.166</pub-id>.<pub-id pub-id-type="pmid">34052276</pub-id></mixed-citation></ref><ref id="ref123"><mixed-citation publication-type="journal" id="cit123"><name name-style="western"><surname>Datta</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Rameshbabu</surname><given-names>A. P.</given-names></name>; <name name-style="western"><surname>Bankoti</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Roy</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Gupta</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Jana</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Das</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Sen</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Dhara</surname><given-names>S.</given-names></name><article-title>Decellularized bone
matrix/oleoyl chitosan derived supramolecular
injectable hydrogel promotes efficient bone integration</article-title>. <source>Materials Science and Engineering C</source><year>2021</year>, <volume>119</volume>, <elocation-id>111604</elocation-id><pub-id pub-id-type="doi">10.1016/j.msec.2020.111604</pub-id>.<pub-id pub-id-type="pmid">33321648</pub-id></mixed-citation></ref><ref id="ref124"><mixed-citation publication-type="journal" id="cit124"><name name-style="western"><surname>Vlasceanu</surname><given-names>G. M.</given-names></name>; <name name-style="western"><surname>S&#808;elaru</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Dinescu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Balta</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Herman</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Gharbia</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hermenean</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ionita</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Costache</surname><given-names>M.</given-names></name><article-title>Comprehensive appraisal
of graphene&#8211;oxide
ratio in porous biopolymer hybrids targeting bone-tissue regeneration</article-title>. <source>Nanomaterials</source><year>2020</year>, <volume>10</volume> (<issue>8</issue>), <fpage>1</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.3390/nano10081444</pub-id>.<pub-id pub-id-type="pmcid">PMC7466474</pub-id><pub-id pub-id-type="pmid">32722040</pub-id></mixed-citation></ref><ref id="ref125"><mixed-citation publication-type="journal" id="cit125"><name name-style="western"><surname>Lewandowska-&#321;a&#324;cucka</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Gilarska</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bu&#322;a</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Horak</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>&#321;atkiewicz</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Nowakowska</surname><given-names>M.</given-names></name><article-title>Genipin crosslinked
bioactive collagen/chitosan/hyaluronic acid injectable hydrogels structurally
amended via covalent attachment of surface-modified silica particles</article-title>. <source>Int. J. Biol. Macromol.</source><year>2019</year>, <volume>136</volume>, <fpage>1196</fpage>&#8211;<lpage>1208</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.06.184</pub-id>.<pub-id pub-id-type="pmid">31252014</pub-id></mixed-citation></ref><ref id="ref126"><mixed-citation publication-type="journal" id="cit126"><name name-style="western"><surname>Gilarska</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Lewandowska-&#321;a&#324;cucka</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Guzdek-Zaj&#261;c</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Karewicz</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Horak</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Lach</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>W&#243;jcik</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Nowakowska</surname><given-names>M.</given-names></name><article-title>Bioactive yet antimicrobial structurally
stable collagen/chitosan/lysine functionalized hyaluronic acid &#8211;
based injectable hydrogels for potential bone tissue engineering applications</article-title>. <source>Int. J. Biol. Macromol.</source><year>2020</year>, <volume>155</volume>, <fpage>938</fpage>&#8211;<lpage>950</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.11.052</pub-id>.<pub-id pub-id-type="pmid">31712140</pub-id></mixed-citation></ref><ref id="ref127"><mixed-citation publication-type="journal" id="cit127"><name name-style="western"><surname>Filipowska</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lewandowska-&#321;a&#324;cucka</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Gilarska</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Nied&#378;wiedzki</surname><given-names>&#321;.</given-names></name>; <name name-style="western"><surname>Nowakowska</surname><given-names>M.</given-names></name><article-title>In vitro osteogenic
potential of collagen/chitosan-based hydrogels-silica particles hybrids
in human bone marrow-derived mesenchymal stromal cell cultures</article-title>. <source>Int. J. Biol. Macromol.</source><year>2018</year>, <volume>113</volume>, <fpage>692</fpage>&#8211;<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.02.161</pub-id>.<pub-id pub-id-type="pmid">29525638</pub-id></mixed-citation></ref><ref id="ref128"><mixed-citation publication-type="journal" id="cit128"><name name-style="western"><surname>Zazakowny</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Lewandowska-&#321;a&#324;cucka</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Mastalska-Pop&#322;awska</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Kami&#324;ski</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Kusior</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Radecka</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Nowakowska</surname><given-names>M.</given-names></name><article-title>Biopolymeric
hydrogels &#8211; nanostructured TiO2 hybrid materials as potential
injectable scaffolds for bone regeneration</article-title>. <source>Colloids Surf., B</source><year>2016</year>, <volume>148</volume>, <fpage>607</fpage>&#8211;<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2016.09.031</pub-id>.<pub-id pub-id-type="pmid">27694050</pub-id></mixed-citation></ref><ref id="ref129"><mixed-citation publication-type="journal" id="cit129"><name name-style="western"><surname>Nath</surname><given-names>S. D.</given-names></name>; <name name-style="western"><surname>Abueva</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>B. T.</given-names></name><article-title>Chitosan-hyaluronic
acid polyelectrolyte complex scaffold crosslinked with genipin for
immobilization and controlled release of BMP-2</article-title>. <source>Carbohydr. Polym.</source><year>2015</year>, <volume>115</volume>, <fpage>207</fpage>&#8211;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2014.08.077</pub-id>.<pub-id pub-id-type="pmid">25439881</pub-id></mixed-citation></ref><ref id="ref130"><mixed-citation publication-type="journal" id="cit130"><name name-style="western"><surname>Xiong</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Gao</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Weng</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Zeng</surname><given-names>H.</given-names></name><article-title>The fabrication of
a highly efficient hydrogel based on a functionalized double network
loaded with magnesium ion and BMP2 for bone defect synergistic treatment</article-title>. <source>Materials Science and Engineering C</source><year>2021</year>, <volume>128</volume>, <elocation-id>112347</elocation-id><pub-id pub-id-type="doi">10.1016/j.msec.2021.112347</pub-id>.<pub-id pub-id-type="pmid">34474897</pub-id></mixed-citation></ref><ref id="ref131"><mixed-citation publication-type="journal" id="cit131"><name name-style="western"><surname>Ghorbani</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Pourhaghgouy</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Mohammadi-hafshehjani</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Zamanian</surname><given-names>A.</given-names></name><article-title>Effect of Silane-Coupling
Modification on the Performance
of chitosan-poly vinyl Alcohol-Hybrid Scaffolds in Bone Tissue Engineering</article-title>. <source>Silicon</source><year>2020</year>, <volume>12</volume> (<issue>12</issue>), <fpage>3015</fpage>&#8211;<lpage>3026</lpage>. <pub-id pub-id-type="doi">10.1007/s12633-020-00397-2</pub-id>.</mixed-citation></ref><ref id="ref132"><mixed-citation publication-type="journal" id="cit132"><name name-style="western"><surname>Shokri</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Movahedi</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Rafieinia</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Salehi</surname><given-names>H.</given-names></name><article-title>A new approach to fabrication of Cs/BG/CNT nanocomposite
scaffold towards bone tissue engineering and evaluation of its properties</article-title>. <source>Appl. Surf. Sci.</source><year>2015</year>, <volume>357</volume>, <fpage>1758</fpage>&#8211;<lpage>1764</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsusc.2015.10.048</pub-id>.</mixed-citation></ref><ref id="ref133"><mixed-citation publication-type="journal" id="cit133"><name name-style="western"><surname>Nie</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Long</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Dong</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wei</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Suo</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Hua</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Yuan</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name><article-title>Development
of chitosan/gelatin hydrogels incorporation of biphasic calcium phosphate
nanoparticles for bone tissue engineering</article-title>. <source>Journal
of Biomaterials Science, Polymer Edition</source><year>2019</year>, <volume>30</volume> (<issue>17</issue>), <fpage>1636</fpage>&#8211;<lpage>1657</lpage>. <pub-id pub-id-type="doi">10.1080/09205063.2019.1654210</pub-id>.<pub-id pub-id-type="pmid">31393229</pub-id></mixed-citation></ref><ref id="ref134"><mixed-citation publication-type="journal" id="cit134"><name name-style="western"><surname>Kosowska</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Domalik-Pyzik</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Krok-Borkowicz</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ch&#322;opek</surname><given-names>J.</given-names></name><article-title>Polylactide/hydroxyapatite nonwovens
incorporated into
chitosan/graphene materials hydrogels to form novel hierarchical scaffolds</article-title>. <source>International Journal of Molecular Sciences</source><year>2020</year>, <volume>21</volume> (<issue>7</issue>), <elocation-id>2330</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21072330</pub-id>.<pub-id pub-id-type="pmid">32230916</pub-id><pub-id pub-id-type="pmcid">PMC7178071</pub-id></mixed-citation></ref><ref id="ref135"><mixed-citation publication-type="journal" id="cit135"><name name-style="western"><surname>Ji</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Cui</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Feng</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Guo</surname><given-names>X.</given-names></name><article-title>Chitosan/nHAC/PLGA microsphere vehicle
for sustained release of rhBMP-2 and its derived synthetic oligopeptide
for bone regeneration</article-title>. <source>Journal of Biomedical
Materials Research - Part A</source><year>2017</year>, <volume>105</volume> (<issue>6</issue>), <fpage>1593</fpage>&#8211;<lpage>1606</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.35962</pub-id>.<pub-id pub-id-type="pmid">27862940</pub-id></mixed-citation></ref><ref id="ref136"><mixed-citation publication-type="journal" id="cit136"><name name-style="western"><surname>Ali</surname><given-names>H. U.</given-names></name>; <name name-style="western"><surname>Iqbal</surname><given-names>D. N.</given-names></name>; <name name-style="western"><surname>Iqbal</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ezzine</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Arshad</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Zeeshan</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Chaudhry</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Alshawwa</surname><given-names>S. Z.</given-names></name>; <name name-style="western"><surname>Nazir</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Khan</surname><given-names>A. F.</given-names></name><article-title>HPMC crosslinked
chitosan/hydroxyapatite
scaffolds containing Lemongrass oil for potential bone tissue engineering
applications</article-title>. <source>Arabian Journal of Chemistry</source><year>2022</year>, <volume>15</volume> (<issue>7</issue>), <elocation-id>103850</elocation-id><pub-id pub-id-type="doi">10.1016/j.arabjc.2022.103850</pub-id>.</mixed-citation></ref><ref id="ref137"><mixed-citation publication-type="journal" id="cit137"><name name-style="western"><surname>Zeeshan</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Mutahir</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Iqbal</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ali</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Iqbal</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Ijaz</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Sharif</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Shah</surname><given-names>A. T.</given-names></name>; <name name-style="western"><surname>Chaudhry</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Yar</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Luan</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Khan</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Ihtesham ur</surname><given-names>R.</given-names></name><article-title>Hydroxypropylmethyl
cellulose (HPMC) crosslinked chitosan
(CH) based scaffolds containing bioactive glass (BG) and zinc oxide
(ZnO) for alveolar bone repair</article-title>. <source>Carbohydr. Polym.</source><year>2018</year>, <volume>193</volume>, <fpage>9</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2018.03.046</pub-id>.<pub-id pub-id-type="pmid">29773402</pub-id></mixed-citation></ref><ref id="ref138"><mixed-citation publication-type="journal" id="cit138"><name name-style="western"><surname>Kolanthai</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Sindu</surname><given-names>P. A.</given-names></name>; <name name-style="western"><surname>Khajuria</surname><given-names>D. K.</given-names></name>; <name name-style="western"><surname>Veerla</surname><given-names>S. C.</given-names></name>; <name name-style="western"><surname>Kuppuswamy</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Catalani</surname><given-names>L. H.</given-names></name>; <name name-style="western"><surname>Mahapatra</surname><given-names>D. R.</given-names></name><article-title>Graphene
Oxide - A Tool for the Preparation of Chemically Crosslinking Free
Alginate-Chitosan-Collagen Scaffolds for Bone Tissue Engineering</article-title>. <source>ACS Appl. Mater. Interfaces</source><year>2018</year>, <volume>10</volume> (<issue>15</issue>), <fpage>12441</fpage>&#8211;<lpage>12452</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.8b00699</pub-id>.<pub-id pub-id-type="pmid">29589895</pub-id></mixed-citation></ref><ref id="ref139"><mixed-citation publication-type="journal" id="cit139"><name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yin</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Xia</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Mao</surname><given-names>C.</given-names></name><article-title>Multifunctional
Copper-Containing Carboxymethyl Chitosan/Alginate
Scaffolds for Eradicating Clinical Bacterial Infection and Promoting
Bone Formation</article-title>. <source>ACS Appl. Mater. Interfaces</source><year>2018</year>, <volume>10</volume> (<issue>1</issue>), <fpage>127</fpage>&#8211;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.7b13750</pub-id>.<pub-id pub-id-type="pmid">29256580</pub-id><pub-id pub-id-type="pmcid">PMC5764773</pub-id></mixed-citation></ref><ref id="ref140"><mixed-citation publication-type="journal" id="cit140"><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Cui</surname><given-names>Z. K.</given-names></name>; <name name-style="western"><surname>Koo</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Aghaloo</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>M.</given-names></name><article-title>Chitosan-Lysozyme Conjugates for Enzyme-Triggered Hydrogel Degradation
in Tissue Engineering Applications</article-title>. <source>ACS Appl.
Mater. Interfaces</source><year>2018</year>, <volume>10</volume> (<issue>48</issue>), <fpage>41138</fpage>&#8211;<lpage>41145</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.8b15591</pub-id>.<pub-id pub-id-type="pmid">30421603</pub-id><pub-id pub-id-type="pmcid">PMC6453716</pub-id></mixed-citation></ref><ref id="ref141"><mixed-citation publication-type="journal" id="cit141"><name name-style="western"><surname>Lu</surname><given-names>H. T.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>T. W.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>C. H.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>K. Y.</given-names></name>; <name name-style="western"><surname>Mi</surname><given-names>F. L.</given-names></name><article-title>Development of nanocomposite scaffolds
based on biomineralization
of N,O-carboxymethyl chitosan/fucoidan conjugates for bone tissue
engineering</article-title>. <source>Int. J. Biol. Macromol.</source><year>2018</year>, <volume>120</volume>, <fpage>2335</fpage>&#8211;<lpage>2345</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.08.179</pub-id>.<pub-id pub-id-type="pmid">30189280</pub-id></mixed-citation></ref><ref id="ref142"><mixed-citation publication-type="journal" id="cit142"><name name-style="western"><surname>Pita-L&#243;pez</surname><given-names>M.
L.</given-names></name>; <name name-style="western"><surname>Fletes-Vargas</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Espinosa-Andrews</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Rodriguez-Rodriguez</surname><given-names>R.</given-names></name><article-title>Physically cross-linked chitosan-based
hydrogels for
tissue engineering applications: A state-of-the-art review</article-title>. <source>Eur. Polym. J.</source><year>2021</year>, <volume>145</volume>, <elocation-id>110176</elocation-id><pub-id pub-id-type="doi">10.1016/j.eurpolymj.2020.110176</pub-id>.</mixed-citation></ref><ref id="ref143"><mixed-citation publication-type="journal" id="cit143"><name name-style="western"><surname>Tejo-Otero</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ritchie</surname><given-names>A. C.</given-names></name><article-title>Biological and mechanical
evaluation
of mineralized-hydrogel scaffolds for tissue engineering applications</article-title>. <source>Journal of Biomaterials Applications</source><year>2021</year>, <volume>36</volume> (<issue>3</issue>), <fpage>460</fpage>&#8211;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1177/0885328221995425</pub-id>.<pub-id pub-id-type="pmid">33596707</pub-id></mixed-citation></ref><ref id="ref144"><mixed-citation publication-type="journal" id="cit144"><name name-style="western"><surname>Pizzolitto</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Scognamiglio</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Sacco</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lipari</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Romano</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Donati</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Marsich</surname><given-names>E.</given-names></name><article-title>Immediate stress dissipation
in dual cross-link hydrogels controls osteogenic commitment of mesenchymal
stem cells</article-title>. <source>Carbohydr. Polym.</source><year>2023</year>, <volume>302</volume>, <elocation-id>120369</elocation-id><pub-id pub-id-type="doi">10.1016/j.carbpol.2022.120369</pub-id>.<pub-id pub-id-type="pmid">36604049</pub-id></mixed-citation></ref><ref id="ref145"><mixed-citation publication-type="journal" id="cit145"><name name-style="western"><surname>Azaman</surname><given-names>F. A.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Blanes-Mart&#237;nez</surname><given-names>M. D. M.</given-names></name>; <name name-style="western"><surname>Brennan Fournet</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Devine</surname><given-names>D. M.</given-names></name><article-title>Bioresorbable Chitosan-Based
Bone Regeneration Scaffold Using Various Bioceramics and the Alteration
of Photoinitiator Concentration in an Extended UV Photocrosslinking
Reaction</article-title>. <source>Gels</source><year>2022</year>, <volume>8</volume> (<issue>11</issue>), <elocation-id>696</elocation-id><pub-id pub-id-type="doi">10.3390/gels8110696</pub-id>.<pub-id pub-id-type="pmid">36354604</pub-id><pub-id pub-id-type="pmcid">PMC9689760</pub-id></mixed-citation></ref><ref id="ref146"><mixed-citation publication-type="journal" id="cit146"><name name-style="western"><surname>Kocak</surname><given-names>F. Z.</given-names></name>; <name name-style="western"><surname>Yar</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Rehman</surname><given-names>I. U.</given-names></name><article-title>Hydroxyapatite-Integrated,
Heparin-and Glycerol-Functionalized Chitosan-Based Injectable Hydrogels
with Improved Mechanical and Proangiogenic Performance</article-title>. <source>International Journal of Molecular Sciences</source><year>2022</year>, <volume>23</volume> (<issue>10</issue>), <elocation-id>5370</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23105370</pub-id>.<pub-id pub-id-type="pmid">35628172</pub-id><pub-id pub-id-type="pmcid">PMC9140455</pub-id></mixed-citation></ref><ref id="ref147"><mixed-citation publication-type="journal" id="cit147"><name name-style="western"><surname>Zhu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Shi</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>G.</given-names></name><article-title>Fabrication of Naturally
Derived
Double-Network Hydrogels With a Sustained Aspirin Release System for
Facilitating Bone Regeneration</article-title>. <source>Frontiers in
Chemistry</source><year>2022</year>, <volume>10</volume>, <elocation-id>874985</elocation-id><pub-id pub-id-type="doi">10.3389/fchem.2022.874985</pub-id>.<pub-id pub-id-type="pmid">35419346</pub-id><pub-id pub-id-type="pmcid">PMC8995466</pub-id></mixed-citation></ref><ref id="ref148"><mixed-citation publication-type="journal" id="cit148"><name name-style="western"><surname>Demeyer</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Athipornchai</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Pabunrueang</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Trakulsujaritchok</surname><given-names>T.</given-names></name><article-title>Development
of mangiferin loaded chitosan-silica hybrid
scaffolds: Physicochemical and bioactivity characterization</article-title>. <source>Carbohydr. Polym.</source><year>2021</year>, <volume>261</volume>, <elocation-id>117905</elocation-id><pub-id pub-id-type="doi">10.1016/j.carbpol.2021.117905</pub-id>.<pub-id pub-id-type="pmid">33766383</pub-id></mixed-citation></ref><ref id="ref149"><mixed-citation publication-type="journal" id="cit149"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Gao</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Fan</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name><article-title>A tough chitosan-alginate
porous hydrogel prepared by simple foaming method</article-title>. <source>J. Solid State Chem.</source><year>2021</year>, <volume>294</volume>, <elocation-id>121797</elocation-id><pub-id pub-id-type="doi">10.1016/j.jssc.2020.121797</pub-id>.</mixed-citation></ref><ref id="ref150"><mixed-citation publication-type="journal" id="cit150"><name name-style="western"><surname>Suneetha</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Rao</surname><given-names>K. M.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>S. S.</given-names></name><article-title>Mechanically improved
porous hydrogels with polysaccharides via polyelectrolyte complexation
for bone tissue engineering</article-title>. <source>Int. J. Biol. Macromol.</source><year>2020</year>, <volume>144</volume>, <fpage>160</fpage>&#8211;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.12.096</pub-id>.<pub-id pub-id-type="pmid">31843617</pub-id></mixed-citation></ref><ref id="ref151"><mixed-citation publication-type="journal" id="cit151"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Jiang</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Qi</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Zeng</surname><given-names>H.</given-names></name><article-title>A novel magnesium ion-incorporating
dual-crosslinked hydrogel to improve bone scaffold-mediated osteogenesis
and angiogenesis</article-title>. <source>Materials Science and Engineering
C</source><year>2021</year>, <volume>121</volume>, <elocation-id>111868</elocation-id><pub-id pub-id-type="doi">10.1016/j.msec.2021.111868</pub-id>.<pub-id pub-id-type="pmid">33579495</pub-id></mixed-citation></ref><ref id="ref152"><mixed-citation publication-type="journal" id="cit152"><name name-style="western"><surname>Patil</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Saha</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Biswas</surname><given-names>A.</given-names></name><article-title>Preparation
and Characterization
of HAp Coated Chitosan-Alginate PEC Porous Scaffold for Bone Tissue
Engineering</article-title>. <source>Macromol. Symp.</source><year>2017</year>, <volume>376</volume> (<issue>1</issue>), <elocation-id>1600205</elocation-id><pub-id pub-id-type="doi">10.1002/masy.201600205</pub-id>.</mixed-citation></ref><ref id="ref153"><mixed-citation publication-type="journal" id="cit153"><name name-style="western"><surname>Dorati</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>De Trizio</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Genta</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Merelli</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Modena</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Conti</surname><given-names>B.</given-names></name><article-title>Formulation
and in vitro characterization
of a composite biodegradable scaffold as antibiotic delivery system
and regenerative device for bone</article-title>. <source>Journal of
Drug Delivery Science and Technology</source><year>2016</year>, <volume>35</volume>, <fpage>124</fpage>&#8211;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.jddst.2016.04.008</pub-id>.</mixed-citation></ref><ref id="ref154"><mixed-citation publication-type="journal" id="cit154"><name name-style="western"><surname>Lou</surname><given-names>C. W.</given-names></name>; <name name-style="western"><surname>Wen</surname><given-names>S. P.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>J. H.</given-names></name><article-title>Chitosan/gelatin
porous bone scaffolds made by crosslinking treatment and freeze-drying
technology: Effects of crosslinking durations on the porous structure,
compressive strength, and in vitro cytotoxicity</article-title>. <source>J. Appl. Polym. Sci.</source><year>2015</year>, <volume>132</volume> (<issue>17</issue>), <elocation-id>41851</elocation-id><pub-id pub-id-type="doi">10.1002/app.41851</pub-id>.</mixed-citation></ref><ref id="ref155"><mixed-citation publication-type="journal" id="cit155"><name name-style="western"><surname>Kim</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Mercado-Pag&#225;n</surname><given-names>A. E.</given-names></name>; <name name-style="western"><surname>Maloney</surname><given-names>W. J.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><article-title>In vitro evaluation of photo-crosslinkable
chitosan-lactide hydrogels
for bone tissue engineering</article-title>. <source>Journal of Biomedical
Materials Research - Part B Applied Biomaterials</source><year>2014</year>, <volume>102</volume> (<issue>7</issue>), <fpage>1393</fpage>&#8211;<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.b.33118</pub-id>.<pub-id pub-id-type="pmid">24500890</pub-id></mixed-citation></ref><ref id="ref156"><mixed-citation publication-type="journal" id="cit156"><name name-style="western"><surname>Tsai</surname><given-names>W. B.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>Y. R.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>H. L.</given-names></name><article-title>RGD-conjugated
crosslinked
chitosan scaffolds for culture and osteogenic differentiation of mesenchymal
stem cells</article-title>. <source>Journal of the Taiwan Institute
of Chemical Engineers</source><year>2013</year>, <volume>44</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtice.2012.09.003</pub-id>.</mixed-citation></ref><ref id="ref157"><mixed-citation publication-type="journal" id="cit157"><name name-style="western"><surname>Fattahi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Soleimani</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Khani</surname><given-names>M.-M.</given-names></name>; <name name-style="western"><surname>Rasouli</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hosseinzadeh</surname><given-names>S.</given-names></name><article-title>A three-dimensional
structure with osteoconductive
function made of O-carboxymethyl chitosan using aspirin as a cross-linker</article-title>. <source>International Journal of Polymeric Materials and Polymeric
Biomaterials</source><year>2023</year>, <fpage>1</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1080/00914037.2022.2155156</pub-id>.</mixed-citation></ref><ref id="ref158"><mixed-citation publication-type="journal" id="cit158"><name name-style="western"><surname>Arpornmaeklong</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Jaiman</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Apinyauppatham</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Fuongfuchat</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Boonyuen</surname><given-names>S.</given-names></name><article-title>Effects of Calcium Carbonate Microcapsules
and Nanohydroxyapatite on Properties of Thermosensitive Chitosan/Collagen
Hydrogels</article-title>. <source>Polymers</source><year>2023</year>, <volume>15</volume> (<issue>2</issue>), <elocation-id>416</elocation-id><pub-id pub-id-type="doi">10.3390/polym15020416</pub-id>.<pub-id pub-id-type="pmid">36679297</pub-id><pub-id pub-id-type="pmcid">PMC9861171</pub-id></mixed-citation></ref><ref id="ref159"><mixed-citation publication-type="journal" id="cit159"><name name-style="western"><surname>Kumari</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Srivastava</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Mishra</surname><given-names>A.</given-names></name><article-title>Generation of bioactive
porous chitosan/gelatin based scaffold modified with tri-calcium phosphate/nano-bioglass
for bone tissue engineering applications</article-title>. <source>Journal
of Porous Materials</source><year>2022</year>, <fpage>1</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1007/s10934-022-01406-y</pub-id>.</mixed-citation></ref><ref id="ref160"><mixed-citation publication-type="journal" id="cit160"><name name-style="western"><surname>Uswatta</surname><given-names>S. P.</given-names></name>; <name name-style="western"><surname>Okeke</surname><given-names>I. U.</given-names></name>; <name name-style="western"><surname>Jayasuriya</surname><given-names>A. C.</given-names></name><article-title>Injectable
porous nano-hydroxyapatite/chitosan/tripolyphosphate scaffolds with
improved compressive strength for bone regeneration</article-title>. <source>Materials Science and Engineering: C</source><year>2016</year>, <volume>69</volume>, <fpage>505</fpage>&#8211;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2016.06.089</pub-id>.<pub-id pub-id-type="pmid">27612741</pub-id><pub-id pub-id-type="pmcid">PMC5019117</pub-id></mixed-citation></ref><ref id="ref161"><mixed-citation publication-type="journal" id="cit161"><name name-style="western"><surname>Caridade</surname><given-names>S. G.</given-names></name>; <name name-style="western"><surname>Monge</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Almod&#243;var</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Guillot</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Lavaud</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Josserand</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Coll</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Mano</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Picart</surname><given-names>C.</given-names></name><article-title>Myoconductive and osteoinductive
free-standing polysaccharide membranes</article-title>. <source>Acta
Biomaterialia</source><year>2015</year>, <volume>15</volume>, <fpage>139</fpage>&#8211;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2014.12.027</pub-id>.<pub-id pub-id-type="pmid">25575853</pub-id><pub-id pub-id-type="pmcid">PMC4540078</pub-id></mixed-citation></ref><ref id="ref162"><mixed-citation publication-type="journal" id="cit162"><name name-style="western"><surname>Osmond</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Krebs</surname><given-names>M. D.</given-names></name><article-title>Tunable chitosan-calcium phosphate
composites as cell-instructive dental pulp capping agents</article-title>. <source>Journal of Biomaterials Science, Polymer Edition</source><year>2021</year>, <volume>32</volume> (<issue>11</issue>), <fpage>1450</fpage>&#8211;<lpage>1465</lpage>. <pub-id pub-id-type="doi">10.1080/09205063.2021.1925390</pub-id>.<pub-id pub-id-type="pmid">33941040</pub-id></mixed-citation></ref><ref id="ref163"><mixed-citation publication-type="journal" id="cit163"><name name-style="western"><surname>Bi</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Pang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Cheng</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Xing</surname><given-names>S.</given-names></name>; et al. <article-title>Construction
of physical-crosslink chitosan/PVA double-network
hydrogel with surface mineralization for bone repair</article-title>. <source>Carbohydr. Polym.</source><year>2019</year>, <volume>224</volume>, <elocation-id>115176</elocation-id><pub-id pub-id-type="doi">10.1016/j.carbpol.2019.115176</pub-id>.<pub-id pub-id-type="pmid">31472871</pub-id></mixed-citation></ref><ref id="ref164"><mixed-citation publication-type="journal" id="cit164"><name name-style="western"><surname>Kosowska</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Domalik-Pyzik</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Krok-Borkowicz</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ch&#322;opek</surname><given-names>J.</given-names></name><article-title>Synthesis and characterization of chitosan/reduced
graphene oxide hybrid composites</article-title>. <source>Materials</source><year>2019</year>, <volume>12</volume> (<issue>13</issue>), <elocation-id>2077</elocation-id><pub-id pub-id-type="doi">10.3390/ma12132077</pub-id>.<pub-id pub-id-type="pmid">31261610</pub-id><pub-id pub-id-type="pmcid">PMC6651717</pub-id></mixed-citation></ref><ref id="ref165"><mixed-citation publication-type="journal" id="cit165"><name name-style="western"><surname>Pineda-Castillo</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Bernal-Ballen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bernal-L&#243;pez</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Segura-Puello</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Nieto-Mosquera</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Villamil-Ballesteros</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mu&#241;oz-Forero</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Munster</surname><given-names>L.</given-names></name><article-title>Synthesis and characterization of
poly(vinyl alcohol)-chitosan-hydroxyapatite scaffolds: a promising
alternative for bone tissue regeneration</article-title>. <source>Molecules</source><year>2018</year>, <volume>23</volume> (<issue>10</issue>), <elocation-id>2414</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23102414</pub-id>.<pub-id pub-id-type="pmid">30241366</pub-id><pub-id pub-id-type="pmcid">PMC6222900</pub-id></mixed-citation></ref><ref id="ref166"><mixed-citation publication-type="journal" id="cit166"><name name-style="western"><surname>Kiechel</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Beringer</surname><given-names>L. T.</given-names></name>; <name name-style="western"><surname>Donius</surname><given-names>A. E.</given-names></name>; <name name-style="western"><surname>Komiya</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Habas</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Wegst</surname><given-names>U. G. K.</given-names></name>; <name name-style="western"><surname>Schauer</surname><given-names>C. L.</given-names></name><article-title>Osteoblast biocompatibility
of premineralized, hexamethylene-1,6-diaminocarboxysulfonate crosslinked
chitosan fibers</article-title>. <source>Journal of Biomedical Materials
Research - Part A</source><year>2015</year>, <volume>103</volume> (<issue>10</issue>), <fpage>3201</fpage>&#8211;<lpage>3211</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.35451</pub-id>.<pub-id pub-id-type="pmid">25771925</pub-id><pub-id pub-id-type="pmcid">PMC4552608</pub-id></mixed-citation></ref><ref id="ref167"><mixed-citation publication-type="journal" id="cit167"><name name-style="western"><surname>Gohil</surname><given-names>S. V.</given-names></name>; <name name-style="western"><surname>Brittain</surname><given-names>S. B.</given-names></name>; <name name-style="western"><surname>Kan</surname><given-names>H. M.</given-names></name>; <name name-style="western"><surname>Drissi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Rowe</surname><given-names>D. W.</given-names></name>; <name name-style="western"><surname>Nair</surname><given-names>L. S.</given-names></name><article-title>Evaluation of enzymatically
crosslinked
injectable glycol chitosan hydrogel</article-title>. <source>J. Mater.
Chem. B</source><year>2015</year>, <volume>3</volume> (<issue>27</issue>), <fpage>5511</fpage>&#8211;<lpage>5522</lpage>. <pub-id pub-id-type="doi">10.1039/C5TB00663E</pub-id>.<pub-id pub-id-type="pmid">32262522</pub-id></mixed-citation></ref><ref id="ref168"><mixed-citation publication-type="journal" id="cit168"><name name-style="western"><surname>Maturavongsadit</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Paravyan</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Shrivastava</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Benhabbour</surname><given-names>S. R.</given-names></name><article-title>Thermo-/pH-responsive
chitosan-cellulose nanocrystals
based hydrogel with tunable mechanical properties for tissue regeneration
applications</article-title>. <source>Materialia</source><year>2020</year>, <volume>12</volume>, <elocation-id>100681</elocation-id><pub-id pub-id-type="doi">10.1016/j.mtla.2020.100681</pub-id>.</mixed-citation></ref><ref id="ref169"><mixed-citation publication-type="journal" id="cit169"><name name-style="western"><surname>Song</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Xiao</surname><given-names>Y.</given-names></name><article-title>Sequential drug delivery
of vancomycin
and rhBMP-2 via pore-closed PLGA microparticles embedded photo-crosslinked
chitosan hydrogel for enhanced osteointegration</article-title>. <source>Int. J. Biol. Macromol.</source><year>2021</year>, <volume>182</volume>, <fpage>612</fpage>&#8211;<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2021.03.181</pub-id>.<pub-id pub-id-type="pmid">33838200</pub-id></mixed-citation></ref><ref id="ref170"><mixed-citation publication-type="journal" id="cit170"><name name-style="western"><surname>Rodr&#237;guez-M&#233;ndez</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Fern&#225;ndez-Guti&#233;rrez</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Rodr&#237;guez-Navarrete</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Rosales-Ib&#225;&#241;ez</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Benito-Garz&#243;n</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>V&#225;zquez-Lasa</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Rom&#225;n</surname><given-names>J. S.</given-names></name><article-title>Bioactive
Sr(II)/chitosan/poly(&#949;-caprolactone) scaffolds for craniofacial
tissue regeneration. In vitro and in vivo behavior</article-title>. <source>Polymers</source><year>2018</year>, <volume>10</volume> (<issue>3</issue>), <elocation-id>279</elocation-id><pub-id pub-id-type="doi">10.3390/polym10030279</pub-id>.<pub-id pub-id-type="pmid">30966314</pub-id><pub-id pub-id-type="pmcid">PMC6415099</pub-id></mixed-citation></ref><ref id="ref171"><mixed-citation publication-type="journal" id="cit171"><name name-style="western"><surname>Rahman</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Maria</surname><given-names>K. H.</given-names></name>; <name name-style="western"><surname>Ishtiaque</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Nahar</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Das</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>HOQUE</surname><given-names>S.</given-names></name><article-title>Evaluation of a novel
nanocrystalline hydroxyapatite powder and a solid hydroxyapatite/Chitosan-Gelatin
bioceramic for scaffold preparation used as a bone substitute material</article-title>. <source>Turkish Journal of Chemistry</source><year>2020</year>, <volume>44</volume> (<issue>4</issue>), <fpage>884</fpage>&#8211;<lpage>900</lpage>. <pub-id pub-id-type="doi">10.3906/kim-1912-40</pub-id>.<pub-id pub-id-type="pmid">33488200</pub-id><pub-id pub-id-type="pmcid">PMC7751930</pub-id></mixed-citation></ref><ref id="ref172"><mixed-citation publication-type="journal" id="cit172"><name name-style="western"><surname>Prasadh</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>R. C. W.</given-names></name><article-title>Unraveling the
mechanical strength
of biomaterials used as a bone scaffold in oral and maxillofacial
defects</article-title>. <source>Oral Science International</source><year>2018</year>, <volume>15</volume> (<issue>2</issue>), <fpage>48</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/S1348-8643(18)30005-3</pub-id>.</mixed-citation></ref><ref id="ref173"><mixed-citation publication-type="journal" id="cit173"><name name-style="western"><surname>Babis</surname><given-names>G. C.</given-names></name>; <name name-style="western"><surname>Soucacos</surname><given-names>P. N.</given-names></name><article-title>Bone scaffolds:
the role of mechanical
stability and instrumentation</article-title>. <source>Injury</source><year>2005</year>, <volume>36</volume> (<issue>4</issue>), <fpage>S38</fpage>&#8211;<lpage>S44</lpage>. <pub-id pub-id-type="doi">10.1016/j.injury.2005.10.009</pub-id>.<pub-id pub-id-type="pmid">16291322</pub-id></mixed-citation></ref><ref id="ref174"><mixed-citation publication-type="journal" id="cit174"><name name-style="western"><surname>Gerhardt</surname><given-names>L.-C.</given-names></name>; <name name-style="western"><surname>Boccaccini</surname><given-names>A. R.</given-names></name><article-title>Bioactive glass and glass-ceramic
scaffolds for bone tissue engineering</article-title>. <source>Materials</source><year>2010</year>, <volume>3</volume> (<issue>7</issue>), <fpage>3867</fpage>&#8211;<lpage>3910</lpage>. <pub-id pub-id-type="doi">10.3390/ma3073867</pub-id>.<pub-id pub-id-type="pmid">28883315</pub-id><pub-id pub-id-type="pmcid">PMC5445790</pub-id></mixed-citation></ref><ref id="ref175"><mixed-citation publication-type="journal" id="cit175"><name name-style="western"><surname>Nie</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Long</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Dong</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wei</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Suo</surname><given-names>J.</given-names></name>; et al. <article-title>Development of chitosan/gelatin hydrogels incorporation
of biphasic calcium phosphate nanoparticles for bone tissue engineering</article-title>. <source>Journal of Biomaterials Science, Polymer Edition</source><year>2019</year>, <volume>30</volume> (<issue>17</issue>), <fpage>1636</fpage>&#8211;<lpage>1657</lpage>. <pub-id pub-id-type="doi">10.1080/09205063.2019.1654210</pub-id>.<pub-id pub-id-type="pmid">31393229</pub-id></mixed-citation></ref><ref id="ref176"><mixed-citation publication-type="journal" id="cit176"><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><article-title>Porous Scaffold
Design for Additive
Manufacturing in Orthopedics: A Review</article-title>. <source>Front.
Bioeng. Biotechnol.</source><year>2020</year>, <volume>8</volume>, <elocation-id>609</elocation-id>.<pub-id pub-id-type="pmid">32626698</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fbioe.2020.00609</pub-id><pub-id pub-id-type="pmcid">PMC7311579</pub-id></mixed-citation></ref><ref id="ref177"><mixed-citation publication-type="journal" id="cit177"><name name-style="western"><surname>Dinescu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ionita</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Ignat</surname><given-names>S.-R.</given-names></name>; <name name-style="western"><surname>Costache</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hermenean</surname><given-names>A.</given-names></name><article-title>Graphene oxide
enhances chitosan-based 3D scaffold
properties for bone tissue engineering</article-title>. <source>International
journal of molecular sciences</source><year>2019</year>, <volume>20</volume> (<issue>20</issue>), <elocation-id>5077</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20205077</pub-id>.<pub-id pub-id-type="pmid">31614903</pub-id><pub-id pub-id-type="pmcid">PMC6834324</pub-id></mixed-citation></ref><ref id="ref178"><mixed-citation publication-type="journal" id="cit178"><name name-style="western"><surname>Hermenean</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Codreanu</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Herman</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Balta</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Rosu</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Mihali</surname><given-names>C. V.</given-names></name>; <name name-style="western"><surname>Ivan</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Dinescu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ionita</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Costache</surname><given-names>M.</given-names></name><article-title>Chitosan-Graphene Oxide
3D scaffolds
as Promising Tools for Bone Regeneration in Critical-Size Mouse Calvarial
Defects</article-title>. <source>Sci. Rep.</source><year>2017</year>, <volume>7</volume> (<issue>1</issue>), <elocation-id>16641</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-16599-5</pub-id>.<pub-id pub-id-type="pmid">29192253</pub-id><pub-id pub-id-type="pmcid">PMC5709492</pub-id></mixed-citation></ref><ref id="ref179"><mixed-citation publication-type="journal" id="cit179"><name name-style="western"><surname>Roseti</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Parisi</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Petretta</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Cavallo</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Desando</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Bartolotti</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Grigolo</surname><given-names>B.</given-names></name><article-title>Scaffolds for bone
tissue engineering: state of the art and new perspectives</article-title>. <source>Materials Science and Engineering: C</source><year>2017</year>, <volume>78</volume>, <fpage>1246</fpage>&#8211;<lpage>1262</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2017.05.017</pub-id>.<pub-id pub-id-type="pmid">28575964</pub-id></mixed-citation></ref><ref id="ref180"><mixed-citation publication-type="journal" id="cit180"><name name-style="western"><surname>Manzini</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Machado</surname><given-names>L. M. R.</given-names></name>; <name name-style="western"><surname>Noritomi</surname><given-names>P. Y.</given-names></name>; <name name-style="western"><surname>da Silva</surname><given-names>J. V. L.</given-names></name><article-title>Advances
in Bone tissue engineering: A fundamental review</article-title>. <source>Journal of Biosciences</source><year>2021</year>, <volume>46</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1007/s12038-020-00122-6</pub-id>.<pub-id pub-id-type="pmid">33737501</pub-id></mixed-citation></ref><ref id="ref181"><mixed-citation publication-type="journal" id="cit181"><name name-style="western"><surname>Szpalski</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Barbaro</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sagebin</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Warren</surname><given-names>S. M.</given-names></name><article-title>Bone tissue
engineering: current strategies and techniques&#8212;part II: cell
types</article-title>. <source>Tissue Engineering Part B: Reviews</source><year>2012</year>, <volume>18</volume> (<issue>4</issue>), <fpage>258</fpage>&#8211;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2011.0440</pub-id>.<pub-id pub-id-type="pmid">22224439</pub-id></mixed-citation></ref><ref id="ref182"><mixed-citation publication-type="journal" id="cit182"><name name-style="western"><surname>Mende</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>G&#246;tzl</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Kubo</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Pufe</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Ruhl</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Beier</surname><given-names>J. P.</given-names></name><article-title>The role of adipose stem cells in
bone regeneration and bone tissue engineering</article-title>. <source>Cells</source><year>2021</year>, <volume>10</volume> (<issue>5</issue>), <elocation-id>975</elocation-id><pub-id pub-id-type="doi">10.3390/cells10050975</pub-id>.<pub-id pub-id-type="pmid">33919377</pub-id><pub-id pub-id-type="pmcid">PMC8143357</pub-id></mixed-citation></ref><ref id="ref183"><mixed-citation publication-type="journal" id="cit183"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Zhuang</surname><given-names>S.</given-names></name><article-title>Chitosan-based materials: Preparation,
modification and application</article-title>. <source>Journal of Cleaner
Production</source><year>2022</year>, <volume>355</volume>, <elocation-id>131825</elocation-id><pub-id pub-id-type="doi">10.1016/j.jclepro.2022.131825</pub-id>.</mixed-citation></ref><ref id="ref184"><mixed-citation publication-type="journal" id="cit184"><name name-style="western"><surname>Maglione</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Spano</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ruaro</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Salvador</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Zanconati</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Tromba</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Turco</surname><given-names>G.</given-names></name><article-title>In vivo evaluation
of chitosan-glycerol gel scaffolds seeded with stem cells for full-thickness
mandibular bone regeneration</article-title>. <source>Journal of Oral
Science</source><year>2017</year>, <volume>59</volume> (<issue>2</issue>), <fpage>225</fpage>&#8211;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.2334/josnusd.16-0235</pub-id>.<pub-id pub-id-type="pmid">28637982</pub-id></mixed-citation></ref><ref id="ref185"><mixed-citation publication-type="journal" id="cit185"><name name-style="western"><surname>Allen</surname><given-names>N. B.</given-names></name>; <name name-style="western"><surname>Abar</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Johnson</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Burbano</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Danilkowicz</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Adams</surname><given-names>S. B.</given-names></name><article-title>3D-bioprinted GelMA-gelatin-hydroxyapatite
osteoblast-laden composite hydrogels for bone tissue engineering</article-title>. <source>Bioprinting</source><year>2022</year>, <volume>26</volume>, <elocation-id>e00196</elocation-id><pub-id pub-id-type="doi">10.1016/j.bprint.2022.e00196</pub-id>.</mixed-citation></ref><ref id="ref186"><mixed-citation publication-type="journal" id="cit186"><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Liao</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Qin</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>B.</given-names></name><article-title>A novel chimeric peptide binds MC3T3-E1 cells to titanium and enhances
their proliferation and differentiation</article-title>. <source>Molecular
Medicine Reports</source><year>2013</year>, <volume>7</volume> (<issue>5</issue>), <fpage>1437</fpage>&#8211;<lpage>1441</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2013.1352</pub-id>.<pub-id pub-id-type="pmid">23467793</pub-id></mixed-citation></ref><ref id="ref187"><mixed-citation publication-type="journal" id="cit187"><name name-style="western"><surname>Pautke</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Schieker</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tischer</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kolk</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Neth</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Mutschler</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Milz</surname><given-names>S.</given-names></name><article-title>Characterization of
Osteosarcoma Cell Lines MG-63, Saos-2 and U-2 OS in Comparison to
Human Osteoblasts</article-title>. <source>Anticancer Res.</source><year>2004</year>, <volume>24</volume> (<issue>6</issue>), <elocation-id>3743</elocation-id>.<pub-id pub-id-type="pmid">15736406</pub-id></mixed-citation></ref><ref id="ref188"><mixed-citation publication-type="journal" id="cit188"><name name-style="western"><surname>Yousefi</surname><given-names>A.-M.</given-names></name>; <name name-style="western"><surname>James</surname><given-names>P. F.</given-names></name>; <name name-style="western"><surname>Akbarzadeh</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Subramanian</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Flavin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Oudadesse</surname><given-names>H.</given-names></name><article-title>Prospect of
stem cells in bone tissue engineering: a review</article-title>. <source>Stem cells international</source><year>2016</year>, <volume>2016</volume>, <elocation-id>6180487</elocation-id><pub-id pub-id-type="doi">10.1155/2016/6180487</pub-id>.<pub-id pub-id-type="pmid">26880976</pub-id><pub-id pub-id-type="pmcid">PMC4736569</pub-id></mixed-citation></ref><ref id="ref189"><mixed-citation publication-type="journal" id="cit189"><name name-style="western"><surname>Tevlin</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Walmsley</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Marecic</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Wan</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Longaker</surname><given-names>M.</given-names></name><article-title>Stem and progenitor cells: advancing bone tissue engineering</article-title>. <source>Drug delivery and translational research</source><year>2016</year>, <volume>6</volume> (<issue>2</issue>), <fpage>159</fpage>&#8211;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1007/s13346-015-0235-1</pub-id>.<pub-id pub-id-type="pmid">25990836</pub-id><pub-id pub-id-type="pmcid">PMC4654714</pub-id></mixed-citation></ref><ref id="ref190"><mixed-citation publication-type="book" id="cit190"><person-group person-group-type="allauthors"><name name-style="western"><surname>Bao</surname><given-names>C. L. M.</given-names></name>; <name name-style="western"><surname>Teo</surname><given-names>E. Y.</given-names></name>; <name name-style="western"><surname>Chong</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Choolani</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Chan</surname><given-names>J.
K.</given-names></name></person-group><article-title>Advances in bone
tissue engineering</article-title>. In <source>Regenerative medicine
and tissue engineering</source>; <publisher-name>IntechOpen</publisher-name>, <year>2013</year>; p <elocation-id>55916</elocation-id>.</mixed-citation></ref><ref id="ref191"><mixed-citation publication-type="journal" id="cit191"><name name-style="western"><surname>Orciani</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Fini</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Di Primio</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Mattioli-Belmonte</surname><given-names>M.</given-names></name><article-title>Biofabrication and bone tissue regeneration: cell source,
approaches, and challenges</article-title>. <source>Frontiers in Bioengineering
and Biotechnology</source><year>2017</year>, <volume>5</volume>, <elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2017.00017</pub-id>.<pub-id pub-id-type="pmid">28386538</pub-id><pub-id pub-id-type="pmcid">PMC5362636</pub-id></mixed-citation></ref><ref id="ref192"><mixed-citation publication-type="journal" id="cit192"><name name-style="western"><surname>Khazaei</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Keshavarz</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Bozorgi</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Nazari</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Khazaei</surname><given-names>M.</given-names></name><article-title>Adipose tissue-derived stem cells: A comparative review
on isolation, culture, and differentiation methods</article-title>. <source>Cell and tissue banking</source><year>2022</year>, <volume>23</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s10561-021-09905-z</pub-id>.<pub-id pub-id-type="pmid">33616792</pub-id></mixed-citation></ref><ref id="ref193"><mixed-citation publication-type="journal" id="cit193"><name name-style="western"><surname>Toosi</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Behravan</surname><given-names>J.</given-names></name><article-title>Osteogenesis and bone
remodeling:
A focus on growth factors and bioactive peptides</article-title>. <source>Biofactors</source><year>2020</year>, <volume>46</volume> (<issue>3</issue>), <fpage>326</fpage>&#8211;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1002/biof.1598</pub-id>.<pub-id pub-id-type="pmid">31854489</pub-id></mixed-citation></ref><ref id="ref194"><mixed-citation publication-type="journal" id="cit194"><name name-style="western"><surname>Kneser</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Schaefer</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Munder</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Klemt</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Andree</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Stark</surname><given-names>G.</given-names></name><article-title>Tissue engineering of bone</article-title>. <source>Minimally Invasive
Therapy &amp; Allied Technologies</source><year>2002</year>, <volume>11</volume> (<issue>3</issue>), <fpage>107</fpage>&#8211;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1080/136457002320174177</pub-id>.<pub-id pub-id-type="pmid">16754059</pub-id></mixed-citation></ref><ref id="ref195"><mixed-citation publication-type="journal" id="cit195"><name name-style="western"><surname>Kneser</surname><given-names>U.</given-names></name>; <name name-style="western"><surname>Schaefer</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Polykandriotis</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Horch</surname><given-names>R. E.</given-names></name><article-title>Tissue engineering of bone: the reconstructive surgeon&#8217;s
point of view</article-title>. <source>Journal of cellular and molecular
medicine</source><year>2006</year>, <volume>10</volume> (<issue>1</issue>), <fpage>7</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2006.tb00287.x</pub-id>.<pub-id pub-id-type="pmid">16563218</pub-id><pub-id pub-id-type="pmcid">PMC3933098</pub-id></mixed-citation></ref><ref id="ref196"><mixed-citation publication-type="journal" id="cit196"><name name-style="western"><surname>Safari</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Davaran</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Aghanejad</surname><given-names>A.</given-names></name><article-title>Osteogenic
potential of the growth factors and bioactive molecules in bone regeneration</article-title>. <source>Int. J. Biol. Macromol.</source><year>2021</year>, <volume>175</volume>, <fpage>544</fpage>&#8211;<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2021.02.052</pub-id>.<pub-id pub-id-type="pmid">33571587</pub-id></mixed-citation></ref><ref id="ref197"><mixed-citation publication-type="journal" id="cit197"><name name-style="western"><surname>Howard</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Buttery</surname><given-names>L. D.</given-names></name>; <name name-style="western"><surname>Shakesheff</surname><given-names>K. M.</given-names></name>; <name name-style="western"><surname>Roberts</surname><given-names>S. J.</given-names></name><article-title>Tissue engineering: strategies, stem cells and scaffolds</article-title>. <source>Journal of anatomy</source><year>2008</year>, <volume>213</volume> (<issue>1</issue>), <fpage>66</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7580.2008.00878.x</pub-id>.<pub-id pub-id-type="pmid">18422523</pub-id><pub-id pub-id-type="pmcid">PMC2475566</pub-id></mixed-citation></ref><ref id="ref198"><mixed-citation publication-type="journal" id="cit198"><name name-style="western"><surname>Hasan</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Byambaa</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Morshed</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Cheikh</surname><given-names>M. I.</given-names></name>; <name name-style="western"><surname>Shakoor</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Mustafy</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Marei</surname><given-names>H. E.</given-names></name><article-title>Advances
in osteobiologic
materials for bone substitutes</article-title>. <source>Journal of Tissue
Engineering and Regenerative Medicine</source><year>2018</year>, <volume>12</volume> (<issue>6</issue>), <fpage>1448</fpage>&#8211;<lpage>1468</lpage>. <pub-id pub-id-type="doi">10.1002/term.2677</pub-id>.<pub-id pub-id-type="pmid">29701908</pub-id></mixed-citation></ref><ref id="ref199"><mixed-citation publication-type="journal" id="cit199"><name name-style="western"><surname>Oliveira</surname><given-names>&#201;. R.</given-names></name>; <name name-style="western"><surname>Nie</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Podstawczyk</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Allahbakhsh</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ratnayake</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Brasil</surname><given-names>D. L.</given-names></name>; <name name-style="western"><surname>Shavandi</surname><given-names>A.</given-names></name><article-title>Advances in
growth factor delivery for bone tissue engineering</article-title>. <source>International Journal of Molecular Sciences</source><year>2021</year>, <volume>22</volume> (<issue>2</issue>), <elocation-id>903</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22020903</pub-id>.<pub-id pub-id-type="pmid">33477502</pub-id><pub-id pub-id-type="pmcid">PMC7831065</pub-id></mixed-citation></ref><ref id="ref200"><mixed-citation publication-type="book" id="cit200"><person-group person-group-type="allauthors"><name name-style="western"><surname>Ana</surname><given-names>I. D.</given-names></name></person-group><article-title>Bone Substituting
Materials in Dental Implantology</article-title>. In <source>Bone
Management in Dental Implantology</source>; <publisher-name>Springer</publisher-name>, <year>2019</year>; pp <fpage>121</fpage>&#8211;<lpage>141</lpage>.</mixed-citation></ref><ref id="ref201"><mixed-citation publication-type="journal" id="cit201"><name name-style="western"><surname>Baino</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Novajra</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Vitale-Brovarone</surname><given-names>C.</given-names></name><article-title>Bioceramics
and scaffolds: a winning combination for tissue engineering</article-title>. <source>Frontiers in bioengineering and biotechnology</source><year>2015</year>, <volume>3</volume>, <elocation-id>202</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2015.00202</pub-id>.<pub-id pub-id-type="pmid">26734605</pub-id><pub-id pub-id-type="pmcid">PMC4681769</pub-id></mixed-citation></ref><ref id="ref202"><mixed-citation publication-type="journal" id="cit202"><name name-style="western"><surname>Saber-Samandari</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Saber-Samandari</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ghonjizade-Samani</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Aghazadeh</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Sadeghi</surname><given-names>A.</given-names></name><article-title>Bioactivity evaluation
of novel nanocomposite
scaffolds for bone tissue engineering: The impact of hydroxyapatite</article-title>. <source>Ceram. Int.</source><year>2016</year>, <volume>42</volume> (<issue>9</issue>), <fpage>11055</fpage>&#8211;<lpage>11062</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceramint.2016.04.002</pub-id>.</mixed-citation></ref><ref id="ref203"><mixed-citation publication-type="journal" id="cit203"><name name-style="western"><surname>Saber-Samandari</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Saber-Samandari</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Kiyazar</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Aghazadeh</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Sadeghi</surname><given-names>A.</given-names></name><article-title>In vitro evaluation
for apatite-forming ability of
cellulose-based nanocomposite scaffolds for bone tissue engineering</article-title>. <source>Int. J. Biol. Macromol.</source><year>2016</year>, <volume>86</volume>, <fpage>434</fpage>&#8211;<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2016.01.102</pub-id>.<pub-id pub-id-type="pmid">26836617</pub-id></mixed-citation></ref><ref id="ref204"><mixed-citation publication-type="journal" id="cit204"><name name-style="western"><surname>Hajiali</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ouyang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Llopis-Hernandez</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Dobre</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Rose</surname><given-names>F. R.</given-names></name><article-title>Review of emerging nanotechnology
in bone regeneration: progress, challenges, and perspectives</article-title>. <source>Nanoscale</source><year>2021</year>, <volume>13</volume> (<issue>23</issue>), <fpage>10266</fpage>&#8211;<lpage>10280</lpage>. <pub-id pub-id-type="doi">10.1039/D1NR01371H</pub-id>.<pub-id pub-id-type="pmid">34085085</pub-id></mixed-citation></ref><ref id="ref205"><mixed-citation publication-type="journal" id="cit205"><name name-style="western"><surname>Bharathi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Ganesh</surname><given-names>S. S.</given-names></name>; <name name-style="western"><surname>Harini</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Vatsala</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Anushikaa</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Aravind</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Abinaya</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Selvamurugan</surname><given-names>N.</given-names></name><article-title>Chitosan-based
scaffolds as drug delivery systems in bone tissue engineering</article-title>. <source>Int. J. Biol. Macromol.</source><year>2022</year>, <volume>222</volume>, <fpage>132</fpage>&#8211;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.09.058</pub-id>.<pub-id pub-id-type="pmid">36108752</pub-id></mixed-citation></ref><ref id="ref206"><mixed-citation publication-type="journal" id="cit206"><name name-style="western"><surname>Salave</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Rana</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Sharma</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bharathi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Khode</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Benival</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kommineni</surname><given-names>N.</given-names></name><article-title>Polysaccharide
Based Implantable Drug Delivery: Development Strategies, Regulatory
Requirements, and Future Perspectives</article-title>. <source>Polysaccharides</source><year>2022</year>, <volume>3</volume> (<issue>3</issue>), <fpage>625</fpage>&#8211;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.3390/polysaccharides3030037</pub-id>.</mixed-citation></ref><ref id="ref207"><mixed-citation publication-type="journal" id="cit207"><name name-style="western"><surname>Turnbull</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Clarke</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Picard</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Riches</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Jia</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Shu</surname><given-names>W.</given-names></name><article-title>3D bioactive composite
scaffolds for bone tissue engineering</article-title>. <source>Bioactive
materials</source><year>2018</year>, <volume>3</volume> (<issue>3</issue>), <fpage>278</fpage>&#8211;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioactmat.2017.10.001</pub-id>.<pub-id pub-id-type="pmid">29744467</pub-id><pub-id pub-id-type="pmcid">PMC5935790</pub-id></mixed-citation></ref><ref id="ref208"><mixed-citation publication-type="journal" id="cit208"><name name-style="western"><surname>King</surname><given-names>W. J.</given-names></name>; <name name-style="western"><surname>Krebsbach</surname><given-names>P. H.</given-names></name><article-title>Growth
factor delivery: how surface
interactions modulate release in vitro and in vivo</article-title>. <source>Advanced drug delivery reviews</source><year>2012</year>, <volume>64</volume> (<issue>12</issue>), <fpage>1239</fpage>&#8211;<lpage>1256</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2012.03.004</pub-id>.<pub-id pub-id-type="pmid">22433783</pub-id><pub-id pub-id-type="pmcid">PMC3586795</pub-id></mixed-citation></ref><ref id="ref209"><mixed-citation publication-type="journal" id="cit209"><name name-style="western"><surname>Enriquez-Ochoa</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Robles-Ovalle</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Mayolo-Deloisa</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Brunck</surname><given-names>M. E.</given-names></name><article-title>Immobilization of growth factors
for cell therapy manufacturing</article-title>. <source>Frontiers in
bioengineering and biotechnology</source><year>2020</year>, <volume>8</volume>, <elocation-id>00620</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2020.00620</pub-id>.<pub-id pub-id-type="pmcid">PMC7317031</pub-id><pub-id pub-id-type="pmid">32637403</pub-id></mixed-citation></ref><ref id="ref210"><mixed-citation publication-type="journal" id="cit210"><name name-style="western"><surname>Blackwood</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Bock</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Dargaville</surname><given-names>T. R.</given-names></name>; <name name-style="western"><surname>Ann Woodruff</surname><given-names>M.</given-names></name><article-title>Scaffolds for growth factor delivery as applied to
bone tissue engineering</article-title>. <source>International Journal
of Polymer Science</source><year>2012</year>, <volume>2012</volume>, <elocation-id>174942</elocation-id><pub-id pub-id-type="doi">10.1155/2012/174942</pub-id>.</mixed-citation></ref><ref id="ref211"><mixed-citation publication-type="journal" id="cit211"><name name-style="western"><surname>Herdiana</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wathoni</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Shamsuddin</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Muchtaridi</surname><given-names>M.</given-names></name><article-title>Drug release study of the chitosan-based nanoparticles</article-title>. <source>Heliyon</source><year>2022</year>, <volume>8</volume>, <elocation-id>e08674</elocation-id><pub-id pub-id-type="doi">10.1016/j.heliyon.2021.e08674</pub-id>.<pub-id pub-id-type="pmid">35028457</pub-id><pub-id pub-id-type="pmcid">PMC8741465</pub-id></mixed-citation></ref><ref id="ref212"><mixed-citation publication-type="journal" id="cit212"><name name-style="western"><surname>Filipowska</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Tomaszewski</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Nied&#378;wiedzki</surname><given-names>&#321;.</given-names></name>; <name name-style="western"><surname>Walocha</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Nied&#378;wiedzki</surname><given-names>T.</given-names></name><article-title>The role of vasculature in bone development,
regeneration and proper systemic functioning</article-title>. <source>Angiogenesis</source><year>2017</year>, <volume>20</volume> (<issue>3</issue>), <fpage>291</fpage>&#8211;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1007/s10456-017-9541-1</pub-id>.<pub-id pub-id-type="pmid">28194536</pub-id><pub-id pub-id-type="pmcid">PMC5511612</pub-id></mixed-citation></ref><ref id="ref213"><mixed-citation publication-type="journal" id="cit213"><name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Yan</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Jia</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name>; et al. <article-title>Osteoblasts secrete Cxcl9 to regulate angiogenesis
in bone</article-title>. <source>Nat. Commun.</source><year>2016</year>, <volume>7</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms13885</pub-id>.<pub-id pub-id-type="pmcid">PMC5171795</pub-id><pub-id pub-id-type="pmid">27966526</pub-id></mixed-citation></ref><ref id="ref214"><mixed-citation publication-type="journal" id="cit214"><name name-style="western"><surname>Brennan</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Davaine</surname><given-names>J.-M.</given-names></name>; <name name-style="western"><surname>Layrolle</surname><given-names>P.</given-names></name><article-title>Pre-vascularization
of bone tissue-engineered constructs</article-title>. <source>Stem cell
research &amp; therapy</source><year>2013</year>, <volume>4</volume> (<issue>4</issue>), <elocation-id>96</elocation-id><pub-id pub-id-type="doi">10.1186/scrt307</pub-id>.<pub-id pub-id-type="pmid">23953741</pub-id><pub-id pub-id-type="pmcid">PMC3856614</pub-id></mixed-citation></ref><ref id="ref215"><mixed-citation publication-type="journal" id="cit215"><name name-style="western"><surname>Ma</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>van den Beucken</surname><given-names>J. J.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Both</surname><given-names>S. K.</given-names></name>; <name name-style="western"><surname>Cui</surname><given-names>F.-Z.</given-names></name>; <name name-style="western"><surname>Pan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Jansen</surname><given-names>J. A.</given-names></name><article-title>Coculture of osteoblasts
and endothelial cells: optimization of culture medium and cell ratio</article-title>. <source>Tissue Engineering Part C: Methods</source><year>2011</year>, <volume>17</volume> (<issue>3</issue>), <fpage>349</fpage>&#8211;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tec.2010.0215</pub-id>.<pub-id pub-id-type="pmid">20932081</pub-id></mixed-citation></ref><ref id="ref216"><mixed-citation publication-type="journal" id="cit216"><name name-style="western"><surname>Ghiasi</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Vaziri</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Rodriguez</surname><given-names>E. K.</given-names></name>; <name name-style="western"><surname>Nazarian</surname><given-names>A.</given-names></name><article-title>Bone fracture healing in mechanobiological
modeling:
A review of principles and methods</article-title>. <source>Bone reports</source><year>2017</year>, <volume>6</volume>, <fpage>87</fpage>&#8211;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.bonr.2017.03.002</pub-id>.<pub-id pub-id-type="pmid">28377988</pub-id><pub-id pub-id-type="pmcid">PMC5365304</pub-id></mixed-citation></ref><ref id="ref217"><mixed-citation publication-type="journal" id="cit217"><name name-style="western"><surname>Mercado-Pag&#225;n</surname><given-names>&#193;. E.</given-names></name>; <name name-style="western"><surname>Stahl</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Shanjani</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><article-title>Vascularization in
bone tissue engineering constructs</article-title>. <source>Annals of
biomedical engineering</source><year>2015</year>, <volume>43</volume> (<issue>3</issue>), <fpage>718</fpage>&#8211;<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1007/s10439-015-1253-3</pub-id>.<pub-id pub-id-type="pmid">25616591</pub-id><pub-id pub-id-type="pmcid">PMC4979539</pub-id></mixed-citation></ref><ref id="ref218"><mixed-citation publication-type="journal" id="cit218"><name name-style="western"><surname>Unger</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>Dohle</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Kirkpatrick</surname><given-names>C. J.</given-names></name><article-title>Improving
vascularization of engineered bone through the generation of pro-angiogenic
effects in co-culture systems</article-title>. <source>Advanced drug
delivery reviews</source><year>2015</year>, <volume>94</volume>, <fpage>116</fpage>&#8211;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2015.03.012</pub-id>.<pub-id pub-id-type="pmid">25817732</pub-id></mixed-citation></ref><ref id="ref219"><mixed-citation publication-type="journal" id="cit219"><name name-style="western"><surname>Jin</surname><given-names>G.-Z.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>H.-W.</given-names></name><article-title>Co-culture of human dental pulp stem
cells and endothelial cells using porous biopolymer microcarriers:
a feasibility study for bone tissue engineering</article-title>. <source>Tissue engineering and regenerative medicine</source><year>2017</year>, <volume>14</volume> (<issue>4</issue>), <fpage>393</fpage>&#8211;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1007/s13770-017-0061-2</pub-id>.<pub-id pub-id-type="pmid">30603495</pub-id><pub-id pub-id-type="pmcid">PMC6171605</pub-id></mixed-citation></ref><ref id="ref220"><mixed-citation publication-type="journal" id="cit220"><name name-style="western"><surname>Tian</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Cai</surname><given-names>X.</given-names></name><article-title>Vascularization
in craniofacial bone tissue engineering</article-title>. <source>Journal
of dental research</source><year>2018</year>, <volume>97</volume> (<issue>9</issue>), <fpage>969</fpage>&#8211;<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1177/0022034518767120</pub-id>.<pub-id pub-id-type="pmid">29608865</pub-id></mixed-citation></ref><ref id="ref221"><mixed-citation publication-type="journal" id="cit221"><name name-style="western"><surname>Lafage-Proust</surname><given-names>M.-H.</given-names></name>; <name name-style="western"><surname>Roche</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Langer</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Cleret</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Bossche</surname><given-names>A. V.</given-names></name>; <name name-style="western"><surname>Olivier</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Vico</surname><given-names>L.</given-names></name><article-title>Assessment
of bone
vascularization and its role in bone remodeling</article-title>. <source>BoneKEy reports</source><year>2015</year>, <volume>4</volume>, <elocation-id>662</elocation-id><pub-id pub-id-type="doi">10.1038/bonekey.2015.29</pub-id>.<pub-id pub-id-type="pmid">25861447</pub-id><pub-id pub-id-type="pmcid">PMC4389660</pub-id></mixed-citation></ref><ref id="ref222"><mixed-citation publication-type="journal" id="cit222"><name name-style="western"><surname>Santos</surname><given-names>M. I.</given-names></name>; <name name-style="western"><surname>Unger</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>Sousa</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Reis</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Kirkpatrick</surname><given-names>C. J.</given-names></name><article-title>Crosstalk between osteoblasts and endothelial cells
co-cultured on a polycaprolactone&#8211;starch scaffold and the in
vitro development of vascularization</article-title>. <source>Biomaterials</source><year>2009</year>, <volume>30</volume> (<issue>26</issue>), <fpage>4407</fpage>&#8211;<lpage>4415</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2009.05.004</pub-id>.<pub-id pub-id-type="pmid">19487022</pub-id></mixed-citation></ref><ref id="ref223"><mixed-citation publication-type="journal" id="cit223"><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Cao</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Qu</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><article-title>An injectable
double-network hydrogel for the co-culture
of vascular endothelial cells and bone marrow mesenchymal stem cells
for simultaneously enhancing vascularization and osteogenesis</article-title>. <source>J. Mater. Chem. B</source><year>2018</year>, <volume>6</volume> (<issue>47</issue>), <fpage>7811</fpage>&#8211;<lpage>7821</lpage>. <pub-id pub-id-type="doi">10.1039/C8TB02244E</pub-id>.<pub-id pub-id-type="pmid">32255027</pub-id></mixed-citation></ref><ref id="ref224"><mixed-citation publication-type="journal" id="cit224"><name name-style="western"><surname>Rouwkema</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Gibbs</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Lutolf</surname><given-names>M. P.</given-names></name>; <name name-style="western"><surname>Martin</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Vunjak-Novakovic</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Malda</surname><given-names>J.</given-names></name><article-title>In vitro platforms
for tissue engineering:
implications for basic research and clinical translation</article-title>. <source>Journal of tissue engineering and regenerative medicine</source><year>2011</year>, <volume>5</volume> (<issue>8</issue>), <fpage>e164</fpage>&#8211;<lpage>e167</lpage>. <pub-id pub-id-type="doi">10.1002/term.414</pub-id>.<pub-id pub-id-type="pmid">21774080</pub-id><pub-id pub-id-type="pmcid">PMC3412051</pub-id></mixed-citation></ref><ref id="ref225"><mixed-citation publication-type="journal" id="cit225"><name name-style="western"><surname>Holstein</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Garcia</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Histing</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kristen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Scheuer</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Menger</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Pohlemann</surname><given-names>T.</given-names></name><article-title>Advances in
the establishment of defined mouse models for the study of fracture
healing and bone regeneration</article-title>. <source>Journal of orthopaedic
trauma</source><year>2009</year>, <volume>23</volume>, <fpage>S31</fpage>&#8211;<lpage>S38</lpage>. <pub-id pub-id-type="doi">10.1097/BOT.0b013e31819f27e5</pub-id>.<pub-id pub-id-type="pmid">19390374</pub-id></mixed-citation></ref><ref id="ref226"><mixed-citation publication-type="journal" id="cit226"><name name-style="western"><surname>Histing</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Garcia</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Holstein</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Klein</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Matthys</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Nuetzi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Steck</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Laschke</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wehner</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Bindl</surname><given-names>R.</given-names></name>; et al. <article-title>Small animal bone healing
models: standards, tips, and pitfalls results of a consensus meeting</article-title>. <source>Bone</source><year>2011</year>, <volume>49</volume> (<issue>4</issue>), <fpage>591</fpage>&#8211;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2011.07.007</pub-id>.<pub-id pub-id-type="pmid">21782988</pub-id></mixed-citation></ref><ref id="ref227"><mixed-citation publication-type="journal" id="cit227"><name name-style="western"><surname>Jahan</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Manickam</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Tabrizian</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Murshed</surname><given-names>M.</given-names></name><article-title>In vitro and in vivo investigation of osteogenic properties
of self-contained phosphate-releasing injectable purine-crosslinked
chitosan-hydroxyapatite constructs</article-title>. <source>Sci. Rep.</source><year>2020</year>, <volume>10</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-67886-7</pub-id>.<pub-id pub-id-type="pmid">32665560</pub-id><pub-id pub-id-type="pmcid">PMC7360623</pub-id></mixed-citation></ref><ref id="ref228"><mixed-citation publication-type="journal" id="cit228"><name name-style="western"><surname>Georgopoulou</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Papadogiannis</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Batsali</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Marakis</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Alpantaki</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Eliopoulos</surname><given-names>A. G.</given-names></name>; <name name-style="western"><surname>Pontikoglou</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chatzinikolaidou</surname><given-names>M.</given-names></name><article-title>Chitosan/gelatin
scaffolds support bone regeneration</article-title>. <source>J. Mater.
Sci.: Mater. Med.</source><year>2018</year>, <volume>29</volume> (<issue>5</issue>), <fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1007/s10856-018-6064-2</pub-id>.<pub-id pub-id-type="pmid">29730855</pub-id></mixed-citation></ref><ref id="ref229"><mixed-citation publication-type="journal" id="cit229"><name name-style="western"><surname>Kruck</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Zimmermann</surname><given-names>E. A.</given-names></name>; <name name-style="western"><surname>Damerow</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Figge</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Julien</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Wulsten</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Thiele</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Martin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Hamdy</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Reumann</surname><given-names>M. K.</given-names></name>; et al. <article-title>Sclerostin neutralizing
antibody treatment enhances bone formation but does not rescue mechanically
induced delayed healing</article-title>. <source>Journal of Bone and
Mineral Research</source><year>2018</year>, <volume>33</volume> (<issue>9</issue>), <fpage>1686</fpage>&#8211;<lpage>1697</lpage>. <pub-id pub-id-type="doi">10.1002/jbmr.3454</pub-id>.<pub-id pub-id-type="pmid">29694687</pub-id></mixed-citation></ref><ref id="ref230"><mixed-citation publication-type="journal" id="cit230"><name name-style="western"><surname>Luca</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Rougemont</surname><given-names>A. L.</given-names></name>; <name name-style="western"><surname>Walpoth</surname><given-names>B. H.</given-names></name>; <name name-style="western"><surname>Boure</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Tami</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Anderson</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Jordan</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Gurny</surname><given-names>R.</given-names></name><article-title>Injectable
rhBMP-2-loaded chitosan hydrogel composite: Osteoinduction at ectopic
site and in segmental long bone defect</article-title>. <source>J. Biomed.
Mater. Res., Part A</source><year>2011</year>, <volume>96</volume> (<issue>1</issue>), <fpage>66</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.32957</pub-id>.<pub-id pub-id-type="pmid">21105153</pub-id></mixed-citation></ref><ref id="ref231"><mixed-citation publication-type="journal" id="cit231"><name name-style="western"><surname>Saravanan</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Leena</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Selvamurugan</surname><given-names>N.</given-names></name><article-title>Chitosan based
biocomposite scaffolds for bone tissue engineering</article-title>. <source>Int. J. Biol. Macromol.</source><year>2016</year>, <volume>93</volume>, <fpage>1354</fpage>&#8211;<lpage>1365</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2016.01.112</pub-id>.<pub-id pub-id-type="pmid">26845481</pub-id></mixed-citation></ref><ref id="ref232"><mixed-citation publication-type="journal" id="cit232"><name name-style="western"><surname>Rouwkema</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Rivron</surname><given-names>N. C.</given-names></name>; <name name-style="western"><surname>van Blitterswijk</surname><given-names>C. A.</given-names></name><article-title>Vascularization
in tissue engineering</article-title>. <source>Trends Biotechnol.</source><year>2008</year>, <volume>26</volume> (<issue>8</issue>), <fpage>434</fpage>&#8211;<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2008.04.009</pub-id>.<pub-id pub-id-type="pmid">18585808</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>